≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other eating disorders

DOID EFO Endpoint Browser PheWeb

F5_EATOTH

eating disorder: A broad group of psychological disorders with abnormal eating behaviors leading to physiological effects from overeating or insufficient food intake.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F50
  • Hospital discharge: ICD-9 — 3075
  • Hospital discharge: excluded ICD-10 — F50.0, F50.1, F50.2, F50.3
  • Hospital discharge: excluded ICD-9 — 3075A
  • Cause of death: ICD-10 — F50
  • Cause of death: ICD-9 — 3075
  • Cause of death: excluded ICD-10 — F50.0, F50.1, F50.2, F50.3
  • Cause of death: excluded ICD-9 — 3075A

2 out of 7 registries used, show all original rules.

2388

4. Check minimum number of events

None

2388

5. Include endpoints

None

2388

6. Filter based on genotype QC (FinnGen only)

2275

Control definitions (FinnGen only)

Control exclude
F5_BEHAVE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F50-F59
Name in latin
Perturbationes edendi

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 19921 17070 2777
Only index persons 18958 16525 2433
Unadjusted period prevalence (%)
Whole population 0.43 0.49 0.08
Only index persons 0.54 0.61 0.09
Median age at first event (years)
Whole population 18.12 18.14 17.60
Only index persons 17.97 18.06 17.30

-FinnGen-

Key figures

All Female Male
Number of individuals 2275 2045 230
Unadjusted period prevalence (%) 0.66 0.73 0.11
Median age at first event (years) 23.92 23.02 31.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2388
Matched controls
23860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
8.2
321.3
484
720
F50.9
ICD-10 Finland
Eating disorder, unspecified
1260.4
307.7
1809
59
F50.8
ICD-10 Finland
Other eating disorders
431.4
307.7
680
22
N06AX11
ATC
mirtazapine; oral
5.2
307.7
1144
3561
F50.1
ICD-10 Finland
Atypical anorexia nervosa
389.5
307.7
470
15
N05AH03
ATC
olanzapine; systemic
8.0
307.7
502
768
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
8.2
307.7
586
908
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
9.5
307.7
706
1010
P86
ICPC
Anorexia nervosa/bulimia
64.5
307.7
249
43
F50.2
ICD-10 Finland
Bulimia nervosa
391.6
307.7
472
15
F50.3
ICD-10 Finland
Atypical bulimia nervosa
235.6
307.7
326
16
N05AX12
ATC
aripiprazole; systemic
8.3
307.7
483
710
F32.9
ICD-10 Finland
Depressive episode, unspecified
7.3
307.7
1109
2548
N06AB06
ATC
sertraline; oral
5.7
307.7
813
1983
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
8.6
307.7
508
725
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
15.3
307.7
296
218
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
9.1
307.7
506
686
N06AX16
ATC
venlafaxine; oral
6.3
307.7
873
1999
F50.0
ICD-10 Finland
Anorexia nervosa
2012.4
307.7
601
*
F51.0
ICD-10 Finland
Nonorganic insomnia
+∞
307.7
615
*
ZY010
NOMESCO Finland
Hospital outpatient
7.6
307.7
558
918
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
6.5
307.7
798
1718
N06AB03
ATC
fluoxetine; oral
13.2
307.7
1070
1379
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
10.4
307.7
518
617
N05AH04
ATC
quetiapine; oral
9.1
307.7
1222
2464
N05BA04
ATC
oxazepam; oral
5.3
307.7
1060
3104
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.7
307.7
906
2305
T36
ICD-10 Finland
Poisoning by systemic antibiotics
9.1
301.7
405
524
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
9.0
296.2
400
521
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
11.9
284.4
304
288
N03AX09
ATC
lamotrigine; oral
7.2
283.1
478
801
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
9.9
282.2
348
403
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
7.8
278.0
431
658
N06AX12
ATC
bupropion; oral
5.9
274.8
599
1288
IGY99
NOMESCO Finland
Other psychiatric treatment contact
8.7
256.5
352
465
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.4
252.0
913
2954
N05AX08
ATC
risperidone; systemic
6.8
235.9
409
699
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.8
231.2
485
997
Z2445
NOMESCO Finland
Psychologist
6.7
228.8
405
706
N06AB04
ATC
citalopram; systemic
4.5
223.4
711
2065
R4190
NOMESCO Finland
Nutritional therapy
7.1
211.9
346
553
F60.9
ICD-10 Finland
Personality disorder, unspecified
16.9
210.5
179
114
IGY02
NOMESCO Finland
Psychiatric monitoring contact
6.6
208.8
373
654
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
7.5
206.8
319
479
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
11.4
206.3
223
213
IER01
NOMESCO Finland
Psychoeducation, group
15.0
204.7
186
134
N05CF01
ATC
zopiclone; oral
4.2
204.6
718
2227
N06AB10
ATC
escitalopram; oral
3.7
201.5
1013
4006
E66.8
ICD-10 Finland
Other obesity
6.1
196.4
383
730
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
6.6
195.5
345
596
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.0
194.6
384
740
F50
ICD-10 Finland
Eating disorders
65.8
194.5
107
17
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
9.2
193.9
247
295
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
7.6
189.6
288
424
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.8
185.4
782
2733
N05AA02
ATC
levomepromazine; systemic
10.3
184.8
214
225
Z3226
NOMESCO Finland
Physiotherapist
4.1
180.9
631
1931
F61.0
ICD-10 Finland
Mixed personality disorders
12.6
180.2
181
154
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
7.6
178.9
270
394
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.3
175.2
321
574
N05AF03
ATC
chlorprothixene; systemic
11.3
174.8
189
180
Z2446
NOMESCO Finland
Social worker
5.3
174.3
399
876
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
8.7
169.1
225
283
N06AX05
ATC
trazodone; oral
13.7
168.5
160
124
F34.1
ICD-10 Finland
Dysthymia
7.0
168.4
273
430
P29
ICPC
Psychological sympt/compl other
3.9
168.2
635
2044
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
6.2
164.9
308
560
T05
ICPC
Feeding problem of adult
10.9
163.9
182
180
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.6
163.8
283
476
P76
ICPC
Depressive disorder
4.3
163.2
506
1413
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
5.7
162.1
329
647
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
9.8
162.0
194
213
N06AX26
ATC
vortioxetine; oral
4.4
161.8
481
1301
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
11.4
161.7
173
162
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.8
160.5
323
630
Z3231
NOMESCO Finland
Registered nurse
3.3
158.8
875
3569
N05AN01
ATC
lithium; oral
8.8
154.6
202
248
N06AX03
ATC
mianserin; oral
10.1
154.0
180
191
IBZ05
NOMESCO Finland
Evaluation of patient with eating disorder
390.7
148.7
148
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
7.5
148.6
224
325
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
16.1
146.9
127
83
C07AA05
ATC
propranolol; systemic
3.2
144.8
795
3208
N03AG01
ATC
valproic acid; systemic, rectal
5.7
144.6
294
577
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
8.3
141.2
193
250
N05BA01
ATC
diazepam; systemic, rectal
4.4
139.8
395
1021
ZYC01
NOMESCO Finland
Remote contact by phone
4.9
136.0
335
776
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.9
135.4
476
1441
N05BA06
ATC
lorazepam; systemic, sublingual
7.6
133.8
198
281
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
7.3
133.5
205
303
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.3
133.5
648
2415
N05BE01
ATC
buspirone; oral
9.3
133.1
165
189
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
5.5
132.2
275
550
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
5.1
131.9
301
653
N06AX21
ATC
duloxetine; oral
4.0
131.6
439
1280
F93.89
ICD-10 Finland
Other childhood emotional disorders
8.1
130.5
182
241
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.4
130.2
277
565
F43.1
ICD-10 Finland
Post-traumatic stress disorder
5.3
130.0
286
601
AA400
NOMESCO Finland
Electroconvulsive therapy
19.3
129.5
102
55
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
6.0
129.4
242
438
RD210, ,
NOMESCO Finland
8.3
128.6
175
225
N91.1
ICD-10 Finland
Secondary amenorrhoea
5.5
127.8
266
532
N06AX22
ATC
agomelatine; oral
7.8
126.0
182
251
N03AX16
ATC
[U] pregabalin
3.5
125.2
527
1791
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
8.5
125.1
166
207
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
11.0
123.2
134
128
N05CF02
ATC
zolpidem; oral
3.7
122.6
449
1392
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
9.8
121.9
145
157
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
5.5
120.8
248
489
F50.4
ICD-10 Finland
Overeating associated with other psychological disturbances
320.7
120.4
121
*
N05AB03
ATC
perphenazine; systemic, rectal
8.1
119.8
166
218
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.6
117.8
239
466
P74
ICPC
Anxiety disorder/anxiety state
3.9
117.3
401
1184
N06AB05
ATC
paroxetine; oral
5.3
115.9
248
507
R63.0
ICD-10 Finland
Anorexia
32.2
115.7
75
24
P03
ICPC
Feeling depressed
3.0
115.5
704
2961
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
5.8
114.2
219
405
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
4.0
113.2
363
1023
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
6.6
110.6
186
302
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
7.1
108.5
169
253
F31.8
ICD-10 Finland
Other bipolar affective disorders
6.8
107.8
176
277
P01
ICPC
Feeling anxious/nervous/tense
2.6
107.7
953
4823
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
17.0
107.5
90
55
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.5
107.1
183
302
ZY000
NOMESCO Finland
Hospital inpatient
8.6
106.6
140
172
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
106.4
627
2575
SPAT1240
SPAT
Therapeutic discussion
2.9
101.4
619
2583
N05CD07
ATC
temazepam; oral
6.0
101.4
186
329
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
13.1
100.3
97
77
R4140
NOMESCO Finland
Psychotherapy
13.1
98.5
95
75
P06
ICPC
Sleep disturbance
3.2
95.9
447
1598
P99
ICPC
Psychological disorders other
4.8
95.4
231
523
N05AH02
ATC
clozapine; systemic
7.5
94.1
139
196
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
9.6
93.6
112
122
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
8.7
93.0
120
144
F50.5
ICD-10 Finland
Vomiting associated with other psychological disturbances
475.4
92.9
92
*
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
7.0
91.7
143
214
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.9
89.4
499
1971
F33
ICD-10 Finland
Recurrent depressive disorder
5.2
88.6
193
399
X78
ICD-10 Finland
Intentional self-harm by sharp object
9.8
87.9
103
109
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
8.2
87.6
119
152
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
9.1
87.2
108
123
F33.8
ICD-10 Finland
Other recurrent depressive disorders
10.0
86.4
100
104
F32.1
ICD-10 Finland
Moderate depressive episode
3.3
85.6
369
1253
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
6.9
84.9
135
206
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.2
84.9
241
617
E66.01
ICD-10 Finland
Obesity due to excess calories
3.0
84.6
446
1703
F99
ICD-10 Finland
Mental disorder, not otherwise specified
5.9
84.0
157
282
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
7.0
82.7
130
196
ZXY60
NOMESCO Finland
2-person team, nurses
11.5
82.3
86
77
Z2221
NOMESCO Finland
Medical doctor
2.4
82.3
803
4150
G47.3
ICD-10 Finland
Sleep apnoea
3.0
82.0
423
1593
F32
ICD-10 Finland
Depressive episode
3.6
80.1
296
910
F40.1
ICD-10 Finland
Social phobias
4.1
79.9
235
617
N03AX11
ATC
topiramate; oral
5.4
78.7
163
322
T08
ICPC
Weight loss
7.3
78.2
117
167
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
12.2
77.4
78
66
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
10.6
76.7
85
83
T82
ICPC
Obesity
4.0
76.3
233
628
SPAT1307
SPAT
Psychosocial counselling and guidance
2.7
76.1
498
2122
R63.4
ICD-10 Finland
Abnormal weight loss
6.1
76.0
136
234
K03.21
ICD-10 Finland
Erosion of teeth due to: persistent vomiting
34.9
75.7
48
14
F39
ICD-10 Finland
Unspecified mood [affective] disorder
5.3
75.5
157
311
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
9.4
75.4
91
100
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
9.4
75.4
91
100
N06AG02
ATC
moclobemide; oral
7.0
74.9
117
175
F60.5
ICD-10 Finland
Anankastic personality disorder
8.5
74.6
98
120
IGV01
NOMESCO Finland
Psychiatric network contact
6.3
74.3
128
212
E87.6
ICD-10 Finland
Hypokalaemia
7.3
72.6
108
153
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.9
72.4
230
637
N03AE01
ATC
clonazepam; systemic
5.1
72.3
157
323
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.0
71.8
352
1283
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
9.9
70.9
82
85
N07BB01
ATC
disulfiram; oral
5.9
70.7
131
233
IEY01
NOMESCO Finland
Psychoeducation, individual
7.8
70.7
99
131
Z3229
NOMESCO Finland
Other healthcare associate professional
3.7
69.9
238
691
R4110
NOMESCO Finland
Physiotherapy
2.4
69.1
628
3109
E66.9
ICD-10 Finland
Obesity, unspecified
4.2
68.8
195
497
E66.00
ICD-10 Finland
Metabolic syndrome
4.7
68.6
168
382
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
68.5
1160
7367
RF220, ,
NOMESCO Finland
11.2
66.9
71
65
P11
ICPC
Eating problem in child
19.6
66.8
52
27
ICB06, ,
NOMESCO Finland
7.1
65.4
100
146
N06AA12
ATC
doxepin; systemic
6.6
65.0
107
169
A02BC02
ATC
pantoprazole; systemic
2.1
64.3
1351
9217
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
6.4
64.0
108
175
IDR02
NOMESCO Finland
Systematic group therapy, cognitive
26.3
63.5
44
17
F31
ICD-10 Finland
Bipolar affective disorder
7.3
62.0
92
130
SPAT1139
SPAT
Nutrition survey
5.0
61.9
138
290
N06BA04
ATC
methylphenidate; oral
3.0
61.7
305
1112
X84
ICD-10 Finland
Intentional self-harm by unspecified means
14.8
61.4
55
38
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
10.7
61.3
67
64
E66
ICD-10 Finland
Obesity
3.4
61.1
240
763
N02AX02
ATC
tramadol; systemic, rectal
2.2
61.1
752
4188
AA1AD
NOMESCO Finland
CT of head and brain
2.5
61.0
439
1943
N05BA12
ATC
alprazolam; oral
3.4
60.9
237
749
IBA03
NOMESCO Finland
Psychotherapy evaluation
6.1
60.8
107
181
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
14.0
60.5
56
41
IEV99
NOMESCO Finland
Other psychiatric network intervention
7.3
60.3
90
128
R53
ICD-10 Finland
Malaise and fatigue
2.1
60.0
764
4305
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
12.3
59.1
59
49
A06AC01
ATC
ispaghula (psylla seeds); oral
2.4
59.1
508
2434
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
58.9
302
1123
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
58.6
804
4652
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
6.6
58.5
96
151
N06AA06
ATC
trimipramine; systemic
9.1
57.7
71
80
R5599
NOMESCO Finland
Other rehabilitation service
5.3
57.2
117
228
N06AX18
ATC
reboxetine; oral
14.9
57.1
51
35
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
7.3
56.0
83
117
N06AB08
ATC
fluvoxamine; oral
7.3
56.0
83
117
F41.3
ICD-10 Finland
Other mixed anxiety disorders
4.4
55.0
145
349
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
8.4
54.8
72
88
A04
ICPC
Weakness/tiredness general
2.2
54.4
605
3216
Z50.4
ICD-10 Finland
Psychotherapy, not elsewhere classified
12.2
54.0
54
45
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
11.4
53.6
56
50
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
7.1
53.5
81
117
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.1
53.2
248
872
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.7
52.9
178
511
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
11.5
52.7
55
49
G47.0
ICD-10 Finland
Disorders of initiating and maintaining sleep [insomnias]
+∞
52.3
50
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.9
51.8
159
428
M79.6
ICD-10 Finland
Pain in limb
1.9
51.1
1048
6901
R02
ICPC
Shortness of breath/dyspnoea
2.5
51.0
359
1563
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.2
50.8
218
730
Z72.8
ICD-10 Finland
Other problems related to lifestyle
10.0
50.8
58
59
R11
ICD-10 Finland
Nausea and vomiting
2.6
50.8
339
1439
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
12.8
50.4
49
39
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.8
50.1
279
1080
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
7.7
50.1
71
95
R51.80
ICD-10 Finland
Headache
2.1
50.1
591
3200
P80
ICPC
Personality disorder
11.8
49.9
51
44
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
49.7
914
5793
L17
ICPC
Foot/toe symptom/complaint
2.0
49.6
799
4839
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
11.0
49.5
53
49
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
14.3
49.4
45
32
G03DB01
ATC
dydrogesterone; oral
2.4
49.2
398
1845
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
4.5
49.1
123
284
N05AE04
ATC
ziprasidone; systemic
8.1
49.1
66
83
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
9.2
49.0
60
67
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
48.8
477
2396
Z71.8
ICD-10 Finland
Other specified counselling
1.9
48.6
1100
7442
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
10.4
48.5
54
53
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
7.8
48.1
67
88
K59.09
ICD-10 Finland
Constipation, unspecified
3.7
47.9
158
447
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
7.9
47.7
66
86
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.4
47.6
183
572
IDY04
NOMESCO Finland
Systematic individual therapy, dialectical behaviour therapy (DBT)
14.0
47.6
44
32
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
9.0
47.6
59
67
H03AA01
ATC
levothyroxine sodium; systemic
2.1
47.3
549
2947
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.6
46.8
313
1327
F60.8
ICD-10 Finland
Other specific personality disorders
8.4
46.7
61
74
N05AD01
ATC
haloperidol; systemic
5.9
46.5
85
149
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
6.2
46.1
79
130
F32.8
ICD-10 Finland
Other depressive episodes
4.8
46.0
105
225
S51.7
ICD-10 Finland
Multiple open wounds of forearm
10.4
45.8
51
50
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.9
45.7
103
218
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
6.0
45.6
81
138
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.3
45.5
186
604
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.9
45.1
790
4892
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
5.5
45.0
89
168
P15
ICPC
Chronic alcohol abuse
5.3
45.0
92
179
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.6
45.0
284
1170
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.0
44.9
217
777
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
5.9
44.6
81
141
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
6.1
44.6
78
131
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.9
43.8
218
793
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
12.1
43.7
44
37
E66.0
ICD-10 Finland
Obesity due to excess calories
10.0
43.7
50
51
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
43.6
673
3985
A10BJ02
ATC
liraglutide; parenteral
5.4
43.2
87
167
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.9
43.0
212
767
ZXY49
NOMESCO Finland
Other health care provider
8.6
43.0
55
65
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.4
42.9
345
1589
A06AD11
ATC
lactulose; oral
2.8
42.7
232
884
N05AX16
ATC
brexpiprazole; oral
12.5
42.7
42
34
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
6.7
42.6
68
104
103
Kela drug reimbursment
Diabetes, insulin-treated
2.3
42.5
354
1655
R06.0
ICD-10 Finland
Dyspnoea
2.1
42.4
531
2918
K59.0
ICD-10 Finland
Constipation
3.3
42.3
171
551
D01
ICPC
Abdominal pain/cramps general
2.0
42.2
534
2946
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
8.4
42.0
55
67
R42
ICD-10 Finland
Dizziness and giddiness
2.1
41.7
465
2446
F20.9
ICD-10 Finland
Schizophrenia, unspecified
5.2
41.6
86
169
F10.20
ICD-10 Finland
Alcohol dependence currently independent
7.1
41.6
63
91
F41.00
ICD-10 Finland
Moderate panic disorder
4.2
41.5
112
274
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
41.3
638
3768
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
7.7
41.2
58
77
N04AA02
ATC
biperiden; systemic
6.2
40.9
70
115
R5140
NOMESCO Finland
Monitoring the use of the aid
3.1
40.5
178
603
SPAT1234
SPAT
Support of social functional capacity
4.0
40.4
118
306
IGP01
NOMESCO Finland
Psychiatric family contact
4.5
40.4
101
233
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
40.2
372
1816
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
10.0
40.1
46
47
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.1
40.0
175
591
F60.0
ICD-10 Finland
Paranoid personality disorder
15.4
40.0
35
23
N06AA04
ATC
clomipramine; systemic
7.3
39.9
59
83
C03CA01
ATC
furosemide; systemic
2.6
39.6
250
1027
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
5.7
39.6
75
136
C07AB07
ATC
bisoprolol; oral
2.0
39.5
562
3221
N06AA09
ATC
amitriptyline; systemic
3.5
39.5
140
415
IEY03
NOMESCO Finland
Vocational rehabilitation
10.7
39.3
43
41
Z91.5
ICD-10 Finland
Personal history of self-harm
10.7
39.3
43
41
ZYA02
NOMESCO Finland
Contact at day ward in specialised medical care or in other intensive outpatient care setting
13.4
39.1
37
28
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
39.1
581
3379
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
38.7
232
929
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.3
38.6
153
487
R55
ICD-10 Finland
Syncope and collapse
2.7
38.5
228
908
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.7
38.3
216
838
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
8.3
38.1
50
61
L28
ICPC
Limited function/disability (L)
2.4
38.1
292
1313
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.8
38.0
121
334
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
38.0
476
2606
N06AX17
ATC
milnacipran; oral
10.4
37.8
42
41
N05AX15
ATC
cariprazine; oral
9.2
37.8
46
51
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
6.0
37.4
67
115
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
37.3
959
6587
F84.5
ICD-10 Finland
Asperger syndrome
5.4
37.0
74
141
E86
ICD-10 Finland
Volume depletion
7.9
37.0
51
66
S18
ICPC
Laceration/cut
1.8
37.0
909
6162
A28
ICPC
Limited function/disability NOS
2.8
36.7
192
716
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.8
36.5
115
315
Z01.7
ICD-10 Finland
Laboratory examination
2.0
36.4
456
2491
N05AE05
ATC
lurasidone; oral
8.3
36.3
48
59
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.8
36.3
191
715
P18
ICPC
Medication abuse
9.1
36.0
44
49
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.3
35.9
140
441
A02BC05
ATC
esomeprazole; systemic
1.8
35.8
717
4565
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.3
35.8
317
1514
3075B
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Other and unspecified disorders of eating[AHMIMISHÄIRIÖ]
+∞
35.5
34
*
J01FF01
ATC
clindamycin; systemic
1.9
35.4
549
3224
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.3
35.4
141
450
A10BA02
ATC
metformin; oral
2.1
35.3
396
2076
T90
ICPC
Diabetes non-insulin dependent
2.4
35.2
269
1207
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
7.7
34.8
49
65
N03AX12
ATC
[U] gabapentin; oral
2.3
34.6
277
1268
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
7.7
34.4
48
63
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
11.8
34.3
35
30
R50.9
ICD-10 Finland
Fever, unspecified
2.0
34.1
425
2313
N02BF02
ATC
pregabalin; oral
2.9
34.1
164
584
SPAT1243
SPAT
Psychiatric/psychological examination
2.9
34.1
169
612
WX892
NOMESCO Finland
Monitored bed care
3.0
33.9
154
531
A10BJ06
ATC
semaglutide; parenteral
3.7
33.6
110
309
RS214, ,
NOMESCO Finland
11.9
33.4
34
29
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
33.2
402
2164
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
33.2
419
2290
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
12.9
33.2
32
25
RD112, ,
NOMESCO Finland
12.9
33.2
32
25
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
32.8
471
2689
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
32.8
421
2313
F33.0
ICD-10 Finland
Recurrent depressive disorder, current episode mild
4.9
32.8
73
153
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
7.5
32.7
47
64
IDY02
NOMESCO Finland
Systematic individual therapy, cognitive
10.4
32.5
36
35
A01
ICPC
Pain general/multiple sites
2.4
32.4
247
1105
S06.0
ICD-10 Finland
Concussion
2.1
32.1
324
1629
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.6
32.0
108
310
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
31.9
830
5661
R4120
NOMESCO Finland
Occupational therapy
2.9
31.8
160
584
F51
ICD-10 Finland
Nonorganic sleep disorders
3.1
31.8
139
469
N05AF01
ATC
flupentixol; systemic
8.5
31.7
41
49
A02BC01
ATC
omeprazole; systemic
1.8
31.7
544
3287
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
3.1
31.6
137
460
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.8
31.6
97
261
OAB74, ,
SPAT
5.7
31.3
58
103
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.9
31.3
158
578
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
31.2
166
624
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
8.2
30.7
41
51
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.5
30.4
75
171
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
30.4
430
2438
M79.7
ICD-10 Finland
Fibromyalgia
3.3
30.4
120
381
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
30.1
481
2836
IFB02
NOMESCO Finland
Transcranial magnetic stimulation (TMS)
9.3
30.0
36
39
A46
ICD-10 Finland
Erysipelas
2.5
30.0
192
792
N05AA01
ATC
chlorpromazine; systemic, rectal
7.8
29.8
41
53
ZXE00
NOMESCO Finland
One hour or less
1.7
29.6
879
6180
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
5.3
29.6
60
116
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
6.8
29.3
46
69
3071A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Anorexia nervosa
+∞
29.2
28
*
N17
ICPC
Vertigo/dizziness
2.1
29.1
312
1602
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
8.9
28.9
36
41
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
7.8
28.9
40
52
WX002
NOMESCO Finland
Sedation and analgesia
2.1
28.9
302
1536
A29
ICPC
General symptom/complaint other
2.1
28.7
303
1546
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
28.7
458
2696
160
Kela drug reimbursment
exenatide
6.6
28.5
46
71
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
28.5
546
3396
F21
ICD-10 Finland
Schizotypal disorder
7.9
28.5
39
50
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
7.7
28.4
40
53
G44.2
ICD-10 Finland
Tension-type headache
1.9
28.4
411
2342
P72
ICPC
Schizophrenia
4.5
28.3
70
160
M54.5
ICD-10 Finland
Low back pain
1.7
28.3
855
6020
K59.1
ICD-10 Finland
Functional diarrhoea
2.7
28.2
154
587
F41
ICD-10 Finland
Other anxiety disorders
3.4
28.1
103
312
D64.9
ICD-10 Finland
Anaemia, unspecified
2.8
28.1
146
542
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
4.8
28.1
64
137
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
28.0
457
2706
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
6.9
28.0
43
63
S97
ICPC
Chronic ulcer skin
3.8
27.9
86
232
SPAT1389
SPAT
Visit based on need for special support
2.3
27.9
219
991
L03
ICPC
Low back symptom/complaint
1.7
27.8
768
5279
D11
ICPC
Diarrhoea
1.9
27.8
430
2504
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
27.7
142
523
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
27.7
785
5431
IBZ99
NOMESCO Finland
Other behavioural observation
146.6
27.7
29
*
A97
ICPC
No disease
1.7
27.7
592
3798
IDY99
NOMESCO Finland
Other individual psychotherapy intervention
7.9
27.6
38
49
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
27.6
1206
9276
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
27.5
221
1010
IEP99
NOMESCO Finland
Other psychiatric family intervention
5.3
27.5
55
105
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
7.5
27.1
39
53
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
9.5
27.1
32
34
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
26.9
690
4643
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
10.9
26.9
29
27
F33.01
ICD-10 Finland
Recurrent depression, mild episode of somatic syndrome
9.0
26.8
33
37
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.6
26.8
1312
10338
RS210, ,
NOMESCO Finland
9.8
26.8
31
32
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
26.7
467
2821
F10.24
ICD-10 Finland
Alcohol depence active use
6.3
26.6
45
73
A10BH01
ATC
sitagliptin; oral
3.3
26.6
100
308
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
26.5
379
2148
S29
ICPC
Skin symptom/complaint other
1.8
26.3
501
3102
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
5.6
26.3
50
91
N05AL01
ATC
sulpiride; systemic
7.4
26.3
38
52
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
4.9
26.2
58
121
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
4.5
26.2
64
145
IEY15
NOMESCO Finland
Acute psychiatry, stabilising intervention
8.1
26.0
35
44
ICA04
NOMESCO Finland
Psychiatric treatment plan, psychotherapy supported by Social Insurance Institution
6.6
26.0
42
65
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
7.3
25.9
38
53
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
2.8
25.8
133
491
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.7
25.8
141
537
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
4.4
25.8
64
147
D12
ICPC
Constipation
3.3
25.7
97
299
S51.8
ICD-10 Finland
Open wound of other parts of forearm
5.3
25.6
51
97
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.7
25.6
146
569
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
25.6
125
449
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
25.5
203
923
UJF32
NOMESCO Finland
Coloscopy
1.9
25.4
346
1928
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
25.3
327
1791
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
4.8
25.3
57
121
G43.9
ICD-10 Finland
Migraine, unspecified
2.0
25.2
289
1517
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.5
25.2
41
64
N04BC05
ATC
pramipexole; oral
3.2
25.2
102
329
N02BE01
ATC
paracetamol; systemic, rectal
1.8
25.0
1965
17251
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
24.5
151
611
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
24.4
192
868
D09
ICPC
Nausea
2.1
24.4
263
1350
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.7
24.3
529
3394
ZYY01
NOMESCO Finland
Contact between professionals
5.7
24.3
45
80
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
24.2
798
5690
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
24.2
1151
8928
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
7.1
24.2
36
51
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
24.2
212
1004
N30.0
ICD-10 Finland
Acute cystitis
1.7
24.1
525
3366
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
9.7
24.1
28
29
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.8
24.1
121
441
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
4.1
24.1
67
168
M79.1
ICD-10 Finland
Myalgia
1.8
23.9
425
2572
U04
ICPC
Incontinence urine
3.2
23.9
96
308
F45.8
ICD-10 Finland
Other somatoform disorders
2.0
23.9
295
1589
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
7.8
23.8
33
43
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
23.8
377
2204
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.0
23.7
51
104
N05BA02
ATC
chlordiazepoxide; systemic
6.2
23.6
40
65
SFA30
NOMESCO Finland
Three-surface restoration
1.6
23.6
797
5708
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
23.5
427
2599
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
23.5
982
7385
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
4.2
23.4
63
154
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
7.9
23.4
32
41
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
23.3
872
6389
A11
ICPC
Chest pain NOS
2.5
23.3
146
596
M25.5
ICD-10 Finland
Pain in joint
1.6
23.2
735
5178
B03BA03
ATC
hydroxocobalamin; parenteral
3.5
23.2
80
233
XCK10
NOMESCO Finland
Photography of fundus of eye
2.6
23.2
141
567
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
6.4
23.1
38
60
G47.9
ICD-10 Finland
Sleep disorder, unspecified
3.4
23.0
83
249
IGY02, ,
SPAT
3.6
22.9
75
211
J45
ICD-10 Finland
Asthma
2.0
22.8
257
1338
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
6.2
22.8
39
64
R52.2
ICD-10 Finland
Other chronic pain
3.2
22.8
92
296
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
22.8
919
6843
B01AB05
ATC
enoxaparin; parenteral
1.7
22.7
467
2943
Z02.7
ICD-10 Finland
Issue of medical certificate
2.2
22.7
196
922
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.9
22.7
107
377
R33
ICD-10 Finland
Retention of urine
3.2
22.5
88
278
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
22.4
469
2968
F61
ICD-10 Finland
Mixed and other personality disorders
8.8
22.4
28
32
R00.2
ICD-10 Finland
Palpitations
2.1
22.3
236
1201
K62.3
ICD-10 Finland
Rectal prolapse
8.4
22.2
29
35
JDF01
NOMESCO Finland
Laparoscopic gastroplasty
8.0
22.1
30
38
T91
ICPC
Vitamin/nutritional deficiency
6.7
22.1
35
53
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
9.1
22.1
27
30
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
22.0
1939
17127
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.4
21.8
150
639
SPAT1241
SPAT
Extensive assessment of psychosocial situation
3.5
21.8
77
228
T74.1
ICD-10 Finland
Physical abuse
3.3
21.6
81
249
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
4.7
21.5
49
105
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
21.5
193
922
G04BD12
ATC
mirabegron; oral
2.6
21.5
123
480
R4110, ,
SPAT
2.0
21.5
235
1211
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
21.4
266
1434
R06AE07
ATC
cetirizine; oral
1.5
21.3
1131
8894
SGC00
NOMESCO Finland
Medication, disinfection of root canals
1.9
21.3
286
1583
X58
ICD-10 Finland
Exposure to other specified factors
1.8
21.2
385
2337
IFA37
NOMESCO Finland
Ketamine treatment
20.9
21.2
31
15
ZXY03
NOMESCO Finland
Occupational therapist
7.3
21.2
31
43
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.7
21.2
414
2568
R03BA02
ATC
budesonide; inhalant
1.7
21.2
416
2584
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
21.1
202
989
IHZ05, ,
SPAT
1.9
21.1
281
1550
A10AE04
ATC
insulin glargine; parenteral
2.3
21.0
163
732
L13
ICPC
Hip symptom/complaint
1.9
21.0
294
1648
RS140, ,
NOMESCO Finland
8.5
21.0
27
32
R96
ICPC
Asthma
2.0
21.0
230
1185
TKC20
NOMESCO Finland
Catheterisation of bladder
3.0
20.9
96
333
P28
ICPC
Limited function/disability (P)
5.1
20.9
44
88
H53.1
ICD-10 Finland
Subjective visual disturbances
2.3
20.8
163
736
F10.25
ICD-10 Finland
Alcohol dependence continuous use
6.1
20.7
36
60
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.8
20.7
368
2219
N02BF01
ATC
gabapentin; oral
2.2
20.7
183
868
P01AB01
ATC
metronidazole; oral, rectal
1.5
20.7
840
6227
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
2.5
20.6
131
538
A02BC03
ATC
lansoprazole; oral
1.8
20.6
358
2146
P16
ICPC
Acute alcohol abuse
4.5
20.6
50
113
P27
ICPC
Fear of mental disorder
3.4
20.5
74
222
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.3
20.5
79
247
WX722
NOMESCO Finland
PEEP
3.7
20.5
65
179
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.9
20.5
299
1698
L15
ICPC
Knee symptom/complaint
1.6
20.5
546
3672
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
4.0
20.5
59
152
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.0
20.4
251
1347
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
20.4
275
1523
ZYD01
NOMESCO Finland
Emergency clinic
7.5
20.4
29
39
F28
ICD-10 Finland
Other nonorganic psychotic disorders
7.5
20.4
29
39
F51.2
ICD-10 Finland
Nonorganic disorder of the sleep-wake schedule
7.0
20.4
31
45
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
20.1
244
1304
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
2.9
20.1
94
330
M35.7
ICD-10 Finland
Hypermobility syndrome
3.2
20.0
79
251
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
6.6
20.0
32
49
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
5.4
19.9
39
73
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
7.0
19.9
30
43
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
19.9
142
615
Z63.0
ICD-10 Finland
Problems in relationship with spouse or partner
5.7
19.9
37
66
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
19.9
1859
16373
S76
ICPC
Skin infection other
2.6
19.8
119
476
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
4.1
19.8
55
138
L29
ICPC
Musculoskeletal sympt/complt other
2.0
19.7
216
1113
Z71.9
ICD-10 Finland
Counselling, unspecified
2.0
19.7
211
1078
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
5.3
19.7
39
74
J01DB01
ATC
cefalexin; oral
1.6
19.6
1933
17203
L12
ICPC
Hand/finger symptom/complaint
1.6
19.6
482
3171
K03.22
ICD-10 Finland
Erosion of teeth due to: diet
3.5
19.6
68
199
ZXD35
NOMESCO Finland
Usual procedure
3.7
19.6
61
166
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
201.4
19.6
20
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.0
19.5
237
1267
K04.1
ICD-10 Finland
Necrosis of pulp
1.9
19.4
266
1479
ZYC02
NOMESCO Finland
Remote contact by video link
6.2
19.4
33
54
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
4.0
19.3
54
136
Z00.0
ICD-10 Finland
General medical examination
1.6
19.3
492
3268
M01AB05
ATC
diclofenac; systemic, rectal
1.5
19.2
1159
9283
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.0
19.2
55
141
J01MA12
ATC
levofloxacin; systemic
1.9
19.2
242
1310
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
7.0
19.1
29
42
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.2
19.1
50
120
C09CA06
ATC
candesartan; oral
1.7
19.0
361
2215
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
2.0
19.0
228
1212
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
6.1
19.0
33
55
IAZ99
NOMESCO Finland
Other psychiatric consultation
5.7
19.0
35
62
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.8
18.9
95
347
B82
ICPC
Anaemia other/unspecified
3.4
18.8
66
195
X23
ICPC
Fear sexually transm dis female
1.7
18.7
420
2696
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.9
18.7
86
299
N91.0
ICD-10 Finland
Primary amenorrhoea
6.0
18.7
33
56
B18.2
ICD-10 Finland
Chronic viral hepatitis C
4.8
18.7
42
89
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
18.7
293
1700
R52.9
ICD-10 Finland
Pain, unspecified
2.0
18.6
231
1242
M03BX02
ATC
tizanidine; oral
1.5
18.6
1181
9531
A10BK03
ATC
empagliflozin; oral
2.6
18.6
113
454
SPAT1254
SPAT
Administration of medicine
1.7
18.6
424
2733
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
6.1
18.6
32
53
F32.0
ICD-10 Finland
Mild depressive episode
2.5
18.5
113
456
Z25
ICPC
Assault/harmful event problem
3.7
18.4
59
164
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.8
18.4
319
1907
R03AC03
ATC
terbutaline; inhalant
1.8
18.4
297
1739
C03DA01
ATC
spironolactone; oral
2.3
18.3
140
625
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
6.7
18.3
29
44
XA820, ,
NOMESCO Finland
7.9
18.3
25
32
SPAT1310
SPAT
Counselling related to known health issue
1.5
18.3
825
6217
Z08
ICPC
Social welfare problem
4.4
18.3
46
107
R60.0
ICD-10 Finland
Localized oedema
2.1
18.3
180
891
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
18.3
481
3215
WX402
NOMESCO Finland
General anaesthesia
1.6
18.3
487
3265
K04
ICPC
Palpitations/awareness of heart
2.3
18.2
140
627
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.0
18.2
194
989
RT230, ,
NOMESCO Finland
19.5
18.2
27
14
R03AC02
ATC
salbutamol; inhalant
1.5
18.2
1286
10581
F41.01
ICD-10 Finland
Severe panic disorder
4.4
18.0
45
104
SFA10
NOMESCO Finland
One-surface restoration
1.5
18.0
1485
12575
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.0
18.0
214
1134
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
4.5
18.0
43
96
SGA01
NOMESCO Finland
Emergency treatment
1.6
17.9
435
2848
A91
ICPC
Abnormal result investigation NOS
2.4
17.8
124
531
SPAT1229
SPAT
Assessment of need for aid
2.8
17.8
90
330
M01AH01
ATC
celecoxib; oral
2.0
17.7
202
1055
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.4
17.7
123
527
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.7
17.7
343
2116
WYA10
NOMESCO Finland
Emergency care or similar visit
1.9
17.7
239
1323
A02BA02
ATC
ranitidine; systemic
2.0
17.6
205
1079
WZC00, ,
SPAT
1.6
17.6
451
2993
SPAT1260
SPAT
Consultation of another employee
1.7
17.5
402
2595
F43.8
ICD-10 Finland
Other reactions to severe stress
2.5
17.4
115
481
RS220, ,
NOMESCO Finland
4.3
17.4
45
107
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
7.4
17.4
25
34
K04.08
ICD-10 Finland
Other specified pulpit
1.8
17.3
260
1488
S71.1
ICD-10 Finland
Open wound of thigh
4.6
17.3
41
91
K03.00
ICD-10 Finland
Approximal wear
1.9
17.3
218
1179
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
17.2
455
3040
L01
ICPC
Neck symptom/complaint
1.6
17.2
438
2900
N89
ICPC
Migraine
1.9
17.1
219
1189
UKC02
NOMESCO Finland
Cystoscopy
2.2
17.1
154
736
WX290
NOMESCO Finland
Other blockage of nerve
1.5
17.1
1443
12215
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.9
17.0
217
1177
L08
ICPC
Shoulder symptom/complaint
1.7
17.0
385
2473
IEP01
NOMESCO Finland
Psychoeducation, family
6.6
17.0
27
41
T07
ICPC
Weight gain
2.8
17.0
85
310
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
16.9
406
2647
IER02, ,
SPAT
17.5
16.9
26
15
D06
ICPC
Abdominal pain localized other
1.8
16.9
299
1796
Z72.2
ICD-10 Finland
Drug use
4.9
16.8
37
77
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.9
16.7
226
1250
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
16.7
140
650
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.7
16.7
546
7464
S10
ICPC
Boil/carbuncle
2.2
16.6
151
724
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.2
16.6
144
678
N03AF02
ATC
oxcarbazepine; oral
2.8
16.6
84
308
A08
ICPC
Swelling
2.8
16.6
85
314
C07AB02
ATC
metoprolol; systemic
2.0
16.5
193
1016
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
16.5
137
634
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
16.5
200
1067
P19
ICPC
Drug abuse
4.0
16.5
46
116
EBA00
NOMESCO Finland
Extraction of tooth
1.4
16.4
1033
8253
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
16.4
136
629
R5110, ,
SPAT
2.4
16.4
110
464
M01AG02
ATC
tolfenamic acid; oral, rectal
1.7
16.3
316
1946
N76.0
ICD-10 Finland
Acute vaginitis
1.7
16.3
351
2224
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.2
16.3
33
64
H02AB06
ATC
prednisolone; systemic
1.5
16.2
829
6365
K30
ICD-10 Finland
Functional dyspepsia
1.8
16.2
249
1433
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
5.9
16.2
29
50
J01MA02
ATC
ciprofloxacin; systemic
1.5
16.2
568
4043
R03BB04
ATC
tiotropium bromide; inhalant
2.5
16.2
101
412
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
16.1
506
3512
R07.3
ICD-10 Finland
Other chest pain
2.0
16.1
181
940
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.8
16.1
280
1673
G03DA02
ATC
medroxyprogesterone; systemic
2.4
16.1
110
468
Z63.5
ICD-10 Finland
Disruption of family by separation and divorce
5.3
16.1
32
61
U02
ICPC
Urinary frequency/urgency
1.6
16.0
380
2467
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.8
16.0
268
1583
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
5.6
16.0
30
54
K03.29
ICD-10 Finland
Erosion of teeth occupational
3.3
16.0
59
180
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
16.0
193
1028
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.7
15.9
50
137
K03.2
ICD-10 Finland
Erosion of teeth
3.1
15.9
65
211
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
3.8
15.9
48
128
P58
ICPC
Psychological, Therapeutic counselling/listening
2.5
15.9
98
397
D02
ICPC
Abdominal pain epigastric
2.0
15.9
187
987
J02AC01
ATC
fluconazole; systemic
1.4
15.8
922
7248
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.8
15.7
80
294
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.0
15.7
44
111
T83
ICPC
Overweight
2.6
15.7
88
340
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.4
15.7
113
492
SPAT1058
SPAT
PEF monitoring instruction
2.1
15.7
163
823
K80
ICPC
Cardiac arrhythmia NOS
2.1
15.6
144
695
K03.28
ICD-10 Finland
Other erosion of teeth
2.6
15.6
91
359
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
15.6
484
3349
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
15.6
234
1338
XKD06
NOMESCO Finland
Physiologic investigation of micturition
4.0
15.6
44
112
SPAT1301
SPAT
No procedures
1.5
15.6
696
5200
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
11.8
15.5
28
24
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
15.5
179
938
ZXA05
NOMESCO Finland
Left side
1.7
15.5
286
1737
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
15.5
160
806
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
13.8
15.5
26
19
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
4.3
15.5
39
91
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
15.4
245
1424
M01AH05
ATC
etoricoxib; oral
1.4
15.4
1092
8883
N01
ICPC
Headache
1.5
15.4
564
4046
UJD02
NOMESCO Finland
Gastroscopy
2.8
15.3
75
270
IDY24
NOMESCO Finland
Systematic individual treatment, dialectical behaviour therapy (DBT), pre-treatment
12.4
15.3
27
22
N06BA12
ATC
lisdexamfetamine; oral
2.7
15.3
81
304
P23
ICPC
Adolescent behaviour sympt/compl
3.6
15.3
50
141
WZA90
NOMESCO Finland
Other medical or dental certificate
1.5
15.3
657
4866
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
6.7
15.3
24
36
P73
ICPC
Affective psychosis
6.7
15.3
24
36
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.6
15.3
89
351
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
15.3
377
2471
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.7
15.3
287
1752
S21
ICPC
Skin texture symptom/complaint
1.7
15.3
345
2212
N05AF05
ATC
zuclopenthixol; systemic
5.9
15.2
27
46
SPAT1262
SPAT
Handing over of treatment supplies
1.8
15.2
232
1333
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
15.2
381
2507
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.7
15.2
341
2183
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.9
15.1
69
239
C08CA01
ATC
amlodipine; oral
1.7
15.1
284
1732
G03FB06
ATC
medroxyprogesterone and estrogen; systemic
3.0
15.1
65
218
A08AB01
ATC
orlistat; oral
23.5
15.1
21
9
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.3
15.0
56
172
WX780
NOMESCO Finland
Remote monitoring CPAP
2.8
15.0
73
262
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.5
14.9
97
403
WX730
NOMESCO Finland
Conventional respirator
4.7
14.9
34
73
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
3.8
14.8
44
116
RF210, ,
NOMESCO Finland
2.8
14.8
72
259
A99
ICPC
Disease/condition unspecnature/site
1.8
14.7
224
1287
EB1AA, ,
SPAT
2.0
14.6
160
823
SPAT1281
SPAT
Other administrative function
1.9
14.6
202
1125
U13
ICPC
Bladder symptom/complaint other
2.9
14.6
68
239
SPAT1312
SPAT
General health counselling
1.4
14.5
954
7629
IHZ05
NOMESCO Finland
Therapeutic conversation
4.3
14.5
37
87
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.6
14.5
85
336
R60.9
ICD-10 Finland
Oedema, unspecified
2.5
14.5
90
366
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
14.5
480
3363
A10AB05
ATC
insulin aspart; parenteral
2.1
14.5
144
715
S61.7
ICD-10 Finland
Multiple open wounds of wrist and hand
4.4
14.5
36
83
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
14.5
452
3126
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.5
14.5
521
3717
F05.9
ICD-10 Finland
Delirium, unspecified
5.8
14.4
26
45
A27
ICPC
Fear of other disease NOS
2.3
14.4
111
498
C10AA01
ATC
simvastatin; oral
1.8
14.4
222
1279
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
15.5
14.4
23
15
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
14.4
215
1227
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
14.4
181
978
N94.1
ICD-10 Finland
Dyspareunia
2.5
14.3
87
350
E0000UV, ,
ATC
1.4
14.3
1025
8314
R20.2
ICD-10 Finland
Paraesthesia of skin
1.9
14.3
176
943
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.0
14.3
25
42
R74
ICPC
Upper respiratory infection acute
1.4
14.3
1166
9671
R32
ICD-10 Finland
Unspecified urinary incontinence
3.5
14.3
49
143
3051, ,
Kela drug reimbursment
4.4
14.2
35
80
QBJ30
NOMESCO Finland
Correction of abdominal apron
4.8
14.2
32
68
Z07
ICPC
Education problem
3.0
14.2
62
210
A03FA02
ATC
cisapride; oral, rectal
2.3
14.1
109
489
G43.3
ICD-10 Finland
Complicated migraine
2.6
14.1
81
317
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.3
14.1
107
477
N05AX13
ATC
paliperidone; systemic
5.9
14.0
25
43
N03AF01
ATC
carbamazepine; oral, rectal
2.8
13.9
70
256
W19
ICD-10 Finland
Unspecified fall
1.8
13.9
201
1135
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.3
13.9
107
480
RS221, ,
NOMESCO Finland
3.7
13.9
43
117
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
5.0
13.8
29
58
R00.1
ICD-10 Finland
Bradycardia, unspecified
4.3
13.8
35
82
IBA01, ,
SPAT
2.3
13.8
101
443
XG466
NOMESCO Finland
Sleep oxymetry
3.9
13.8
40
104
E03
ICD-10 Finland
Other hypothyroidism
2.1
13.7
136
675
B81
ICPC
Anaemia vit B12/folate deficiency
3.4
13.7
48
142
K02.1
ICD-10 Finland
Caries of dentine
1.4
13.7
1598
14040
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
13.7
199
1126
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.7
13.7
276
1716
A10BX07
ATC
[U] liraglutide
5.7
13.7
25
44
U05
ICPC
Urination problems other
2.6
13.6
79
311
IAA02
NOMESCO Finland
Consultation concerning further psychiatric treatment
5.1
13.6
28
55
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
12.1
13.6
24
20
A10AB01
ATC
insulin (human); parenteral
2.4
13.6
90
378
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
13.5
235
1401
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
4.4
13.5
33
75
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
5.5
13.5
26
48
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.4
13.5
92
391
L86
ICPC
Back syndrome with radiating pain
2.2
13.5
117
551
ZXY84
NOMESCO Finland
Occupational therapist in multidisciplinary team
16.3
13.4
21
13
N73.9
ICD-10 Finland
Female pelvic inflammatory disease, unspecified
2.6
13.4
75
290
K04.0
ICD-10 Finland
Pulpitis
1.7
13.4
262
1614
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.9
13.4
160
849
Z50.1
ICD-10 Finland
Other physical therapy
2.6
13.4
79
314
U07
ICPC
Urine symptom/complaint other
1.9
13.4
162
864
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
2.3
13.3
104
469
N02AA05
ATC
oxycodone; systemic
2.0
13.3
155
815
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.6
13.3
78
309
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.7
13.3
230
1370
T89
ICPC
Diabetes insulin dependent
2.2
13.3
112
522
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
13.2
1006
8209
J01DA01
ATC
[U] cefalexin
1.4
13.2
1206
10140
ZXA00
NOMESCO Finland
Right side
1.6
13.2
299
1915
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
5.1
13.1
27
53
L02
ICPC
Back symptom/complaint
1.6
13.1
310
2007
ICB03, ,
SPAT
5.0
13.1
28
57
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.1
13.1
118
565
RF120, ,
NOMESCO Finland
4.5
13.1
31
69
P25
ICPC
Phase of life problem adult
1.9
13.0
163
878
M02AA07
ATC
piroxicam; topical
1.5
13.0
408
2818
H02AB07
ATC
prednisone; oral
1.8
13.0
187
1055
X05
ICPC
Menstruation absent/scanty
2.3
13.0
97
430
R45.8
ICD-10 Finland
Other symptoms and signs involving emotional state
4.2
12.9
34
82
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.5
12.9
500
3610
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
13.0
12.9
22
17
N06AA10
ATC
nortriptyline; systemic
3.5
12.9
44
128
IHZ04, ,
SPAT
2.5
12.9
78
314
188
Kela drug reimbursment
Psychosis requiring demanding treatment
5.6
12.9
24
43
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.5
12.9
79
320
M01AE02
ATC
naproxen; oral, rectal
1.4
12.8
1387
11960
H3603, E103,
ICD-10 Finland
4.5
12.8
31
70
R15
ICD-10 Finland
Faecal incontinence
3.9
12.8
37
96
P17
ICPC
Tobacco abuse
3.4
12.7
46
139
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.1
12.7
123
605
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.4
12.7
84
353
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
4.9
12.6
27
55
IEP03
NOMESCO Finland
Focused parental counselling
4.9
12.6
27
55
R63.3
ICD-10 Finland
Feeding difficulties and mismanagement
15.5
12.6
20
13
SPAT1051
SPAT
Guidance regarding sleep disorders
3.2
12.6
48
150
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
6.0
12.6
22
37
TQW40
NOMESCO Finland
Remowal of suture of skin
2.2
12.6
109
514
J01EA01
ATC
trimethoprim; systemic
1.4
12.5
569
4234
CL2S4, ,
SPAT
3.5
12.5
43
126
L84
ICPC
Back syndrome without radiat pain
2.2
12.4
110
523
F43.00
ICD-10 Finland
Acute stress reaction mild
2.4
12.4
87
375
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
5.6
12.4
23
41
A10AB04
ATC
insulin lispro; parenteral
2.5
12.4
79
326
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
4.0
12.4
34
85
F92.0
ICD-10 Finland
Depressive conduct disorder
4.9
12.4
27
56
IHZ07, ,
SPAT
4.6
12.3
29
64
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
12.3
620
4701
W26
ICD-10 Finland
Contact with other sharp object(s)
3.0
12.3
55
189
D19
ICPC
Teeth/gum symptom/complaint
1.4
12.3
859
6890
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.9
12.3
57
200
R06.4
ICD-10 Finland
Hyperventilation
3.1
12.3
51
168
D07AC01
ATC
betamethasone; topical
1.4
12.2
660
5065
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
12.2
101
467
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.5
12.2
73
292
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.9
12.2
58
206
IAB11
NOMESCO Finland
Psychiatric mood consultation
9.0
12.2
25
28
L16
ICPC
Ankle symptom/complaint
1.6
12.2
346
2335
XA800
NOMESCO Finland
Neuropsychological investigation
2.3
12.2
96
435
W78
ICPC
Pregnancy
0.7
12.2
584
7544
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
12.2
186
1068
I50.0
ICD-10 Finland
Congestive heart failure
3.6
12.1
39
109
A05
ICPC
Feeling ill
1.6
12.1
322
2141
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
15.9
12.1
19
12
K58
ICD-10 Finland
Irritable bowel syndrome
2.3
12.1
93
417
R06AX27
ATC
desloratadine; oral
1.4
12.1
817
6511
F22.0
ICD-10 Finland
Delusional disorder
4.5
12.1
29
65
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
12.1
586
4409
SPAT1227
SPAT
Substance abuse rehabilitation
6.0
12.1
21
35
RK110, ,
NOMESCO Finland
6.0
12.1
21
35
OAB93, ,
SPAT
1.8
12.1
206
1221
IBC98
NOMESCO Finland
Other child protection assessment
5.5
12.1
23
42
K07.60
ICD-10 Finland
Snapping jaw
1.8
12.1
184
1056
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.0
12.0
51
170
SFA20
NOMESCO Finland
Two-surface restoration
1.4
12.0
1400
12156
RT250, ,
NOMESCO Finland
9.3
12.0
24
26
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
5.7
11.9
22
39
S22
ICPC
Nail symptom/complaint
1.9
11.9
155
846
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.2
11.9
97
446
A10BB12
ATC
glimepiride; oral
3.3
11.9
43
130
SPAT1167
SPAT
Insertion of urinary catheter
4.7
11.9
27
58
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.9
11.8
147
791
SPAT1104
SPAT
Monitoring of emergency patient
2.1
11.8
113
554
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.0
11.8
51
172
R03BA05
ATC
fluticasone; inhalant
1.5
11.8
424
3011
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
11.8
250
1573
U01
ICPC
Dysuria/painful urination
1.7
11.8
252
1589
SPAT1276
SPAT
Outlining of treatment with patient or their family members
3.4
11.8
41
121
F60.1
ICD-10 Finland
Schizoid personality disorder
14.7
11.8
19
13
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
2.9
11.8
53
183
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
11.8
126
644
SPAT1379
SPAT
Health check-up of pregnant person
0.7
11.7
370
5172
SGC10
NOMESCO Finland
Pulp capping
1.6
11.7
279
1809
A10AC01
ATC
insulin (human); parenteral
1.9
11.6
142
759
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
2.2
11.6
100
470
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
4.6
11.6
27
59
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.1
11.6
106
510
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.0
11.6
49
163
S04
ICPC
Lump/swelling localized
1.6
11.6
313
2089
D02AE01
ATC
carbamide; topical
1.9
11.5
137
726
A10BX04
ATC
[U] exenatide
11.1
11.5
21
19
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
11.5
106
512
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
4.3
11.5
29
68
XKD00
NOMESCO Finland
Uroflowmetry
2.2
11.4
98
460
S80.0
ICD-10 Finland
Contusion of knee
1.7
11.4
204
1225
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.8
11.4
192
1134
Z01.2
ICD-10 Finland
Dental examination
1.3
11.4
1307
11278
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.3
11.4
81
352
A10BJ05
ATC
dulaglutide; parenteral
3.9
11.4
33
86
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.8
11.4
57
209
D10
ICPC
Vomiting
1.6
11.3
268
1732
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
3.6
11.3
36
100
R4190, ,
SPAT
4.1
11.3
30
73
SPAT1153
SPAT
Removal of sutures
1.5
11.3
425
3043
EB1SA, ,
SPAT
1.9
11.3
155
861
A03CA02
ATC
clidinium and psycholeptics; oral
3.0
11.3
50
171
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
11.3
81
353
N05AD03
ATC
melperone; systemic
8.3
11.3
24
29
F43.0
ICD-10 Finland
Acute stress reaction
1.8
11.3
183
1070
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.6
11.3
256
1639
U08
ICPC
Urinary retention
5.1
11.2
23
45
TKC22
NOMESCO Finland
Catheterisation instruction
4.6
11.2
26
57
SPAT1380
SPAT
Postpartum check-up
0.6
11.2
293
4264
T78.4
ICD-10 Finland
Allergy, unspecified
1.9
11.2
153
850
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
12.7
11.1
19
15
K08.80
ICD-10 Finland
Toothache NOS
1.6
11.1
247
1572
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
20.1
11.1
16
8
G04BD07
ATC
tolterodine; oral
3.2
11.1
44
141
H01
ICPC
Ear pain/earache
1.5
11.1
420
3010
N02CC04
ATC
rizatriptan; oral
1.8
11.1
161
910
N06BA09
ATC
atomoxetine; oral
3.9
11.1
32
83
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
3.2
11.1
42
131
F30.0
ICD-10 Finland
Hypomania
11.2
11.0
20
18
S00.0
ICD-10 Finland
Superficial injury of scalp
3.1
11.0
45
147
SPAT1197
SPAT
Extensive health check-up of expecting family
0.7
11.0
412
5586
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
5.0
11.0
23
46
BEF00, ,
SPAT
5.0
11.0
23
46
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
2.0
11.0
112
563
IDP01
NOMESCO Finland
Systematic family therapy, family therapy
13.9
11.0
18
13
L04
ICPC
Chest symptom/complaint
1.9
10.9
146
804
J20
ICD-10 Finland
Acute bronchitis
1.7
10.9
212
1303
R41.0
ICD-10 Finland
Disorientation, unspecified
3.8
10.9
32
84
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.3
10.9
84
378
F29
ICPC
Eye symptom/complaint other
1.6
10.9
258
1669
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.6
10.8
63
249
H04AA01
ATC
glucagon; nasal, parenteral
2.2
10.8
91
424
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
10.8
94
444
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.8
10.8
158
895
I95.1
ICD-10 Finland
Orthostatic hypotension
3.9
10.8
31
80
R25.2
ICD-10 Finland
Cramp and spasm
2.9
10.8
51
181
ZX120
NOMESCO Finland
Intravenous
1.8
10.8
150
837
A02BA04
ATC
nizatidine; systemic
2.6
10.8
61
238
C01CA24
ATC
epinephrine; parenteral
1.7
10.8
189
1130
SGA03
NOMESCO Finland
Opening and preparing the root canals, complicated
1.6
10.7
236
1498
A10AE05
ATC
insulin detemir; parenteral
2.1
10.7
103
506
J01AA02
ATC
doxycycline; systemic
1.3
10.7
1308
11347
Z61.8
ICD-10 Finland
Other negative life events in childhood
4.7
10.7
24
51
F64.0
ICD-10 Finland
Transsexualism
4.6
10.7
25
55
F20
ICD-10 Finland
Schizophrenia
5.6
10.7
20
36
A02BX02
ATC
sucralfate; oral
3.4
10.7
37
109
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.2
10.7
41
129
H3601, E103,
ICD-10 Finland
4.1
10.7
29
72
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
10.7
832
6754
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
12.9
10.6
18
14
WZC30
NOMESCO Finland
Teaching
1.6
10.6
235
1494
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.9
10.6
133
718
K10.3
ICD-10 Finland
Alveolitis of jaws
1.8
10.6
155
879
ZXY61
NOMESCO Finland
2-person team, special workers
8.0
10.6
23
29
H36.01
ICD-10 Finland
Diabetic maculopathy
4.3
10.5
27
64
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.3
10.5
39
120
R03DC03
ATC
montelukast; oral
1.5
10.5
364
2561
SPAT1284
SPAT
Extensive health certificate
2.2
10.5
88
410
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
10.1
10.5
20
20
F30.9
ICD-10 Finland
Manic episode, unspecified
10.1
10.5
20
20
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
9.2
10.5
21
23
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
2.3
10.5
76
333
R21
ICPC
Throat symptom/complaint
1.3
10.5
892
7331
N02CC06
ATC
eletriptan; oral
1.9
10.5
125
664
B02AA02
ATC
tranexamic acid; systemic
1.5
10.4
316
2162
N91.2
ICD-10 Finland
Amenorrhoea, unspecified
3.0
10.4
45
152
T99
ICPC
Endocr/metab/nutrit disease other
3.4
10.4
36
106
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
4.1
10.4
28
69
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
5.4
10.4
20
37
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.9
10.4
139
767
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
2.5
10.3
63
255
SPAT1377
SPAT
Polysomnography
2.8
10.3
50
180
IAB13
NOMESCO Finland
Psychiatric sleep disorder consultation
32.6
10.3
13
*
ZXA10
NOMESCO Finland
Bilateral
1.6
10.3
270
1787
M54.3
ICD-10 Finland
Sciatica
2.2
10.3
88
413
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
3.5
10.3
34
97
R03AC13
ATC
formoterol; inhalant
2.4
10.3
69
292
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
5.2
10.3
21
41
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.1
10.3
41
132
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
10.3
40
127
XQ800
NOMESCO Finland
Prick test
1.6
10.3
223
1411
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
4.4
10.3
25
57
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
4.4
10.3
25
57
F34.9
ICD-10 Finland
Persistent mood [affective] disorder, unspecified
4.9
10.2
22
45
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.7
10.2
212
1325
RT120, ,
NOMESCO Finland
9.6
10.2
20
21
G81.9
ICD-10 Finland
Hemiplegia, unspecified
4.7
10.2
23
49
G04BD04
ATC
oxybutynin; oral, transdermal
2.3
10.2
73
318
J45.1
ICD-10 Finland
Nonallergic asthma
1.8
10.2
149
844
P02
ICPC
Acute stress reaction
1.7
10.2
200
1232
J01FA06
ATC
roxithromycin; oral
1.4
10.2
623
4859
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
10.2
567
4356
Z73.9
ICD-10 Finland
Problem related to life-management difficulty, unspecified
3.2
10.1
40
128
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
10.1
92
443
WX882
NOMESCO Finland
High dependency care
2.5
10.1
60
240
SPAT1216
SPAT
Assessment of functional ability
1.7
10.1
178
1066
L14
ICPC
Leg/thigh symptom/complaint
1.8
10.1
166
975
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
10.1
112
581
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
2.4
10.1
67
283
K02.0
ICD-10 Finland
Caries limited to enamel
1.4
10.0
751
6044
P20
ICPC
Memory disturbance
2.4
10.0
65
271
P77
ICPC
Suicide/suicide attempt
8.5
10.0
21
25
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
10.0
94
458
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
10.0
177
1061
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.3
10.0
36
109
A10BD07
ATC
metformin and sitagliptin; systemic
3.3
10.0
36
109
205
Kela drug reimbursment
Chronic hypertension
1.9
10.0
134
740
R3110
NOMESCO Finland
Psychosocial training
2.4
10.0
65
272
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.7
9.9
686
8432
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.3
9.9
73
322
R35
ICD-10 Finland
Polyuria
2.2
9.9
82
380
SPAT1211
SPAT
Application of soft bandage
1.6
9.9
214
1352
ZXD05
NOMESCO Finland
Urgent procedure
1.4
9.9
611
4769
WX110, ,
SPAT
1.8
9.9
152
875
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
4.2
9.9
26
63
K04.09
ICD-10 Finland
Pulpit UNS
1.9
9.9
132
728
A06AC51
ATC
ispaghula, combinations; oral
2.2
9.9
78
355
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.4
9.9
69
298
ICB01, ,
SPAT
3.2
9.9
38
120
D93
ICPC
Irritable bowel syndrome
2.7
9.8
50
185
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
8.1
9.8
21
26
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
8.1
9.8
21
26
M54.8
ICD-10 Finland
Other dorsalgia
2.0
9.8
102
517
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
9.8
209
1317
R13
ICD-10 Finland
Dysphagia
2.0
9.8
103
524
IBZ08
NOMESCO Finland
Gender identity assessment
4.0
9.8
27
68
S81.7
ICD-10 Finland
Multiple open wounds of lower leg
9.6
9.7
19
20
L90
ICPC
Osteoarthrosis of knee
2.7
9.7
50
186
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
3.5
9.7
33
96
J31.0
ICD-10 Finland
Chronic rhinitis
1.7
9.7
190
1170
UJH02
NOMESCO Finland
Anoscopy
2.6
9.7
56
221
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
9.7
227
1463
D25
ICPC
Abdominal distension
2.3
9.6
69
301
N05AC02
ATC
thioridazine; oral
2.8
9.6
47
170
SPAT1283
SPAT
Restricted health certificate
1.3
9.6
720
5787
R51
ICD-10 Finland
Headache
1.7
9.6
176
1066
Z87.8
ICD-10 Finland
Personal history of other specified conditions
4.3
9.6
24
56
N05AL05
ATC
amisulpride; oral
11.4
9.5
17
15
D03
ICPC
Heartburn
2.0
9.5
99
501
R05
ICPC
Cough
1.4
9.5
609
4776
3007
Kela drug reimbursment
Erenumab and fremanezumab
2.5
9.5
58
235
IEZ99, ,
SPAT
9.1
9.5
19
21
E66.1
ICD-10 Finland
Drug-induced obesity
9.1
9.5
19
21
SPAT1252
SPAT
Overall medication plan or its review
2.3
9.5
69
303
IAB01, ,
SPAT
4.0
9.5
26
65
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
7.1
9.5
22
31
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.6
9.5
232
1511
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.8
9.5
46
166
K03.66
ICD-10 Finland
Tooth plaque
1.6
9.4
198
1242
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.6
9.4
199
1251
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
7.6
9.4
21
28
L20.0
ICD-10 Finland
Besnier prurigo
1.5
9.4
316
2208
IBA05, ,
NOMESCO Finland
17.6
9.4
14
8
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
17.6
9.4
14
8
30650
ICD-8 Finland
Special symptoms not elsewhere classified, Feeding disturbance
+∞
9.4
9
*
X04
ICPC
Painful intercourse female
2.9
9.4
44
156
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
9.4
1111
9525
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
9.4
1917
17765
S14
ICPC
Burn/scald
2.0
9.4
97
491
L20
ICPC
Joint symptom/complaint NOS
2.1
9.3
91
450
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.7
9.3
47
173
WX290, ,
SPAT
1.9
9.3
110
582
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.5
9.3
59
244
F34.0
ICD-10 Finland
Cyclothymia
4.7
9.3
21
45
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.4
9.3
63
269
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.8
9.2
128
714
K08.3
ICD-10 Finland
Retained dental root
2.1
9.2
91
452
XF404
NOMESCO Finland
Ambulatory ECG
2.0
9.2
102
528
H02
ICPC
Hearing complaint
1.8
9.2
150
878
F40.2
ICD-10 Finland
Specific (isolated) phobias
2.9
9.2
41
141
SHA04
NOMESCO Finland
Stomatognathic treatment, very demanding
2.9
9.2
43
152
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
3.8
9.2
27
71
OAB72, ,
SPAT
2.4
9.2
59
245
X14
ICPC
Vaginal discharge
1.8
9.2
131
737
E87.5
ICD-10 Finland
Hyperkalaemia
7.3
9.2
21
29
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.7
9.2
392
5220
N30.9
ICD-10 Finland
Cystitis, unspecified
1.7
9.2
162
971
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
3.4
9.2
32
95
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
9.2
169
1025
-1, ,
NOMESCO Finland
1.3
9.2
1004
8508
B80
ICPC
Iron deficiency anaemia
2.1
9.2
85
413
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.6
9.1
52
204
R06AX22
ATC
ebastine; oral
1.5
9.1
346
2475
J01CF05
ATC
flucloxacillin; systemic
1.7
9.1
163
980
N05AE03
ATC
sertindole; oral
7.7
9.1
20
26
KMAK, ,
NOMESCO Finland
1.3
9.1
1151
9942
OAA11, ,
SPAT
0.7
9.1
246
3571
RT420, ,
NOMESCO Finland
8.3
9.1
19
23
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
8.3
9.1
19
23
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
9.0
181
1122
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.4
9.0
31
91
M70.6
ICD-10 Finland
Trochanteric bursitis
1.7
9.0
154
914
RT310, ,
NOMESCO Finland
15.6
9.0
14
9
OAB43, ,
SPAT
0.8
9.0
786
9385
RT253, ,
NOMESCO Finland
36.8
9.0
11
*
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
10.1
9.0
17
17
D07AA02
ATC
hydrocortisone; topical
1.4
9.0
401
2956
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.0
9.0
38
127
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.1
9.0
85
416
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.8
9.0
44
160
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.7
8.9
158
947
K04.00
ICD-10 Finland
Hyperemia of pulp
1.8
8.9
140
811
IDP99
NOMESCO Finland
Other psychotherapeutic family intervention
7.5
8.9
20
27
C08CA13
ATC
lercanidipine; oral
2.0
8.9
95
486
OAA43, ,
SPAT
2.0
8.9
97
500
F38.8
ICD-10 Finland
Other specified mood [affective] disorders
4.9
8.8
19
39
M54
ICD-10 Finland
Dorsalgia
1.5
8.8
281
1941
SPAT1255
SPAT
Intravenous administration of medicine
2.0
8.8
93
474
F43.25
ICD-10 Finland
Adaptive disorder with mixed mental disorder and behavioral disorder
4.7
8.8
20
43
IHZ02, ,
SPAT
1.9
8.8
110
594
OAA12, ,
SPAT
0.6
8.8
157
2508
RK320, ,
NOMESCO Finland
8.6
8.8
18
21
OAB38, ,
SPAT
1.7
8.8
164
998
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
8.8
290
2018
Z2230
NOMESCO Finland
Head nurse
9.5
8.8
17
18
G04BD08
ATC
solifenacin; oral
2.4
8.7
58
245
R12
ICD-10 Finland
Heartburn
1.7
8.7
174
1077
SPA02
NOMESCO Finland
Preparation for dental prosthetics
2.7
8.7
45
168
NH1AD
NOMESCO Finland
Ankle and foot CT
2.6
8.7
50
197
C09AA05
ATC
ramipril; oral
1.7
8.7
149
885
D50
ICD-10 Finland
Iron deficiency anaemia
2.1
8.7
78
374
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
8.7
247
1664
SPAT1360
SPAT
Extensive global examination
1.9
8.7
112
611
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.1
8.7
36
119
M01AB01
ATC
indometacin; systemic, rectal
2.8
8.7
41
146
2768A
ICD-9 Finland
Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]
50.1
8.7
10
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.0
8.7
85
422
OAA80, ,
SPAT
0.6
8.7
111
1936
R40.2
ICD-10 Finland
Coma, unspecified
6.6
8.6
21
32
T11.1
ICD-10 Finland
Open wound of upper limb, level unspecified
6.6
8.6
21
32
OAB76, ,
SPAT
2.0
8.6
90
458
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.9
8.6
99
521
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
8.2
8.6
18
22
A06AX04
ATC
linaclotide; oral
8.2
8.6
18
22
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.6
8.6
221
1458
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
16.3
8.5
13
8
M81.8
ICD-10 Finland
Other osteoporosis
6.9
8.5
20
29
ICA03
NOMESCO Finland
Psychiatric treatment plan, outsourced psychotherapy
9.0
8.5
17
19
A07AA02
ATC
nystatin; oral
2.2
8.5
71
331
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
10.1
8.5
16
16
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.1
8.5
23
57
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
8.5
1659
15113
G43
ICD-10 Finland
Migraine
1.6
8.5
225
1493
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.1
8.5
78
378
S01
ICPC
Pain/tenderness of skin
1.9
8.5
99
523
G47.2
ICD-10 Finland
Disorders of the sleep-wake schedule
27.6
8.5
11
*
RS141, ,
NOMESCO Finland
20.1
8.5
12
6
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.0
8.5
36
121
F51.8
ICD-10 Finland
Other nonorganic sleep disorders
4.2
8.4
22
53
C08CA02
ATC
felodipine; oral
2.4
8.4
57
243
Y94.8
ICD-10 Finland
Other leisure activity accident
2.3
8.4
61
268
T06
ICPC
ANOREXIA NERVOSA W/WO BULIMIA
90.3
8.4
9
*
IEY18
NOMESCO Finland
Psychiatric sleep coaching, individual
90.3
8.4
9
*
IEP02
NOMESCO Finland
Child-centred family therapy
3.9
8.4
24
62
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
3.9
8.4
24
62
M89.0
ICD-10 Finland
Algoneurodystrophy
3.9
8.4
24
62
P98
ICPC
Psychosis NOS/other
3.9
8.4
24
62
WZA10
NOMESCO Finland
Extensive medical or dental certificate
3.1
8.4
34
111
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.5
8.4
52
213
S91.3
ICD-10 Finland
Open wound of other parts of foot
2.3
8.4
62
275
G43.8
ICD-10 Finland
Other migraine
2.3
8.4
64
288
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.0
8.4
83
414
D16
ICPC
Rectal bleeding
2.3
8.4
61
269
AA40B, ,
NOMESCO Finland
12.8
8.4
14
11
IDR99
NOMESCO Finland
Other psychotherapeutic group intervention
12.8
8.4
14
11
Y96.8
ICD-10 Finland
Other type of accident
4.5
8.4
20
45
IFA01, ,
SPAT
4.5
8.4
20
45
T03
ICPC
Loss of appetite
4.5
8.4
20
45
F20.0
ICD-10 Finland
Paranoid schizophrenia
7.9
8.4
18
23
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
7.9
8.4
18
23
E16.19
ICD-10 Finland
Other specified hypoglycaemia
4.9
8.3
18
37
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.4
8.3
371
2732
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.5
8.3
248
1688
RD220, ,
NOMESCO Finland
+∞
8.3
8
*
F55
ICD-10 Finland
Abuse of non-dependence-producing substances
+∞
8.3
8
*
B01AA03
ATC
warfarin; systemic
1.9
8.3
103
555
R25.1
ICD-10 Finland
Tremor, unspecified
2.7
8.3
43
161
H13
ICPC
Plugged feeling ear
1.5
8.3
265
1831
G03FB08
ATC
dydrogesterone and estrogen; systemic
2.1
8.3
77
375
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
2.6
8.3
45
173
W02
ICPC
Fear of pregnancy
2.8
8.3
39
139
X15
ICPC
Vaginal symptom/complaint other
1.6
8.3
201
1308
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.7
8.2
161
992
C10AC01
ATC
colestyramine; oral
2.5
8.2
49
197
IGY99, ,
SPAT
1.8
8.2
131
763
F33.31
ICD-10 Finland
Recurrent depression, severe episode of somatic syndrome
14.5
8.2
13
9
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.5
8.1
51
210
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
7.5
8.1
18
24
M05BA04
ATC
alendronic acid; oral
2.5
8.1
50
204
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
4.4
8.1
20
46
SCA02
NOMESCO Finland
Preventive oral health care
1.4
8.1
425
3218
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
3.1
8.1
33
108
E000003, ,
ATC
1.9
8.1
97
517
ZYY79, ,
SPAT
4.8
8.1
18
38
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
4.8
8.1
18
38
K07.62
ICD-10 Finland
Habitual dislocation of the jaw joint
3.1
8.1
32
103
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.1
8.1
32
103
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
2.0
8.1
89
461
N02CC03
ATC
zolmitriptan; nasal, oral
1.7
8.1
146
881
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
3.5
8.1
27
78
S74
ICPC
Dermatophytosis
2.6
8.1
46
181
F13.00
ICD-10 Finland
Intoxication caused by sedatives and hypnotics uncomplicated
33.4
8.1
10
*
F60.7
ICD-10 Finland
Dependent personality disorder
8.1
8.1
17
21
ZXE22
NOMESCO Finland
Procedure duration at least 4 but less than 5 hours
8.1
8.1
17
21
R06.5
ICD-10 Finland
Mouth breathing
1.7
8.1
134
790
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
17.2
8.1
12
7
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
11.7
8.1
14
12
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
2.0
8.1
83
420
R10.0
ICD-10 Finland
Acute abdomen
2.1
8.0
74
359
ZYC02, ,
SPAT
1.5
8.0
233
1577
M24.2
ICD-10 Finland
Disorder of ligament
3.0
8.0
34
114
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.8
8.0
38
136
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.6
8.0
209
1383
E22.1
ICD-10 Finland
Hyperprolactinaemia
2.9
8.0
35
120
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
7.2
7.9
18
25
A13
ICPC
Concern/fear medical treatment
2.9
7.9
37
131
WZA10, ,
SPAT
1.9
7.9
104
571
TQW80
NOMESCO Finland
Local dermatologic skincare
2.6
7.9
43
165
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.6
7.9
45
177
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
2.5
7.9
47
189
U71
ICPC
Cystitis/urinary infection other
1.6
7.9
176
1122
F43.02
ICD-10 Finland
Acute stress reaction severe
4.0
7.9
22
56
IHZ04
NOMESCO Finland
Psychosocial counselling and guidance
7.8
7.9
17
22
RT130, ,
NOMESCO Finland
7.8
7.9
17
22
XCK00
NOMESCO Finland
Perimetry
2.2
7.9
66
309
LCA06
NOMESCO Finland
Biopsy of endometrium
1.6
7.9
196
1283
R44.0
ICD-10 Finland
Auditory hallucinations
6.1
7.8
20
33
OAB50, ,
SPAT
1.8
7.8
111
625
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.7
7.8
475
6000
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
3.5
7.8
26
75
K11.70
ICD-10 Finland
Hypoptyalism
8.5
7.8
16
19
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.7
7.8
400
5186
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
9.4
7.8
15
16
M01AH02
ATC
rofecoxib; oral
1.9
7.8
99
539
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
2.5
7.7
45
179
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.8
7.7
103
569
L07
ICPC
Jaw symptom/complaint
2.1
7.7
67
318
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
6.4
7.7
19
30
K03.80
ICD-10 Finland
Irradiated enamel
1.7
7.7
146
893
L65.9
ICD-10 Finland
Nonscarring hair loss, unspecified
3.9
7.7
22
57
I95.9
ICD-10 Finland
Hypotension, unspecified
3.9
7.7
22
57
K92.0
ICD-10 Finland
Haematemesis
2.8
7.7
36
128
XLA10, ,
NOMESCO Finland
2.2
7.7
64
299
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.3
7.7
19
44
E000002, ,
ATC
1.5
7.6
292
2090
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.9
7.6
92
492
V03AG01
ATC
sodium cellulose phosphate; systemic
8.0
7.6
16
20
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
6.7
7.6
18
27
A08AA10
ATC
sibutramine; oral
11.9
7.6
13
11
RF242, ,
NOMESCO Finland
25.1
7.6
10
*
X76
ICD-10 Finland
Intentional self-harm by smoke, fire and flames
25.1
7.6
10
*
ICA02
NOMESCO Finland
Psychiatric treatment plan, extended psychotherapy in specialised care
25.1
7.6
10
*
L70.0
ICD-10 Finland
Acne vulgaris
1.6
7.6
194
1278
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.6
7.6
158
991
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.9
7.5
93
501
XG410
NOMESCO Finland
Flow-volume spirometry
2.1
7.5
67
321
R04
ICPC
Breathing problem other
2.0
7.5
75
375
A08AA02
ATC
fenfluramine; oral
8.9
7.5
15
17
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
8.9
7.5
15
17
N07BA03
ATC
varenicline; oral
2.0
7.5
79
403
K29.1
ICD-10 Finland
Other acute gastritis
3.8
7.5
22
58
-58
ICPC
Therapeutic counselling/listening
3.2
7.5
28
87
SFA00
NOMESCO Finland
Small restoration
1.5
7.5
278
1978
-69
ICPC
Other reason for encounter NEC
2.0
7.5
74
369
G50.1
ICD-10 Finland
Atypical facial pain
3.0
7.5
32
108
I73.0
ICD-10 Finland
Raynaud syndrome
2.5
7.5
46
188
SDA03
NOMESCO Finland
Periodontal treatment
1.3
7.5
947
8111
N94.6
ICD-10 Finland
Dysmenorrhoea, unspecified
1.7
7.5
122
716
K85
ICPC
Elevated blood pressure
1.7
7.5
139
846
A50
ICPC
General and Unspecified, Medication/prescr/renewal
2.0
7.5
73
363
X21
ICPC
Breast sympt/compl female other
2.0
7.4
74
370
B01AB04
ATC
dalteparin; parenteral
2.0
7.4
74
370
TAB00
NOMESCO Finland
Lumbar puncture
1.9
7.4
95
518
Z00.8
ICD-10 Finland
Other general examinations
1.6
7.4
193
1276
R40.0
ICD-10 Finland
Somnolence
6.5
7.4
18
28
P79
ICPC
Phobia/compulsive disorder
2.7
7.4
39
148
RF110, ,
NOMESCO Finland
13.4
7.4
12
9
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
6.0
7.4
19
32
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.4
7.4
49
208
N62
ICD-10 Finland
Hypertrophy of breast
1.9
7.3
90
484
A10BG03
ATC
pioglitazone; oral
3.8
7.3
22
59
K05
ICPC
Irregular heartbeat other
2.4
7.3
47
196
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
7.3
1578
14395
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.0
7.3
75
379
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
2.2
7.3
61
285
T18.9
ICD-10 Finland
Foreign body in alimentary tract, part unspecified
8.4
7.3
15
18
N06AX27
ATC
esketamine; nasal
+∞
7.3
7
*
S28
ICPC
Limited function/disability (S)
6.8
7.3
17
25
OAB73, ,
SPAT
9.4
7.3
14
15
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
4.2
7.3
19
46
X57
ICD-10 Finland
Unspecified privation
2.5
7.2
45
185
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.7
7.2
37
138
OAA10, ,
SPAT
0.6
7.2
171
2563
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.5
7.2
195
1299
N94.2
ICD-10 Finland
Vaginismus
6.2
7.2
18
29
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
3.0
7.2
31
105
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
15.8
7.2
11
7
SPAT1097
SPAT
Recording of ECG
1.7
7.2
141
870
J01CA08
ATC
pivmecillinam; oral
1.3
7.2
1052
9158
SPAT1272
SPAT
Drug screening
3.9
7.1
20
51
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.9
7.1
20
51
P75
ICPC
Somatization disorder
20.1
7.1
10
5
Z02
ICPC
Food/water problem
20.1
7.1
10
5
H43.1
ICD-10 Finland
Vitreous haemorrhage
3.1
7.1
28
90
M02AA10
ATC
ketoprofen; topical
1.6
7.1
178
1166
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.8
7.1
112
651
SPAT1131
SPAT
Colonoscopy
2.8
7.1
35
128
R39.1
ICD-10 Finland
Other difficulties with micturition
2.8
7.1
35
128
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.5
7.1
24
70
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
7.1
285
2058
Z09
ICPC
Legal problem
6.6
7.1
17
26
F43.28
ICD-10 Finland
Adaptive disorder with other predominant symptoms
3.4
7.1
25
75
L05
ICPC
Flank/axilla symptom/complaint
1.7
7.1
119
705
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
12.0
7.1
12
10
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
7.1
162
1040
SGB30
NOMESCO Finland
Other complicated root filling
1.4
7.1
291
2112
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
7.1
225
1554
Z73.0
ICD-10 Finland
Burn-out
1.7
7.0
112
654
MAX99
NOMESCO Finland
Assistance to normal delivery
0.7
7.0
250
3453
A85
ICPC
Adverse effect medical agent
3.5
7.0
23
66
C05AA08
ATC
fluocortolone; rectal, topical
1.6
7.0
144
901
IFA99, ,
SPAT
3.9
7.0
20
52
D07AB08
ATC
desonide; topical
1.5
7.0
240
1684
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.0
7.0
30
102
SPAT1263
SPAT
Sampling
1.3
6.9
974
8425
R03AK08
ATC
formoterol and beclometasone; inhalant
2.0
6.9
75
387
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.0
6.9
76
394
J05AB01
ATC
aciclovir; systemic
1.4
6.9
400
3072
J01DA09
ATC
[U] cefadroxil
1.3
6.9
475
3746
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.7
6.9
125
756
R06AX13
ATC
loratadine; oral
1.4
6.9
364
2756
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
1.7
6.9
129
788
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
6.9
103
591
F44.88
ICD-10 Finland
Other definite dissociation disorder
8.3
6.8
14
17
RT150, ,
NOMESCO Finland
4.1
6.8
18
44
P45
ICPC
Psychological, Observ/health educat/advice/diet
6.7
6.8
16
24
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.9
6.8
80
425
X07
ICPC
Menstruation irregular/frequent
1.8
6.8
102
585
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.1
6.8
58
274
A10BH05
ATC
linagliptin; oral
3.0
6.8
29
98
H92.0
ICD-10 Finland
Otalgia
1.5
6.8
187
1252
F12.20
ICD-10 Finland
Dependence caused by cannabis currently independent
10.9
6.8
12
11
C07AA03
ATC
pindolol; systemic
10.9
6.8
12
11
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
6.8
83
447
H02AB04
ATC
methylprednisolone; systemic
1.5
6.8
186
1245
W10
ICD-10 Finland
Fall on and from stairs and steps
1.9
6.8
87
476
183
Kela drug reimbursment
Lamotrigin and topiramate
3.0
6.8
28
93
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
3.0
6.8
28
93
J05AB11
ATC
valaciclovir; oral
1.4
6.8
258
1846
N02CD03
ATC
fremanezumab; systemic
2.5
6.8
40
161
3075A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Other and unspecified disorders of eating[TARKEMMIN MÄÄRITTELEMÄTÖN SYÖMISHÄIRIÖ]
40.1
6.8
8
*
RT236, ,
NOMESCO Finland
40.1
6.8
8
*
D06AX01
ATC
fusidic acid; topical
1.5
6.8
202
1377
Z73.1
ICD-10 Finland
Accentuation of personality traits
5.7
6.7
18
32
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
6.7
1563
14305
F13.09
ICD-10 Finland
Intoxication caused by sedative and hypnotic UNS
16.7
6.7
10
6
XKC03
NOMESCO Finland
Water cystometry
2.7
6.7
35
132
L60.0
ICD-10 Finland
Ingrowing nail
1.7
6.7
111
655
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
3.2
6.7
26
83
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.1
6.7
64
316
M54.1
ICD-10 Finland
Radiculopathy
2.2
6.7
53
243
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
7.2
6.7
15
21
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
7.2
6.7
15
21
S16
ICPC
Bruise/contusion
2.0
6.7
65
323
A07AA09
ATC
vancomycin; oral
3.4
6.7
23
68
R1250
NOMESCO Finland
Evaluation of functional capability
2.4
6.7
42
174
K91.1
ICD-10 Finland
Postgastric surgery syndromes
22.6
6.7
9
*
RT180, ,
NOMESCO Finland
22.6
6.7
9
*
T02
ICPC
Excessive appetite
22.6
6.7
9
*
IDY14
NOMESCO Finland
Systematic individual therapy, solution-focused
22.6
6.7
9
*
R03AC12
ATC
salmeterol; inhalant
2.2
6.7
54
250
-, ,
ICD-10 Finland
3.0
6.6
28
94
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.8
6.6
32
116
OAA67, ,
SPAT
0.7
6.6
285
3814
A10BJ01
ATC
exenatide; parenteral
6.4
6.6
16
25
D07XC01
ATC
betamethasone; topical
1.6
6.6
151
969
G83.4
ICD-10 Finland
Cauda equina syndrome
7.8
6.6
14
18
G04CA02
ATC
tamsulosin; oral
1.8
6.6
91
509
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.1
6.6
26
84
IBB04
NOMESCO Finland
Risk assessment concerning problem behaviour
12.3
6.6
11
9
M03AX01
ATC
botulinum toxin; parenteral
2.2
6.6
53
245
N94.5
ICD-10 Finland
Secondary dysmenorrhoea
1.9
6.6
78
416
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.3
6.6
475
3772
D18
ICPC
Change in faeces/bowel movements
2.1
6.5
59
285
C10AA05
ATC
atorvastatin; oral
1.4
6.5
264
1908
A04AA01
ATC
ondansetron; systemic, rectal
1.7
6.5
122
744
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.6
6.5
143
908
R4120, ,
SPAT
3.4
6.5
23
69
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
4.2
6.5
17
41
ZXY13
NOMESCO Finland
Trainee psychologist, supervised
10.0
6.5
12
12
R1250, ,
SPAT
1.8
6.5
91
511
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.6
6.5
135
846
R52.0
ICD-10 Finland
Acute pain
1.9
6.5
79
425
M01AC06
ATC
meloxicam; systemic, rectal
1.3
6.5
406
3157
SPE01
NOMESCO Finland
Mucosa-supported partial denture
3.7
6.5
20
55
SGC40
NOMESCO Finland
Preparing and restoring tooth to enable root canal treatment
2.1
6.5
55
260
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
5.3
6.4
18
34
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
2.2
6.4
51
234
NBJ62
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus
3.9
6.4
18
46
A01AB04
ATC
amphotericin B; local oral
2.5
6.4
39
159
H29
ICPC
Ear symptom/complaint other
1.5
6.4
205
1417
F34.8
ICD-10 Finland
Other persistent mood [affective] disorders
7.4
6.4
14
19
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
7.4
6.4
14
19
E44.0
ICD-10 Finland
Moderate protein-energy malnutrition
14.3
6.4
10
7
EB1VA, ,
NOMESCO Finland
1.4
6.4
352
2683
OAA68, ,
SPAT
2.4
6.4
42
178
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
3.0
6.4
27
91
R30.1
ICD-10 Finland
Vesical tenesmus
2.6
6.4
36
142
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.8
6.4
90
508
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
3.0
6.3
26
86
ZYC01, ,
SPAT
1.4
6.3
369
2837
WW200
NOMESCO Finland
Immunization
2.2
6.3
49
223
N02AJ13
ATC
tramadol and paracetamol; systemic
2.7
6.3
33
125
SPAT1235
SPAT
Mental health, emotional support
3.1
6.3
25
81
WYA30, ,
SPAT
3.6
6.3
20
56
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.8
6.3
96
554
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
6.0
6.3
16
27
RS313, ,
NOMESCO Finland
9.3
6.3
12
13
F20.08
ICD-10 Finland
Paranoid schizophrenia other definite
9.3
6.3
12
13
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.1
6.3
55
263
Z75.2
ICD-10 Finland
Other waiting period for investigation and treatment
3.5
6.3
21
61
R30.0
ICD-10 Finland
Dysuria
1.7
6.3
101
592
602
Kela drug reimbursment
Children's severe malnutrition
3.0
6.3
27
92
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
18.0
6.3
9
5
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.6
6.3
134
847
E000006, ,
ATC
1.7
6.3
119
730
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
2.8
6.3
29
103
78400
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Anorexia
+∞
6.2
6
*
3075E
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Other and unspecified disorders of eating[PSYKOGEENINEN OKSENTELU]
+∞
6.2
6
*
IER07
NOMESCO Finland
Psychiatric sleep coaching, group
+∞
6.2
6
*
Z04
ICD-10 Finland
Examination and observation for other reasons
2.7
6.2
32
120
X06
ICPC
Menstruation excessive
1.8
6.2
89
504
SPAT1059
SPAT
Spirometry at the office
2.0
6.2
66
339
Z63.2
ICD-10 Finland
Inadequate family support
7.0
6.2
14
20
XF402
NOMESCO Finland
ECG with work load test
1.9
6.2
77
417
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
1.8
6.2
84
468
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.6
6.2
35
138
O81.4
ICD-10 Finland
Vacuum extractor delivery
0.6
6.2
104
1687
SGA05
NOMESCO Finland
Opening and preparing the root canals, extremely complicated And time consuming
1.6
6.2
150
977
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
2.1
6.2
58
285
S02.53
ICD-10 Finland
Fracture of tooth root
2.7
6.2
31
115
C10AA07
ATC
rosuvastatin; oral
1.4
6.2
271
1989
SPAT1369
SPAT
Meeting with student welfare group of educational institution
3.1
6.2
24
77
N94.4
ICD-10 Finland
Primary dysmenorrhoea
1.6
6.2
131
827
R63.1
ICD-10 Finland
Polydipsia
6.3
6.2
15
24
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
6.3
6.2
15
24
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.3
6.2
373
2884
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.7
6.1
228
3132
F43
ICPC
Eye, Other diagnostic procedure
2.9
6.1
27
93
S06.3
ICD-10 Finland
Focal brain injury
5.3
6.1
17
32
JGC01
NOMESCO Finland
Laparoscopic rectopexy
5.7
6.1
16
28
C03AA03
ATC
hydrochlorothiazide; oral
2.2
6.1
51
239
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
3.4
6.1
21
62
M76.6
ICD-10 Finland
Achilles tendinitis
1.9
6.1
78
426
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
6.1
662
5535
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
6.1
56
273
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
3.8
6.1
18
48
F13.2
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome
12.5
6.1
10
8
N02CC07
ATC
frovatriptan; oral
1.6
6.1
124
775
XKD03
NOMESCO Finland
Urethral pressure profilometry
3.0
6.1
25
83
C02AC05
ATC
moxonidine; oral
3.0
6.1
25
83
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
2.1
6.1
55
267
27799
ICD-8 Finland
Obesity not specified as of endocrine origin
8.6
6.0
12
14
B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
1.9
6.0
73
392
CKC12
NOMESCO Finland
Photocoagulation of retina
2.2
6.0
46
208
ECB00
NOMESCO Finland
Suture of gingiva
2.0
6.0
63
322
NGJ60
NOMESCO Finland
Internal fixation of fracture of knee or lower leg using intramedullary nail, other or unspecified
3.6
6.0
19
53
RK290, ,
NOMESCO Finland
10.0
6.0
11
11
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
2.0
6.0
65
336
SGA04
NOMESCO Finland
Opening and preparing the root canals, extremely complicated
1.4
6.0
253
1842
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
6.0
102
607
A01AB09
ATC
miconazole; local oral
1.6
6.0
130
824
S89.9
ICD-10 Finland
Unspecified injury of lower leg
1.8
6.0
88
502
P81
ICPC
Hyperkinetic disorder
2.1
6.0
54
261
R07.2
ICD-10 Finland
Precordial pain
3.2
6.0
23
73

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Psychiatry
26 [38004469]
2.0e+00
2.7e+00
3.1e+00
6.9e+00
4.0e+00
3.7e+00
2.8e+00
cases:27.79%
controls:5.19%
cases:32.31%
controls:3.09%
cases:22.76%
controls:1.34%
cases:55.80%
controls:0.13%
cases:42.15%
controls:1.37%
cases:59.02%
controls:3.29%
cases:58.86%
controls:8.01%
653
1217
1697
22238
761
725
1594
22766
536
315
1819
23176
1314
30
1041
23461
991
322
1360
23152
1368
763
950
22451
1266
1725
885
19814
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
1.4e+00
2.3e+00
3.0e+00
5.7e+00
3.5e+00
3.2e+00
2.5e+00
cases:13.74%
controls:3.66%
cases:15.54%
controls:1.80%
cases:13.12%
controls:0.74%
cases:16.69%
controls:0.07%
cases:20.03%
controls:0.72%
cases:28.04%
controls:1.64%
cases:23.66%
controls:2.49%
323
859
2027
22596
366
423
1989
23068
309
173
2046
23318
393
16
1962
23475
471
169
1880
23305
650
380
1668
22834
509
536
1642
21003
Depressive episode, unspecified
F32.9 [45571760]
1.8e+00
2.6e+00
2.9e+00
5.2e+00
3.0e+00
2.7e+00
2.0e+00
cases:10.04%
controls:1.82%
cases:10.02%
controls:0.81%
cases:3.61%
controls:0.20%
cases:4.59%
controls:0.03%
cases:5.40%
controls:0.29%
cases:11.48%
controls:0.82%
cases:16.13%
controls:2.50%
236
426
2114
23029
236
190
2119
23301
85
47
2270
23444
108
6
2247
23485
127
67
2224
23407
266
191
2052
23023
347
538
1804
21001
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
2.8e+00
3.2e+00
3.6e+00
1.0e+50
3.8e+00
3.4e+00
3.2e+00
cases:2.64%
controls:0.17%
cases:2.00%
controls:0.09%
cases:1.10%
controls:0.03%
cases:1.57%
controls:0.00%
cases:1.28%
controls:0.03%
cases:3.28%
controls:0.12%
cases:6.23%
controls:0.26%
62
40
2288
23415
47
20
2308
23471
26
7
2329
23484
37
0
2318
23491
30
7
2321
23467
76
27
2242
23187
134
57
2017
21482
fluoxetine; oral
N06AB03 [21604711]
2.4e+00
3.1e+00
3.6e+00
—
3.7e+00
3.3e+00
2.8e+00
cases:13.11%
controls:1.35%
cases:12.78%
controls:0.66%
cases:5.10%
controls:0.14%
—
—
cases:6.08%
controls:0.15%
cases:16.61%
controls:0.71%
cases:19.06%
controls:1.36%
308
317
2042
23138
301
155
2054
23336
120
34
2235
23457
—
143
36
2208
23438
385
164
1933
23050
410
292
1741
21247
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
2.4e+00
3.1e+00
3.2e+00
—
3.4e+00
3.5e+00
3.1e+00
cases:4.30%
controls:0.39%
cases:4.25%
controls:0.19%
cases:2.17%
controls:0.09%
—
—
cases:2.81%
controls:0.09%
cases:6.69%
controls:0.21%
cases:10.69%
controls:0.53%
101
92
2249
23363
100
45
2255
23446
51
22
2304
23469
—
66
22
2285
23452
155
48
2163
23166
230
114
1921
21425
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
2.5e+00
3.2e+00
3.0e+00
—
3.6e+00
3.5e+00
2.6e+00
cases:7.19%
controls:0.62%
cases:6.41%
controls:0.29%
cases:3.10%
controls:0.16%
—
—
cases:4.72%
controls:0.13%
cases:10.31%
controls:0.34%
cases:11.95%
controls:0.96%
169
146
2181
23309
151
68
2204
23423
73
38
2282
23453
—
111
31
2240
23443
239
79
2079
23135
257
206
1894
21333
Other obesity
E66.8 [45533036]
2.2e+00
2.9e+00
3.4e+00
1.0e+50
3.5e+00
3.1e+00
2.6e+00
cases:3.32%
controls:0.38%
cases:3.44%
controls:0.20%
cases:1.44%
controls:0.05%
cases:1.66%
controls:0.00%
cases:1.45%
controls:0.04%
cases:4.57%
controls:0.21%
cases:7.07%
controls:0.54%
78
89
2272
23366
81
46
2274
23445
34
11
2321
23480
39
0
2316
23491
34
10
2317
23464
106
49
2212
23165
152
117
1999
21422
Other therapy enhancing rehabilitation
R4160 [2001310240]
1.3e+00
2.7e+00
4.1e+00
1.0e+50
4.3e+00
3.2e+00
2.1e+00
cases:2.00%
controls:0.53%
cases:2.04%
controls:0.14%
cases:1.27%
controls:0.02%
cases:1.06%
controls:0.00%
cases:1.49%
controls:0.02%
cases:3.84%
controls:0.16%
cases:3.39%
controls:0.42%
47
125
2303
23330
48
33
2307
23458
30
5
2325
23486
25
0
2330
23491
35
5
2316
23469
89
38
2229
23176
73
91
2078
21448
Recurrent depressive disorder, unspecified
F33.9 [45581458]
2.1e+00
2.8e+00
3.0e+00
1.0e+50
3.5e+00
3.2e+00
2.7e+00
cases:3.02%
controls:0.38%
cases:2.04%
controls:0.13%
cases:1.06%
controls:0.05%
cases:2.08%
controls:0.00%
cases:1.45%
controls:0.04%
cases:4.14%
controls:0.18%
cases:8.09%
controls:0.59%
71
90
2279
23365
48
31
2307
23460
25
12
2330
23479
49
0
2306
23491
34
10
2317
23464
96
41
2222
23173
174
128
1977
21411
Anorexia nervosa/bulimia
P86 [2002000878]
4.3e+00
4.2e+00
—
1.0e+50
—
4.3e+00
4.3e+00
cases:1.49%
controls:0.02%
cases:1.87%
controls:0.03%
—
—
cases:0.21%
controls:0.00%
—
—
cases:2.59%
controls:0.03%
cases:4.09%
controls:0.06%
35
5
2315
23450
44
7
2311
23484
—
5
0
2350
23491
—
60
8
2258
23206
88
12
2063
21527
levomepromazine; oral, parenteral
N05AA02 [21604493]
2.6e+00
2.6e+00
2.5e+00
—
2.9e+00
3.2e+00
3.2e+00
cases:1.91%
controls:0.14%
cases:1.32%
controls:0.10%
cases:0.25%
controls:0.02%
—
—
cases:0.38%
controls:0.02%
cases:1.94%
controls:0.08%
cases:4.46%
controls:0.18%
45
34
2305
23421
31
23
2324
23468
6
5
2349
23486
—
9
5
2342
23469
45
19
2273
23195
96
39
2055
21500
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.4e+00
2.2e+00
3.0e+00
3.6e+00
2.7e+00
2.3e+00
1.5e+00
cases:8.81%
controls:2.41%
cases:8.15%
controls:0.95%
cases:4.71%
controls:0.24%
cases:1.06%
controls:0.03%
cases:2.89%
controls:0.19%
cases:7.16%
controls:0.78%
cases:10.09%
controls:2.42%
207
566
2143
22889
192
224
2163
23267
111
56
2244
23435
25
7
2330
23484
68
45
2283
23429
166
181
2152
23033
217
521
1934
21018
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
2.2e+00
2.6e+00
3.0e+00
1.0e+50
3.3e+00
3.0e+00
2.5e+00
cases:4.17%
controls:0.49%
cases:3.27%
controls:0.25%
cases:1.61%
controls:0.08%
cases:2.25%
controls:0.00%
cases:2.59%
controls:0.09%
cases:6.17%
controls:0.32%
cases:10.32%
controls:0.94%
98
115
2252
23340
77
59
2278
23432
38
19
2317
23472
53
0
2302
23491
61
22
2290
23452
143
74
2175
23140
222
202
1929
21337
Mixed obsessional thoughts and acts
F42.2 [45542850]
2.1e+00
2.5e+00
3.0e+00
1.0e+50
3.3e+00
2.9e+00
2.4e+00
cases:0.68%
controls:0.08%
cases:0.89%
controls:0.07%
cases:0.42%
controls:0.02%
cases:0.64%
controls:0.00%
cases:0.60%
controls:0.02%
cases:1.29%
controls:0.07%
cases:2.32%
controls:0.22%
16
19
2334
23436
21
17
2334
23474
10
5
2345
23486
15
0
2340
23491
14
5
2337
23469
30
16
2288
23198
50
48
2101
21491
Social worker
Z2446 [2001311559]
1.0e+00
1.9e+00
3.5e+00
1.0e+50
4.1e+00
3.0e+00
2.6e+00
cases:2.98%
controls:1.08%
cases:2.29%
controls:0.34%
cases:1.10%
controls:0.03%
cases:0.81%
controls:0.00%
cases:1.70%
controls:0.03%
cases:4.23%
controls:0.23%
cases:6.23%
controls:0.49%
70
253
2280
23202
54
81
2301
23410
26
8
2329
23483
19
0
2336
23491
40
7
2311
23467
98
53
2220
23161
134
105
2017
21434
lithium; oral
N05AN01 [21604556]
2.3e+00
2.2e+00
2.9e+00
—
2.9e+00
2.8e+00
2.8e+00
cases:2.13%
controls:0.22%
cases:1.66%
controls:0.18%
cases:0.55%
controls:0.03%
—
—
cases:0.77%
controls:0.04%
cases:2.37%
controls:0.16%
cases:3.91%
controls:0.24%
50
51
2300
23404
39
43
2316
23448
13
7
2342
23484
—
18
10
2333
23464
55
36
2263
23178
84
52
2067
21487
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
1.9e+00
2.6e+00
2.7e+00
—
3.3e+00
3.1e+00
2.0e+00
cases:7.15%
controls:1.16%
cases:6.92%
controls:0.56%
cases:2.93%
controls:0.20%
—
—
cases:4.85%
controls:0.19%
cases:11.73%
controls:0.62%
cases:13.06%
controls:1.92%
168
273
2182
23182
163
132
2192
23359
69
46
2286
23445
—
114
45
2237
23429
272
143
2046
23071
281
414
1870
21125
Psychologist
Z2445 [2001311558]
1.2e+00
2.1e+00
2.9e+00
—
3.7e+00
2.9e+00
2.6e+00
cases:3.02%
controls:0.94%
cases:2.38%
controls:0.29%
cases:1.19%
controls:0.06%
—
—
cases:2.34%
controls:0.06%
cases:4.75%
controls:0.27%
cases:6.00%
controls:0.46%
71
220
2279
23235
56
69
2299
23422
28
15
2327
23476
—
55
14
2296
23460
110
63
2208
23151
129
100
2022
21439
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
2.3e+00
2.3e+00
2.3e+00
—
2.8e+00
3.0e+00
2.8e+00
cases:2.38%
controls:0.26%
cases:1.83%
controls:0.19%
cases:0.93%
controls:0.09%
—
—
cases:1.32%
controls:0.08%
cases:3.88%
controls:0.21%
cases:6.74%
controls:0.45%
56
60
2294
23395
43
44
2312
23447
22
22
2333
23469
—
31
19
2320
23455
90
48
2228
23166
145
97
2006
21442
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
1.1e+00
2.2e+00
3.8e+00
—
3.2e+00
2.8e+00
2.3e+00
cases:2.51%
controls:0.83%
cases:3.35%
controls:0.40%
cases:2.12%
controls:0.05%
—
—
cases:2.21%
controls:0.09%
cases:5.05%
controls:0.34%
cases:6.83%
controls:0.75%
59
195
2291
23260
79
93
2276
23398
50
11
2305
23480
—
52
21
2299
23453
117
78
2201
23136
147
161
2004
21378
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
2.3e+00
2.8e+00
3.4e+00
1.0e+50
—
3.7e+00
3.1e+00
cases:1.74%
controls:0.18%
cases:1.61%
controls:0.10%
cases:0.76%
controls:0.03%
cases:0.68%
controls:0.00%
—
—
cases:2.46%
controls:0.06%
cases:3.95%
controls:0.18%
41
43
2309
23412
38
23
2317
23468
18
6
2337
23485
16
0
2339
23491
—
57
14
2261
23200
85
38
2066
21501
Mixed personality disorders
F61.0 [2000502024]
2.7e+00
2.8e+00
—
—
3.3e+00
3.2e+00
3.2e+00
cases:1.91%
controls:0.14%
cases:1.44%
controls:0.09%
—
—
—
—
cases:0.72%
controls:0.03%
cases:1.86%
controls:0.08%
cases:3.11%
controls:0.13%
45
32
2305
23423
34
21
2321
23470
—
—
17
6
2334
23468
43
18
2275
23196
67
27
2084
21512
Dietary counselling and surveillance
Z71.3 [45552101]
1.8e+00
3.0e+00
4.4e+00
1.0e+50
—
3.4e+00
2.3e+00
cases:3.06%
controls:0.52%
cases:3.14%
controls:0.17%
cases:2.08%
controls:0.03%
cases:1.02%
controls:0.00%
—
—
cases:5.35%
controls:0.19%
cases:5.58%
controls:0.59%
72
121
2278
23334
74
39
2281
23452
49
6
2306
23485
24
0
2331
23491
—
124
45
2194
23169
120
128
2031
21411
Other childhood emotional disorders
F93.89 [2000502046]
1.9e+00
2.3e+00
2.5e+00
1.0e+50
2.4e+00
3.1e+00
2.6e+00
cases:1.91%
controls:0.29%
cases:1.57%
controls:0.15%
cases:0.85%
controls:0.07%
cases:0.76%
controls:0.00%
cases:0.89%
controls:0.09%
cases:3.24%
controls:0.15%
cases:3.63%
controls:0.28%
45
68
2305
23387
37
36
2318
23455
20
16
2335
23475
18
0
2337
23491
21
20
2330
23454
75
35
2243
23179
78
60
2073
21479
Emotionally unstable personality disorder
F60.3 [45566852]
2.2e+00
2.2e+00
2.3e+00
—
2.3e+00
2.8e+00
3.0e+00
cases:1.02%
controls:0.12%
cases:0.55%
controls:0.06%
cases:0.34%
controls:0.03%
—
—
cases:0.38%
controls:0.04%
cases:1.25%
controls:0.08%
cases:2.93%
controls:0.15%
24
28
2326
23427
13
14
2342
23477
8
8
2347
23483
—
9
9
2342
23465
29
18
2289
23196
63
32
2088
21507
Personality disorder, unspecified
F60.9 [45538076]
3.0e+00
3.9e+00
1.0e+50
1.0e+50
1.0e+50
4.3e+00
3.5e+00
cases:1.32%
controls:0.06%
cases:1.06%
controls:0.02%
cases:0.64%
controls:0.00%
cases:0.98%
controls:0.00%
cases:0.55%
controls:0.00%
cases:1.94%
controls:0.03%
cases:2.79%
controls:0.09%
31
15
2319
23440
25
5
2330
23486
15
0
2340
23491
23
0
2332
23491
13
0
2338
23474
45
6
2273
23208
60
19
2091
21520
Hospital outpatient
ZY010 [2001311599]
1.2e+00
1.6e+00
2.5e+00
—
3.5e+00
3.2e+00
2.7e+00
cases:3.32%
controls:1.02%
cases:2.04%
controls:0.41%
cases:1.44%
controls:0.12%
—
—
cases:3.91%
controls:0.12%
cases:6.34%
controls:0.29%
cases:8.60%
controls:0.64%
78
239
2272
23216
48
97
2307
23394
34
28
2321
23463
—
92
28
2259
23446
147
67
2171
23147
185
137
1966
21402
quetiapine; oral
N05AH04 [21604544]
2.0e+00
2.3e+00
2.3e+00
—
2.8e+00
2.7e+00
2.4e+00
cases:14.13%
controls:2.08%
cases:12.82%
controls:1.39%
cases:4.16%
controls:0.42%
—
—
cases:5.74%
controls:0.36%
cases:18.59%
controls:1.56%
cases:25.24%
controls:2.96%
332
489
2018
22966
302
326
2053
23165
98
98
2257
23393
—
135
84
2216
23390
431
361
1887
22853
543
637
1608
20902
Post-traumatic stress disorder
F43.1 [45595909]
1.9e+00
2.2e+00
2.6e+00
—
3.0e+00
2.7e+00
2.0e+00
cases:1.96%
controls:0.29%
cases:2.04%
controls:0.22%
cases:0.93%
controls:0.07%
—
—
cases:1.57%
controls:0.08%
cases:3.06%
controls:0.21%
cases:4.60%
controls:0.62%
46
69
2304
23386
48
52
2307
23439
22
16
2333
23475
—
37
19
2314
23455
71
49
2247
23165
99
134
2052
21405
Psychiatric treatment plan, standard
ICB01 [2001304098]
1.6e+00
1.7e+00
3.1e+00
1.0e+50
3.0e+00
2.7e+00
2.2e+00
cases:1.79%
controls:0.35%
cases:1.23%
controls:0.23%
cases:0.55%
controls:0.03%
cases:0.85%
controls:0.00%
cases:0.85%
controls:0.04%
cases:4.36%
controls:0.30%
cases:6.23%
controls:0.70%
42
82
2308
23373
29
53
2326
23438
13
6
2342
23485
20
0
2335
23491
20
10
2331
23464
101
69
2217
23145
134
151
2017
21388
Unspecified mood [affective] disorder
F39 [45591137]
1.9e+00
2.0e+00
2.5e+00
1.0e+50
3.4e+00
2.8e+00
1.7e+00
cases:0.94%
controls:0.14%
cases:0.55%
controls:0.07%
cases:0.25%
controls:0.02%
cases:0.47%
controls:0.00%
cases:0.64%
controls:0.02%
cases:1.21%
controls:0.07%
cases:1.72%
controls:0.31%
22
33
2328
23422
13
17
2342
23474
6
5
2349
23486
11
0
2344
23491
15
5
2336
23469
28
17
2290
23197
37
67
2114
21472
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
1.4e+00
1.3e+00
2.6e+00
—
2.9e+00
3.1e+00
2.9e+00
cases:1.32%
controls:0.34%
cases:0.64%
controls:0.17%
cases:0.30%
controls:0.02%
—
—
cases:0.60%
controls:0.03%
cases:2.55%
controls:0.12%
cases:3.81%
controls:0.21%
31
79
2319
23376
15
40
2340
23451
7
5
2348
23486
—
14
8
2337
23466
59
27
2259
23187
82
45
2069
21494
chlorprothixene; oral, parenteral
N05AF03 [21604533]
2.6e+00
2.7e+00
—
—
2.8e+00
2.9e+00
3.2e+00
cases:2.09%
controls:0.16%
cases:1.57%
controls:0.10%
—
—
—
—
cases:0.47%
controls:0.03%
cases:1.86%
controls:0.11%
cases:3.86%
controls:0.16%
49
38
2301
23417
37
24
2318
23467
—
—
11
7
2340
23467
43
25
2275
23189
83
34
2068
21505
Outpatient Visit
OP [9202]
4.5e-01
9.0e-01
1.6e+00
5.6e+00
2.3e+00
2.0e+00
1.2e+00
cases:74.04%
controls:64.46%
cases:65.48%
controls:43.57%
cases:38.64%
controls:11.06%
cases:60.38%
controls:0.57%
cases:56.06%
controls:11.19%
cases:84.69%
controls:43.22%
cases:90.70%
controls:73.75%
1740
15119
610
8336
1542
10236
813
13255
910
2599
1445
20892
1422
134
933
23357
1318
2627
1033
20847
1963
10033
355
13181
1951
15884
200
5655
Diagnostic and symptom-mapping evaluation
IBA01 [2001304043]
1.7e+00
1.8e+00
3.3e+00
—
3.3e+00
2.3e+00
1.7e+00
cases:1.19%
controls:0.23%
cases:0.89%
controls:0.14%
cases:0.55%
controls:0.02%
—
—
cases:0.55%
controls:0.02%
cases:1.55%
controls:0.16%
cases:2.51%
controls:0.46%
28
54
2322
23401
21
34
2334
23457
13
5
2342
23486
—
13
5
2338
23469
36
36
2282
23178
54
99
2097
21440
risperidone; oral, parenteral
N05AX08 [21604559]
1.9e+00
2.2e+00
2.4e+00
—
2.5e+00
2.6e+00
2.5e+00
cases:3.53%
controls:0.54%
cases:2.12%
controls:0.25%
cases:1.02%
controls:0.09%
—
—
cases:0.77%
controls:0.06%
cases:2.93%
controls:0.23%
cases:6.42%
controls:0.58%
83
127
2267
23328
50
59
2305
23432
24
21
2331
23470
—
18
15
2333
23459
68
54
2250
23160
138
125
2013
21414
Bipolar affective disorder, current episode mixed
F31.6 [45571757]
2.5e+00
2.6e+00
—
1.0e+50
2.6e+00
3.2e+00
3.0e+00
cases:1.62%
controls:0.14%
cases:0.89%
controls:0.07%
—
—
cases:0.25%
controls:0.00%
cases:0.34%
controls:0.03%
cases:0.95%
controls:0.04%
cases:2.42%
controls:0.12%
38
32
2312
23423
21
16
2334
23475
—
6
0
2349
23491
8
6
2343
23468
22
9
2296
23205
52
26
2099
21513
Internal Medicine
11 [38004456]
7.6e-01
1.1e+00
1.9e+00
5.7e+00
2.0e+00
1.4e+00
1.0e+00
cases:23.62%
controls:12.68%
cases:16.69%
controls:6.37%
cases:7.60%
controls:1.24%
cases:11.38%
controls:0.04%
cases:8.72%
controls:1.27%
cases:21.83%
controls:6.70%
cases:33.89%
controls:15.75%
555
2974
1795
20481
393
1497
1962
21994
179
292
2176
23199
268
10
2087
23481
205
299
2146
23175
506
1556
1812
21658
729
3392
1422
18147
Psychotherapy
R4140 [2001310238]
2.4e+00
3.6e+00
1.0e+50
1.0e+50
—
4.2e+00
3.6e+00
cases:0.81%
controls:0.08%
cases:0.93%
controls:0.03%
cases:0.72%
controls:0.00%
cases:0.59%
controls:0.00%
—
—
cases:1.77%
controls:0.03%
cases:1.95%
controls:0.06%
19
18
2331
23437
22
6
2333
23485
17
0
2338
23491
14
0
2341
23491
—
41
6
2277
23208
42
12
2109
21527
Dysthymia
F34.1 [45586238]
1.6e+00
2.4e+00
2.4e+00
1.0e+50
2.6e+00
2.5e+00
2.2e+00
cases:1.28%
controls:0.25%
cases:1.36%
controls:0.13%
cases:0.42%
controls:0.04%
cases:1.57%
controls:0.00%
cases:0.81%
controls:0.06%
cases:2.16%
controls:0.19%
cases:3.95%
controls:0.44%
30
59
2320
23396
32
30
2323
23461
10
9
2345
23482
37
0
2318
23491
19
14
2332
23460
50
44
2268
23170
85
95
2066
21444
Bipolar affective disorder, current episode severe depression without psychotic symptoms
F31.4 [45581456]
2.6e+00
3.6e+00
1.0e+50
1.0e+50
1.0e+50
4.1e+00
3.3e+00
cases:1.57%
controls:0.12%
cases:0.81%
controls:0.02%
cases:0.38%
controls:0.00%
cases:0.38%
controls:0.00%
cases:0.47%
controls:0.00%
cases:1.29%
controls:0.02%
cases:2.05%
controls:0.08%
37
27
2313
23428
19
5
2336
23486
9
0
2346
23491
9
0
2346
23491
11
0
2340
23474
30
5
2288
23209
44
17
2107
21522
Poisoning by systemic antibiotics
T36 [45756588]
2.0e+00
2.6e+00
—
1.0e+50
2.5e+00
3.5e+00
3.0e+00
cases:3.53%
controls:0.48%
cases:1.66%
controls:0.12%
—
—
cases:0.55%
controls:0.00%
cases:0.26%
controls:0.02%
cases:3.24%
controls:0.10%
cases:6.60%
controls:0.36%
83
112
2267
23343
39
28
2316
23463
—
13
0
2342
23491
6
5
2345
23469
75
24
2243
23190
142
78
2009
21461
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.2e+00
2.1e+00
3.5e+00
1.0e+50
3.2e+00
2.3e+00
1.3e+00
cases:1.83%
controls:0.54%
cases:1.74%
controls:0.21%
cases:0.81%
controls:0.03%
cases:0.42%
controls:0.00%
cases:0.89%
controls:0.04%
cases:2.29%
controls:0.24%
cases:2.84%
controls:0.78%
43
126
2307
23329
41
50
2314
23441
19
6
2336
23485
10
0
2345
23491
21
9
2330
23465
53
56
2265
23158
61
169
2090
21370
Bipolar affective disorder, unspecified
F31.9 [45571758]
1.8e+00
1.6e+00
2.2e+00
1.0e+50
2.6e+00
2.7e+00
2.5e+00
cases:1.87%
controls:0.30%
cases:1.02%
controls:0.20%
cases:0.47%
controls:0.05%
cases:0.72%
controls:0.00%
cases:0.77%
controls:0.06%
cases:2.29%
controls:0.16%
cases:3.91%
controls:0.32%
44
71
2306
23384
24
47
2331
23444
11
12
2344
23479
17
0
2338
23491
18
13
2333
23461
53
38
2265
23176
84
70
2067
21469
Inpatient Hospital
21 [8717]
3.6e-01
9.0e-01
1.7e+00
6.4e+00
2.2e+00
1.2e+00
7.3e-01
cases:36.13%
controls:28.34%
cases:20.04%
controls:9.28%
cases:6.75%
controls:1.25%
cases:13.46%
controls:0.03%
cases:8.93%
controls:1.09%
cases:23.55%
controls:8.82%
cases:40.68%
controls:24.76%
849
6647
1501
16808
472
2180
1883
21311
159
294
2196
23197
317
6
2038
23485
210
255
2141
23219
546
2047
1772
21167
875
5332
1276
16207
Physiotherapist
Z3226 [2001311560]
8.7e-01
1.9e+00
2.5e+00
—
3.6e+00
2.7e+00
1.8e+00
cases:5.40%
controls:2.33%
cases:3.99%
controls:0.64%
cases:1.61%
controls:0.13%
—
—
cases:3.28%
controls:0.09%
cases:7.94%
controls:0.57%
cases:9.95%
controls:1.73%
127
546
2223
22909
94
150
2261
23341
38
31
2317
23460
—
77
21
2274
23453
184
133
2134
23081
214
373
1937
21166
Sleep apnoea
G47.3 [45562094]
1.8e+00
2.2e+00
2.7e+00
1.0e+50
2.6e+00
2.3e+00
1.8e+00
cases:4.09%
controls:0.67%
cases:3.65%
controls:0.44%
cases:1.40%
controls:0.10%
cases:1.10%
controls:0.00%
cases:1.53%
controls:0.11%
cases:4.40%
controls:0.46%
cases:7.53%
controls:1.36%
96
158
2254
23297
86
103
2269
23388
33
23
2322
23468
26
0
2329
23491
36
26
2315
23448
102
106
2216
23108
162
293
1989
21246
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
1.7e+00
1.9e+00
2.0e+00
—
2.8e+00
2.7e+00
2.2e+00
cases:2.00%
controls:0.37%
cases:1.95%
controls:0.30%
cases:1.02%
controls:0.14%
—
—
cases:2.04%
controls:0.13%
cases:5.87%
controls:0.42%
cases:7.11%
controls:0.80%
47
86
2303
23369
46
70
2309
23421
24
32
2331
23459
—
48
31
2303
23443
136
98
2182
23116
153
173
1998
21366
Other bipolar affective disorders
F31.8 [45586237]
2.2e+00
2.2e+00
2.2e+00
—
2.0e+00
2.2e+00
2.5e+00
cases:1.49%
controls:0.17%
cases:1.15%
controls:0.13%
cases:0.34%
controls:0.04%
—
—
cases:0.38%
controls:0.05%
cases:1.51%
controls:0.16%
cases:3.44%
controls:0.28%
35
41
2315
23414
27
31
2328
23460
8
9
2347
23482
—
9
12
2342
23462
35
38
2283
23176
74
61
2077
21478
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
2.4e+00
2.8e+00
—
1.0e+50
3.1e+00
3.1e+00
1.8e+00
cases:1.62%
controls:0.14%
cases:1.32%
controls:0.08%
—
—
cases:0.34%
controls:0.00%
cases:0.55%
controls:0.03%
cases:1.90%
controls:0.09%
cases:1.95%
controls:0.32%
38
34
2312
23421
31
19
2324
23472
—
8
0
2347
23491
13
6
2338
23468
44
20
2274
23194
42
68
2109
21471
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
1.7e+00
1.9e+00
2.4e+00
1.0e+50
2.6e+00
2.7e+00
1.9e+00
cases:1.70%
controls:0.31%
cases:0.76%
controls:0.11%
cases:0.34%
controls:0.03%
cases:0.72%
controls:0.00%
cases:0.38%
controls:0.03%
cases:1.55%
controls:0.10%
cases:3.30%
controls:0.52%
40
73
2310
23382
18
26
2337
23465
8
7
2347
23484
17
0
2338
23491
9
7
2342
23467
36
24
2282
23190
71
111
2080
21428
Unspecified nonorganic psychosis
F29 [45533099]
1.6e+00
1.9e+00
2.0e+00
—
2.3e+00
2.8e+00
2.6e+00
cases:2.55%
controls:0.53%
cases:1.74%
controls:0.26%
cases:0.85%
controls:0.11%
—
—
cases:0.94%
controls:0.09%
cases:2.89%
controls:0.19%
cases:5.49%
controls:0.42%
60
125
2290
23330
41
61
2314
23430
20
27
2335
23464
—
22
22
2329
23452
67
44
2251
23170
118
91
2033
21448
Recurrent depressive disorder, currently in remission
F33.4 [45533100]
1.8e+00
2.0e+00
2.6e+00
1.0e+50
2.8e+00
1.8e+00
2.0e+00
cases:1.06%
controls:0.17%
cases:0.72%
controls:0.09%
cases:0.34%
controls:0.03%
cases:0.55%
controls:0.00%
cases:0.43%
controls:0.03%
cases:1.12%
controls:0.18%
cases:3.95%
controls:0.57%
25
40
2325
23415
17
22
2338
23469
8
6
2347
23485
13
0
2342
23491
10
6
2341
23468
26
42
2292
23172
85
122
2066
21417
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
1.1e+00
1.3e+00
2.3e+00
1.0e+50
3.5e+00
2.6e+00
2.2e+00
cases:1.91%
controls:0.64%
cases:1.06%
controls:0.29%
cases:0.42%
controls:0.04%
cases:1.27%
controls:0.00%
cases:1.11%
controls:0.03%
cases:2.11%
controls:0.17%
cases:3.81%
controls:0.44%
45
149
2305
23306
25
67
2330
23424
10
10
2345
23481
30
0
2325
23491
26
8
2325
23466
49
39
2269
23175
82
94
2069
21445
olanzapine; oral, parenteral
N05AH03 [21604543]
1.7e+00
2.0e+00
1.6e+00
—
2.2e+00
2.8e+00
2.7e+00
cases:3.74%
controls:0.69%
cases:3.10%
controls:0.45%
cases:0.85%
controls:0.17%
—
—
cases:1.02%
controls:0.11%
cases:5.44%
controls:0.35%
cases:9.86%
controls:0.76%
88
162
2262
23293
73
105
2282
23386
20
41
2335
23450
—
24
26
2327
23448
126
81
2192
23133
212
163
1939
21376
aripiprazole; oral, parenteral
N05AX12 [21604562]
1.8e+00
2.1e+00
1.9e+00
—
1.9e+00
2.6e+00
2.7e+00
cases:3.49%
controls:0.60%
cases:3.14%
controls:0.40%
cases:0.89%
controls:0.14%
—
—
cases:0.89%
controls:0.13%
cases:4.70%
controls:0.37%
cases:9.30%
controls:0.68%
82
141
2268
23314
74
94
2281
23397
21
32
2334
23459
—
21
31
2330
23443
109
87
2209
23127
200
147
1951
21392
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
2.3e+00
2.6e+00
1.5e+00
1.0e+50
2.3e+00
3.0e+00
2.7e+00
cases:1.45%
controls:0.14%
cases:1.19%
controls:0.09%
cases:0.21%
controls:0.05%
cases:0.55%
controls:0.00%
cases:0.38%
controls:0.04%
cases:1.47%
controls:0.08%
cases:2.65%
controls:0.18%
34
33
2316
23422
28
21
2327
23470
5
11
2350
23480
13
0
2342
23491
9
9
2342
23465
34
18
2284
23196
57
39
2094
21500
Mixed anxiety and depressive disorder
F41.2 [45566845]
1.7e+00
2.1e+00
2.6e+00
—
2.8e+00
2.1e+00
1.6e+00
cases:6.26%
controls:1.15%
cases:4.67%
controls:0.61%
cases:2.00%
controls:0.16%
—
—
cases:2.30%
controls:0.15%
cases:5.74%
controls:0.71%
cases:10.00%
controls:2.30%
147
269
2203
23186
110
143
2245
23348
47
37
2308
23454
—
54
35
2297
23439
133
165
2185
23049
215
496
1936
21043
Social phobias
F40.1 [45595907]
1.6e+00
1.9e+00
2.0e+00
—
2.6e+00
2.6e+00
2.2e+00
cases:1.79%
controls:0.38%
cases:1.66%
controls:0.25%
cases:0.93%
controls:0.13%
—
—
cases:1.32%
controls:0.10%
cases:3.45%
controls:0.26%
cases:4.51%
controls:0.54%
42
88
2308
23367
39
58
2316
23433
22
31
2333
23460
—
31
24
2320
23450
80
60
2238
23154
97
116
2054
21423
bupropion; oral
N06AX12 [21604741]
2.0e+00
2.0e+00
2.0e+00
1.0e+50
2.4e+00
2.3e+00
2.1e+00
cases:4.00%
controls:0.58%
cases:3.10%
controls:0.43%
cases:0.93%
controls:0.12%
cases:0.34%
controls:0.00%
cases:1.49%
controls:0.14%
cases:4.62%
controls:0.49%
cases:9.86%
controls:1.30%
94
137
2256
23318
73
100
2282
23391
22
29
2333
23462
8
0
2347
23491
35
32
2316
23442
107
113
2211
23101
212
281
1939
21258
Predominantly compulsive acts [obsessional rituals]
F42.1 [45591138]
1.8e+00
1.9e+00
2.3e+00
—
2.1e+00
2.6e+00
2.1e+00
cases:0.68%
controls:0.12%
cases:0.55%
controls:0.08%
cases:0.34%
controls:0.03%
—
—
cases:0.38%
controls:0.05%
cases:1.25%
controls:0.09%
cases:1.63%
controls:0.20%
16
27
2334
23428
13
19
2342
23472
8
8
2347
23483
—
9
11
2342
23463
29
22
2289
23192
35
44
2116
21495
Recurrent depression, severe episode without somatic syndrome
F33.30 [2000501986]
2.1e+00
1.9e+00
2.5e+00
—
—
3.0e+00
3.3e+00
cases:0.64%
controls:0.08%
cases:0.38%
controls:0.06%
cases:0.25%
controls:0.02%
—
—
—
—
cases:0.99%
controls:0.05%
cases:2.14%
controls:0.08%
15
18
2335
23437
9
13
2346
23478
6
5
2349
23486
—
—
23
12
2295
23202
46
18
2105
21521
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
1.0e+00
1.7e+00
2.6e+00
1.0e+50
3.3e+00
2.2e+00
2.0e+00
cases:3.62%
controls:1.35%
cases:3.99%
controls:0.75%
cases:2.29%
controls:0.18%
cases:1.06%
controls:0.00%
cases:3.83%
controls:0.15%
cases:6.13%
controls:0.72%
cases:9.44%
controls:1.46%
85
317
2265
23138
94
176
2261
23315
54
42
2301
23449
25
0
2330
23491
90
35
2261
23439
142
167
2176
23047
203
314
1948
21225
venlafaxine; oral
N06AX16 [21604745]
1.8e+00
2.0e+00
2.2e+00
—
2.2e+00
2.4e+00
2.1e+00
cases:8.26%
controls:1.40%
cases:7.01%
controls:0.97%
cases:2.29%
controls:0.26%
—
—
cases:2.85%
controls:0.34%
cases:9.36%
controls:0.97%
cases:14.60%
controls:2.02%
194
328
2156
23127
165
229
2190
23262
54
61
2301
23430
—
67
79
2284
23395
217
226
2101
22988
314
435
1837
21104
buspirone; oral
N05BE01 [21604601]
1.9e+00
2.2e+00
—
—
2.6e+00
2.8e+00
3.2e+00
cases:0.98%
controls:0.14%
cases:0.59%
controls:0.06%
—
—
—
—
cases:0.34%
controls:0.03%
cases:0.95%
controls:0.06%
cases:1.72%
controls:0.07%
23
33
2327
23422
14
15
2341
23476
—
—
8
6
2343
23468
22
14
2296
23200
37
16
2114
21523
Depressive episode
F32 [45595904]
1.6e+00
2.3e+00
2.8e+00
—
2.6e+00
1.7e+00
1.6e+00
cases:2.13%
controls:0.42%
cases:1.49%
controls:0.16%
cases:0.51%
controls:0.03%
—
—
cases:0.30%
controls:0.02%
cases:1.04%
controls:0.19%
cases:3.16%
controls:0.66%
50
99
2300
23356
35
37
2320
23454
12
7
2343
23484
—
7
5
2344
23469
24
43
2294
23171
68
143
2083
21396
Anxiety disorder, unspecified
F41.9 [45542849]
1.6e+00
1.9e+00
2.4e+00
—
2.7e+00
2.3e+00
1.7e+00
cases:6.89%
controls:1.46%
cases:5.61%
controls:0.86%
cases:2.68%
controls:0.24%
—
—
cases:3.23%
controls:0.23%
cases:8.20%
controls:0.85%
cases:13.76%
controls:2.78%
162
342
2188
23113
132
202
2223
23289
63
57
2292
23434
—
76
54
2275
23420
190
198
2128
23016
296
599
1855
20940
Office Visit
OMOP4822458 [581477]
4.8e-01
8.0e-01
1.7e+00
5.0e+00
2.3e+00
1.4e+00
9.5e-01
cases:16.81%
controls:11.15%
cases:8.24%
controls:3.87%
cases:3.23%
controls:0.58%
cases:4.08%
controls:0.03%
cases:5.66%
controls:0.59%
cases:12.77%
controls:3.63%
cases:19.34%
controls:8.48%
395
2616
1955
20839
194
909
2161
22582
76
137
2279
23354
96
7
2259
23484
133
138
2218
23336
296
842
2022
22372
416
1827
1735
19712
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
9.6e-01
1.2e+00
2.1e+00
—
3.2e+00
2.8e+00
2.3e+00
cases:2.72%
controls:1.06%
cases:1.61%
controls:0.47%
cases:0.89%
controls:0.11%
—
—
cases:2.08%
controls:0.09%
cases:4.23%
controls:0.28%
cases:6.46%
controls:0.68%
64
249
2286
23206
38
110
2317
23381
21
25
2334
23466
—
49
21
2302
23453
98
65
2220
23149
139
147
2012
21392
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
8.4e-01
1.3e+00
2.1e+00
1.0e+50
3.1e+00
2.7e+00
2.4e+00
cases:1.66%
controls:0.72%
cases:1.15%
controls:0.30%
cases:0.30%
controls:0.04%
cases:0.38%
controls:0.00%
cases:1.02%
controls:0.05%
cases:3.24%
controls:0.22%
cases:5.11%
controls:0.47%
39
169
2311
23286
27
71
2328
23420
7
9
2348
23482
9
0
2346
23491
24
11
2327
23463
75
50
2243
23164
110
102
2041
21437
Participation in compiling a psychiatric treatment plan
ICZ03 [2001304119]
1.5e+00
1.5e+00
2.2e+00
1.0e+50
2.8e+00
2.4e+00
2.1e+00
cases:2.17%
controls:0.49%
cases:1.36%
controls:0.32%
cases:0.55%
controls:0.06%
cases:1.15%
controls:0.00%
cases:0.64%
controls:0.04%
cases:3.58%
controls:0.33%
cases:4.65%
controls:0.61%
51
116
2299
23339
32
75
2323
23416
13
14
2342
23477
27
0
2328
23491
15
9
2336
23465
83
77
2235
23137
100
131
2051
21408
Remote contact by phone
ZYC01 [2001311579]
1.1e+00
1.8e+00
2.3e+00
—
2.6e+00
2.5e+00
2.2e+00
cases:1.15%
controls:0.38%
cases:0.93%
controls:0.15%
cases:0.25%
controls:0.03%
—
—
cases:0.64%
controls:0.05%
cases:1.98%
controls:0.17%
cases:3.16%
controls:0.38%
27
89
2323
23366
22
36
2333
23455
6
6
2349
23485
—
15
11
2336
23463
46
40
2272
23174
68
81
2083
21458
temazepam; oral
N05CD07 [21604642]
1.9e+00
2.1e+00
1.7e+00
—
2.3e+00
2.2e+00
2.3e+00
cases:5.32%
controls:0.84%
cases:3.44%
controls:0.46%
cases:0.47%
controls:0.09%
—
—
cases:0.85%
controls:0.09%
cases:4.06%
controls:0.46%
cases:8.88%
controls:0.99%
125
196
2225
23259
81
107
2274
23384
11
21
2344
23470
—
20
20
2331
23454
94
106
2224
23108
191
214
1960
21325
Mild depressive episode without somatic syndrome
F32.00 [2000501978]
1.0e+00
1.6e+00
2.8e+00
—
2.9e+00
2.4e+00
1.5e+00
cases:1.36%
controls:0.49%
cases:0.85%
controls:0.17%
cases:0.51%
controls:0.03%
—
—
cases:0.55%
controls:0.03%
cases:2.03%
controls:0.19%
cases:3.02%
controls:0.70%
32
115
2318
23340
20
39
2335
23452
12
7
2343
23484
—
13
7
2338
23467
47
43
2271
23171
65
151
2086
21388
citalopram; oral, parenteral
N06AB04 [21604712]
1.5e+00
1.6e+00
1.8e+00
3.1e+00
1.7e+00
1.4e+00
1.3e+00
cases:9.15%
controls:2.29%
cases:5.77%
controls:1.24%
cases:1.83%
controls:0.32%
cases:0.47%
controls:0.02%
cases:2.17%
controls:0.40%
cases:5.35%
controls:1.36%
cases:9.48%
controls:2.69%
215
538
2135
22917
136
292
2219
23199
43
75
2312
23416
11
5
2344
23486
51
95
2300
23379
124
315
2194
22899
204
579
1947
20960
escitalopram; oral
N06AB10 [21604718]
1.4e+00
1.6e+00
1.6e+00
2.7e+00
1.9e+00
1.8e+00
1.4e+00
cases:10.94%
controls:2.92%
cases:8.45%
controls:1.78%
cases:2.17%
controls:0.44%
cases:0.51%
controls:0.03%
cases:2.81%
controls:0.45%
cases:10.09%
controls:1.90%
cases:15.85%
controls:4.60%
257
686
2093
22769
199
418
2156
23073
51
103
2304
23388
12
8
2343
23483
66
106
2285
23368
234
441
2084
22773
341
991
1810
20548
Depressive disorder
P76 [2002000870]
1.6e+00
2.3e+00
3.0e+00
—
2.2e+00
1.7e+00
1.6e+00
cases:3.28%
controls:0.69%
cases:3.06%
controls:0.32%
cases:0.89%
controls:0.05%
—
—
cases:0.51%
controls:0.06%
cases:2.07%
controls:0.39%
cases:6.09%
controls:1.35%
77
161
2273
23294
72
75
2283
23416
21
11
2334
23480
—
12
14
2339
23460
48
90
2270
23124
131
290
2020
21249
Obesity due to excess calories
E66.01 [2000501501]
1.4e+00
2.1e+00
2.4e+00
—
2.3e+00
2.1e+00
1.8e+00
cases:3.28%
controls:0.84%
cases:3.14%
controls:0.41%
cases:1.06%
controls:0.09%
—
—
cases:1.06%
controls:0.11%
cases:3.49%
controls:0.44%
cases:6.74%
controls:1.18%
77
198
2273
23257
74
97
2281
23394
25
22
2330
23469
—
25
25
2326
23449
81
101
2237
23113
145
254
2006
21285
doxepin; oral, parenteral
N06AA12 [21604699]
1.9e+00
2.7e+00
—
—
2.5e+00
2.5e+00
2.5e+00
cases:1.53%
controls:0.23%
cases:0.68%
controls:0.05%
—
—
—
—
cases:0.26%
controls:0.02%
cases:0.82%
controls:0.07%
cases:1.95%
controls:0.16%
36
53
2314
23402
16
11
2339
23480
—
—
6
5
2345
23469
19
16
2299
23198
42
35
2109
21504
Severe psychotic and other severe mental disorders
112 [2001600112]
2.1e+00
2.8e+00
—
—
1.0e+50
3.9e+00
3.2e+00
cases:3.62%
controls:0.46%
cases:1.87%
controls:0.11%
—
—
—
—
cases:0.55%
controls:0.00%
cases:2.59%
controls:0.06%
cases:6.00%
controls:0.26%
85
107
2265
23348
44
27
2311
23464
—
—
13
0
2338
23474
60
13
2258
23201
129
56
2022
21483
oxazepam; oral
N05BA04 [21604569]
1.7e+00
2.0e+00
2.1e+00
—
2.2e+00
2.2e+00
1.9e+00
cases:10.85%
controls:2.28%
cases:8.28%
controls:1.19%
cases:2.55%
controls:0.32%
—
—
cases:2.68%
controls:0.32%
cases:9.88%
controls:1.26%
cases:18.46%
controls:3.33%
255
535
2095
22920
195
280
2160
23211
60
75
2295
23416
—
63
74
2288
23400
229
292
2089
22922
397
718
1754
20821
Counselling and guidance related to nutrition and weight management
SPAT1306 [2001700407]
1.5e+00
2.1e+00
3.1e+00
—
2.3e+00
1.7e+00
1.2e+00
cases:5.62%
controls:1.28%
cases:3.69%
controls:0.48%
cases:1.49%
controls:0.07%
—
—
cases:0.72%
controls:0.07%
cases:2.42%
controls:0.43%
cases:5.30%
controls:1.68%
132
301
2218
23154
87
112
2268
23379
35
16
2320
23475
—
17
17
2334
23457
56
100
2262
23114
114
361
2037
21178
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
9.4e-01
1.7e+00
3.0e+00
—
3.2e+00
1.9e+00
1.2e+00
cases:1.11%
controls:0.43%
cases:1.49%
controls:0.27%
cases:0.51%
controls:0.03%
—
—
cases:0.60%
controls:0.03%
cases:1.86%
controls:0.29%
cases:3.44%
controls:1.04%
26
102
2324
23353
35
63
2320
23428
12
6
2343
23485
—
14
6
2337
23468
43
67
2275
23147
74
225
2077
21314
Generalized anxiety disorder
F41.1 [45571764]
1.8e+00
1.8e+00
1.8e+00
—
2.7e+00
2.1e+00
1.7e+00
cases:3.11%
controls:0.54%
cases:2.42%
controls:0.42%
cases:0.85%
controls:0.14%
—
—
cases:1.91%
controls:0.13%
cases:4.23%
controls:0.53%
cases:6.83%
controls:1.35%
73
126
2277
23329
57
98
2298
23393
20
32
2335
23459
—
45
31
2306
23443
98
122
2220
23092
147
291
2004
21248
Moderate depressive episode
F32.1 [45552478]
1.6e+00
2.3e+00
2.2e+00
—
2.2e+00
1.8e+00
1.6e+00
cases:2.26%
controls:0.46%
cases:2.29%
controls:0.23%
cases:0.59%
controls:0.06%
—
—
cases:0.64%
controls:0.07%
cases:1.94%
controls:0.32%
cases:4.37%
controls:0.93%
53
108
2297
23347
54
55
2301
23436
14
15
2341
23476
—
15
16
2336
23458
45
75
2273
23139
94
201
2057
21338
Recurrent depression, mild episode without somatic syndrome
F33.00 [2000501982]
2.6e+00
2.5e+00
2.1e+00
1.0e+50
—
3.6e+00
3.0e+00
cases:1.28%
controls:0.10%
cases:0.68%
controls:0.06%
cases:0.21%
controls:0.03%
cases:0.98%
controls:0.00%
—
—
cases:1.90%
controls:0.05%
cases:3.95%
controls:0.21%
30
23
2320
23432
16
13
2339
23478
5
6
2350
23485
23
0
2332
23491
—
44
12
2274
23202
85
45
2066
21494
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
1.2e+00
2.2e+00
1.9e+00
—
2.8e+00
2.0e+00
1.6e+00
cases:3.32%
controls:1.06%
cases:2.76%
controls:0.32%
cases:0.30%
controls:0.05%
—
—
cases:0.51%
controls:0.03%
cases:2.29%
controls:0.31%
cases:6.37%
controls:1.31%
78
249
2272
23206
65
76
2290
23415
7
11
2348
23480
—
12
7
2339
23467
53
71
2265
23143
137
283
2014
21256
mirtazapine; oral
N06AX11 [21604740]
1.5e+00
2.0e+00
2.0e+00
1.0e+50
2.4e+00
2.1e+00
1.6e+00
cases:9.28%
controls:2.24%
cases:7.09%
controls:0.98%
cases:1.83%
controls:0.25%
cases:0.55%
controls:0.00%
cases:2.47%
controls:0.23%
cases:9.10%
controls:1.26%
cases:14.69%
controls:3.32%
218
526
2132
22929
167
231
2188
23260
43
59
2312
23432
13
0
2342
23491
58
54
2293
23420
211
292
2107
22922
316
716
1835
20823
clozapine; oral, parenteral
N05AH02 [21604542]
2.0e+00
1.8e+00
1.8e+00
—
1.5e+00
2.1e+00
2.4e+00
cases:1.57%
controls:0.21%
cases:1.44%
controls:0.24%
cases:1.15%
controls:0.19%
—
—
cases:0.85%
controls:0.19%
cases:1.98%
controls:0.26%
cases:3.44%
controls:0.33%
37
50
2313
23405
34
56
2321
23435
27
44
2328
23447
—
20
44
2331
23430
46
60
2272
23154
74
71
2077
21468
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
5.3e-01
1.1e+00
1.9e+00
4.0e+00
2.0e+00
1.2e+00
8.7e-01
cases:19.45%
controls:12.42%
cases:20.55%
controls:7.96%
cases:8.32%
controls:1.29%
cases:2.63%
controls:0.05%
cases:8.42%
controls:1.23%
cases:22.43%
controls:8.22%
cases:42.54%
controls:23.59%
457
2912
1893
20543
484
1869
1871
21622
196
304
2159
23187
62
12
2293
23479
198
288
2153
23186
520
1908
1798
21306
915
5080
1236
16459
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
1.1e+00
1.6e+00
2.6e+00
—
2.9e+00
1.8e+00
1.6e+00
cases:6.64%
controls:2.35%
cases:5.77%
controls:1.20%
cases:2.04%
controls:0.16%
—
—
cases:2.72%
controls:0.15%
cases:6.17%
controls:1.03%
cases:14.64%
controls:3.44%
156
551
2194
22904
136
281
2219
23210
48
38
2307
23453
—
64
36
2287
23438
143
240
2175
22974
315
741
1836
20798
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
5.3e-01
1.1e+00
1.9e+00
4.0e+00
2.0e+00
1.2e+00
8.6e-01
cases:19.36%
controls:12.40%
cases:20.51%
controls:7.94%
cases:8.32%
controls:1.30%
cases:2.68%
controls:0.05%
cases:8.29%
controls:1.22%
cases:22.22%
controls:8.19%
cases:42.26%
controls:23.59%
455
2908
1895
20547
483
1866
1872
21625
196
306
2159
23185
63
12
2292
23479
195
286
2156
23188
515
1901
1803
21313
909
5080
1242
16459
zolpidem; oral
N05CF02 [21604655]
1.7e+00
2.0e+00
2.3e+00
—
2.0e+00
1.8e+00
1.7e+00
cases:4.81%
controls:0.91%
cases:3.23%
controls:0.44%
cases:0.89%
controls:0.09%
—
—
cases:0.55%
controls:0.08%
cases:2.98%
controls:0.51%
cases:6.46%
controls:1.21%
113
214
2237
23241
76
103
2279
23388
21
21
2334
23470
—
13
18
2338
23456
69
118
2249
23096
139
261
2012
21278
Accelerated psychiatric treatment contact
IGY01 [2001304321]
1.8e+00
2.4e+00
2.8e+00
—
1.3e+00
2.3e+00
2.1e+00
cases:1.23%
controls:0.20%
cases:1.40%
controls:0.13%
cases:0.42%
controls:0.03%
—
—
cases:0.21%
controls:0.06%
cases:1.94%
controls:0.19%
cases:3.72%
controls:0.47%
29
47
2321
23408
33
30
2322
23461
10
6
2345
23485
—
5
14
2346
23460
45
44
2273
23170
80
101
2071
21438
vortioxetine; oral
N06AX26 [44819158]
1.8e+00
1.8e+00
2.3e+00
—
1.9e+00
2.0e+00
1.6e+00
cases:2.26%
controls:0.39%
cases:2.12%
controls:0.35%
cases:0.72%
controls:0.07%
—
—
cases:0.77%
controls:0.11%
cases:2.59%
controls:0.34%
cases:4.79%
controls:1.02%
53
91
2297
23364
50
82
2305
23409
17
17
2338
23474
—
18
26
2333
23448
60
80
2258
23134
103
220
2048
21319
Nutritional therapy
R4190 [2001310243]
1.1e+00
1.8e+00
2.9e+00
1.0e+50
—
3.3e+00
2.4e+00
cases:1.36%
controls:0.48%
cases:1.27%
controls:0.21%
cases:0.47%
controls:0.03%
cases:0.64%
controls:0.00%
—
—
cases:4.92%
controls:0.19%
cases:3.95%
controls:0.37%
32
112
2318
23343
30
50
2325
23441
11
6
2344
23485
15
0
2340
23491
—
114
45
2204
23169
85
79
2066
21460
hydroxyzine; oral, parenteral
N05BB01 [21604590]
1.2e+00
1.6e+00
2.4e+00
—
2.5e+00
2.1e+00
1.6e+00
cases:4.17%
controls:1.30%
cases:2.21%
controls:0.45%
cases:0.51%
controls:0.05%
—
—
cases:0.77%
controls:0.06%
cases:3.67%
controls:0.45%
cases:8.37%
controls:1.81%
98
304
2252
23151
52
106
2303
23385
12
11
2343
23480
—
18
15
2333
23459
85
104
2233
23110
180
389
1971
21150
Other function in accordance with nutritional therapy nomenclature
SPAT1298 [2001700399]
2.2e+00
3.3e+00
—
—
—
3.4e+00
2.5e+00
cases:0.68%
controls:0.07%
cases:0.55%
controls:0.02%
—
—
—
—
—
—
cases:0.65%
controls:0.02%
cases:0.79%
controls:0.06%
16
17
2334
23438
13
5
2342
23486
—
—
—
15
5
2303
23209
17
14
2134
21525
Hypokalaemia
E87.6 [45537991]
2.3e+00
3.1e+00
—
1.0e+50
1.0e+50
3.3e+00
2.7e+00
cases:0.68%
controls:0.07%
cases:0.64%
controls:0.03%
—
—
cases:0.34%
controls:0.00%
cases:0.34%
controls:0.00%
cases:0.82%
controls:0.03%
cases:1.77%
controls:0.12%
16
16
2334
23439
15
7
2340
23484
—
8
0
2347
23491
8
0
2343
23474
19
7
2299
23207
38
26
2113
21513
sertraline; oral
N06AB06 [21604714]
1.8e+00
1.9e+00
1.9e+00
—
1.9e+00
2.1e+00
1.8e+00
cases:7.74%
controls:1.40%
cases:6.28%
controls:0.98%
cases:1.78%
controls:0.26%
—
—
cases:1.74%
controls:0.27%
cases:7.89%
controls:1.03%
cases:12.46%
controls:2.34%
182
328
2168
23127
148
230
2207
23261
42
62
2313
23429
—
41
64
2310
23410
183
239
2135
22975
268
504
1883
21035
duloxetine; oral
N06AX21 [21604749]
1.8e+00
1.9e+00
1.9e+00
—
2.1e+00
2.0e+00
1.6e+00
cases:3.96%
controls:0.67%
cases:2.76%
controls:0.41%
cases:1.06%
controls:0.16%
—
—
cases:1.32%
controls:0.17%
cases:3.80%
controls:0.53%
cases:5.63%
controls:1.16%
93
156
2257
23299
65
97
2290
23394
25
37
2330
23454
—
31
39
2320
23435
88
123
2230
23091
121
250
2030
21289
Anxious [avoidant] personality disorder
F60.6 [45557213]
2.7e+00
2.5e+00
—
—
—
3.2e+00
3.0e+00
cases:0.51%
controls:0.03%
cases:0.30%
controls:0.03%
—
—
—
—
—
—
cases:0.60%
controls:0.03%
cases:1.21%
controls:0.06%
12
8
2338
23447
7
6
2348
23485
—
—
—
14
6
2304
23208
26
13
2125
21526
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.4e+00
1.7e+00
2.5e+00
—
2.2e+00
1.8e+00
1.6e+00
cases:5.53%
controls:1.36%
cases:3.27%
controls:0.63%
cases:1.02%
controls:0.08%
—
—
cases:0.94%
controls:0.10%
cases:3.84%
controls:0.66%
cases:7.95%
controls:1.65%
130
320
2220
23135
77
147
2278
23344
24
19
2331
23472
—
22
24
2329
23450
89
154
2229
23060
171
356
1980
21183
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
1.5e+00
1.7e+00
2.3e+00
1.0e+50
3.0e+00
1.9e+00
8.6e-01
cases:1.32%
controls:0.29%
cases:0.85%
controls:0.16%
cases:0.34%
controls:0.03%
cases:0.30%
controls:0.00%
cases:0.68%
controls:0.03%
cases:1.08%
controls:0.16%
cases:1.63%
controls:0.70%
31
68
2319
23387
20
37
2335
23454
8
8
2347
23483
7
0
2348
23491
16
8
2335
23466
25
38
2293
23176
35
150
2116
21389
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
9.9e-01
1.7e+00
2.7e+00
1.0e+50
2.7e+00
1.7e+00
1.5e+00
cases:3.23%
controls:1.22%
cases:2.68%
controls:0.52%
cases:0.76%
controls:0.05%
cases:0.21%
controls:0.00%
cases:0.72%
controls:0.05%
cases:2.98%
controls:0.54%
cases:9.48%
controls:2.30%
76
287
2274
23168
63
121
2292
23370
18
12
2337
23479
5
0
2350
23491
17
12
2334
23462
69
125
2249
23089
204
495
1947
21044
Profession-specific psychiatric evaluation
IBZ01 [2001304075]
2.2e+00
1.7e+00
2.6e+00
1.0e+50
—
2.6e+00
2.1e+00
cases:1.53%
controls:0.17%
cases:0.85%
controls:0.15%
cases:0.30%
controls:0.02%
cases:0.21%
controls:0.00%
—
—
cases:2.16%
controls:0.16%
cases:3.21%
controls:0.41%
36
41
2314
23414
20
36
2335
23455
7
5
2348
23486
5
0
2350
23491
—
50
38
2268
23176
69
88
2082
21451
Recurrent depression, moderate episode of somatic syndrome
F33.11 [2000501985]
2.6e+00
3.1e+00
—
1.0e+50
—
2.8e+00
2.8e+00
cases:1.36%
controls:0.10%
cases:1.02%
controls:0.05%
—
—
cases:0.47%
controls:0.00%
—
—
cases:1.08%
controls:0.07%
cases:2.74%
controls:0.18%
32
24
2318
23431
24
11
2331
23480
—
11
0
2344
23491
—
25
16
2293
23198
59
38
2092
21501
Anankastic personality disorder
F60.5 [45591150]
2.3e+00
3.0e+00
—
1.0e+50
—
3.4e+00
2.5e+00
cases:0.72%
controls:0.07%
cases:0.76%
controls:0.04%
—
—
cases:0.81%
controls:0.00%
—
—
cases:1.25%
controls:0.04%
cases:1.44%
controls:0.12%
17
17
2333
23438
18
9
2337
23482
—
19
0
2336
23491
—
29
10
2289
23204
31
25
2120
21514
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.5e+00
1.4e+00
2.1e+00
—
2.2e+00
2.0e+00
1.9e+00
cases:1.19%
controls:0.27%
cases:0.76%
controls:0.19%
cases:0.38%
controls:0.05%
—
—
cases:0.47%
controls:0.05%
cases:0.95%
controls:0.12%
cases:2.14%
controls:0.32%
28
64
2322
23391
18
44
2337
23447
9
11
2346
23480
—
11
12
2340
23462
22
29
2296
23185
46
68
2105
21471
lamotrigine; oral
N03AX09 [21604431]
1.6e+00
1.8e+00
1.7e+00
—
1.9e+00
2.0e+00
2.3e+00
cases:3.96%
controls:0.85%
cases:3.01%
controls:0.51%
cases:0.89%
controls:0.17%
—
—
cases:1.06%
controls:0.16%
cases:4.10%
controls:0.59%
cases:8.23%
controls:0.92%
93
200
2257
23255
71
120
2284
23371
21
40
2334
23451
—
25
37
2326
23437
95
138
2223
23076
177
199
1974
21340
Intentional self-harm by sharp object
X78 [45756450]
2.2e+00
2.7e+00
—
—
—
3.4e+00
2.9e+00
cases:0.85%
controls:0.10%
cases:0.38%
controls:0.03%
—
—
—
—
—
—
cases:0.99%
controls:0.03%
cases:1.86%
controls:0.10%
20
23
2330
23432
9
6
2346
23485
—
—
—
23
8
2295
23206
40
22
2111
21517
Dedicated profession-specific psychiatric intervention, group
IER02 [2001304206]
2.2e+00
2.7e+00
—
—
—
3.7e+00
2.6e+00
cases:0.55%
controls:0.06%
cases:0.38%
controls:0.03%
—
—
—
—
—
—
cases:1.34%
controls:0.03%
cases:1.81%
controls:0.14%
13
14
2337
23441
9
6
2346
23485
—
—
—
31
8
2287
23206
39
31
2112
21508
Nausea and vomiting
R11 [45539317]
1.1e+00
1.7e+00
3.1e+00
—
2.6e+00
1.5e+00
1.2e+00
cases:2.00%
controls:0.71%
cases:1.23%
controls:0.23%
cases:0.89%
controls:0.04%
—
—
cases:0.47%
controls:0.03%
cases:1.21%
controls:0.26%
cases:3.30%
controls:0.99%
47
166
2303
23289
29
55
2326
23436
21
10
2334
23481
—
11
8
2340
23466
28
61
2290
23153
71
214
2080
21325
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
2.0e+00
2.8e+00
—
1.0e+50
—
3.2e+00
3.1e+00
cases:3.06%
controls:0.42%
cases:1.49%
controls:0.09%
—
—
cases:0.42%
controls:0.00%
—
—
cases:2.37%
controls:0.10%
cases:5.58%
controls:0.26%
72
99
2278
23356
35
21
2320
23470
—
10
0
2345
23491
—
55
23
2263
23191
120
56
2031
21483
Bipolar affective disorder, current episode hypomanic
F31.0 [45542840]
2.1e+00
1.7e+00
—
—
—
3.6e+00
3.7e+00
cases:0.89%
controls:0.11%
cases:0.34%
controls:0.06%
—
—
—
—
—
—
cases:0.91%
controls:0.03%
cases:1.86%
controls:0.05%
21
25
2329
23430
8
14
2347
23477
—
—
—
21
6
2297
23208
40
10
2111
21529
Other psychiatric treatment contact
IGY99 [2001304323]
1.5e+00
1.7e+00
1.7e+00
1.0e+50
2.4e+00
3.1e+00
2.3e+00
cases:1.62%
controls:0.36%
cases:1.06%
controls:0.19%
cases:0.21%
controls:0.04%
cases:0.21%
controls:0.00%
cases:0.64%
controls:0.06%
cases:4.18%
controls:0.19%
cases:4.32%
controls:0.44%
38
84
2312
23371
25
45
2330
23446
5
9
2350
23482
5
0
2350
23491
15
13
2336
23461
97
44
2221
23170
93
95
2058
21444
Weight loss
T08 [2002001071]
2.2e+00
3.4e+00
—
—
1.0e+50
3.4e+00
2.1e+00
cases:1.02%
controls:0.12%
cases:1.36%
controls:0.05%
—
—
—
—
cases:0.51%
controls:0.00%
cases:0.78%
controls:0.03%
cases:0.74%
controls:0.09%
24
27
2326
23428
32
11
2323
23480
—
—
12
0
2339
23474
18
6
2300
23208
16
19
2135
21520
Secondary amenorrhoea
N91.1 [45601758]
1.6e+00
2.2e+00
—
1.0e+50
2.3e+00
3.0e+00
2.0e+00
cases:2.21%
controls:0.45%
cases:1.78%
controls:0.20%
—
—
cases:0.30%
controls:0.00%
cases:0.26%
controls:0.03%
cases:3.15%
controls:0.17%
cases:4.42%
controls:0.61%
52
105
2298
23350
42
47
2313
23444
—
7
0
2348
23491
6
6
2345
23468
73
39
2245
23175
95
131
2056
21408
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6.5e-01
1.0e+00
1.8e+00
3.8e+00
1.7e+00
1.1e+00
1.0e+00
cases:12.51%
controls:6.96%
cases:11.30%
controls:4.50%
cases:4.71%
controls:0.82%
cases:1.10%
controls:0.03%
cases:4.04%
controls:0.76%
cases:12.68%
controls:4.40%
cases:28.68%
controls:12.73%
294
1632
2056
21823
266
1056
2089
22435
111
193
2244
23298
26
6
2329
23485
95
178
2256
23296
294
1021
2024
22193
617
2742
1534
18797
UNS Panic Syndrome
F41.09 [2000501997]
1.5e+00
1.9e+00
2.6e+00
1.0e+50
2.2e+00
1.7e+00
1.2e+00
cases:1.66%
controls:0.36%
cases:1.10%
controls:0.17%
cases:0.47%
controls:0.03%
cases:0.38%
controls:0.00%
cases:0.38%
controls:0.04%
cases:1.08%
controls:0.20%
cases:2.00%
controls:0.64%
39
85
2311
23370
26
41
2329
23450
11
8
2344
23483
9
0
2346
23491
9
10
2342
23464
25
46
2293
23168
43
137
2108
21402
trazodone; oral
N06AX05 [21604734]
2.5e+00
2.7e+00
—
—
—
3.1e+00
2.8e+00
cases:1.19%
controls:0.10%
cases:0.85%
controls:0.06%
—
—
—
—
—
—
cases:1.12%
controls:0.05%
cases:3.11%
controls:0.19%
28
23
2322
23432
20
14
2335
23477
—
—
—
26
12
2292
23202
67
42
2084
21497
Other recurrent depressive disorders
F33.8 [45600740]
2.0e+00
2.6e+00
—
1.0e+50
—
3.0e+00
3.4e+00
cases:0.34%
controls:0.05%
cases:0.30%
controls:0.02%
—
—
cases:0.25%
controls:0.00%
—
—
cases:0.60%
controls:0.03%
cases:1.72%
controls:0.06%
8
11
2342
23444
7
5
2348
23486
—
6
0
2349
23491
—
14
7
2304
23207
37
13
2114
21526
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
9.5e-01
1.2e+00
3.0e+00
1.0e+50
2.8e+00
1.7e+00
1.2e+00
cases:5.19%
controls:2.07%
cases:3.18%
controls:0.99%
cases:1.57%
controls:0.08%
cases:0.34%
controls:0.00%
cases:1.91%
controls:0.12%
cases:5.09%
controls:0.94%
cases:12.04%
controls:3.86%
122
486
2228
22969
75
233
2280
23258
37
19
2318
23472
8
0
2347
23491
45
27
2306
23447
118
218
2200
22996
259
832
1892
20707
Dissociative [conversion] disorder, unspecified
F44.9 [45605495]
2.3e+00
2.4e+00
—
1.0e+50
—
2.8e+00
3.4e+00
cases:0.51%
controls:0.05%
cases:0.38%
controls:0.03%
—
—
cases:0.30%
controls:0.00%
—
—
cases:0.60%
controls:0.04%
cases:1.35%
controls:0.05%
12
12
2338
23443
9
8
2346
23483
—
7
0
2348
23491
—
14
9
2304
23205
29
10
2122
21529
Schizoaffective disorder, unspecified
F25.9 [45605490]
1.6e+00
2.3e+00
—
1.0e+50
2.2e+00
2.5e+00
2.2e+00
cases:0.47%
controls:0.09%
cases:0.51%
controls:0.05%
—
—
cases:0.42%
controls:0.00%
cases:0.30%
controls:0.03%
cases:0.69%
controls:0.06%
cases:1.39%
controls:0.16%
11
22
2339
23433
12
12
2343
23479
—
10
0
2345
23491
7
8
2344
23466
16
13
2302
23201
30
34
2121
21505
Psychological sympt/compl other
P29 [2002000823]
1.3e+00
1.9e+00
2.6e+00
—
2.2e+00
1.5e+00
1.3e+00
cases:3.19%
controls:0.87%
cases:2.46%
controls:0.38%
cases:0.68%
controls:0.05%
—
—
cases:0.55%
controls:0.06%
cases:1.81%
controls:0.41%
cases:6.65%
controls:1.89%
75
203
2275
23252
58
90
2297
23401
16
12
2339
23479
—
13
15
2338
23459
42
96
2276
23118
143
408
2008
21131
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
1.2e+00
1.4e+00
2.3e+00
—
2.3e+00
1.7e+00
1.8e+00
cases:1.53%
controls:0.48%
cases:1.02%
controls:0.25%
cases:0.38%
controls:0.04%
—
—
cases:0.30%
controls:0.03%
cases:1.12%
controls:0.20%
cases:4.65%
controls:0.80%
36
112
2314
23343
24
58
2331
23433
9
9
2346
23482
—
7
7
2344
23467
26
47
2292
23167
100
172
2051
21367
Psychiatric monitoring contact
IGY02 [2001304322]
1.5e+00
1.5e+00
1.7e+00
—
2.0e+00
2.0e+00
1.9e+00
cases:1.23%
controls:0.27%
cases:1.19%
controls:0.26%
cases:0.42%
controls:0.08%
—
—
cases:0.55%
controls:0.07%
cases:2.29%
controls:0.30%
cases:4.28%
controls:0.69%
29
64
2321
23391
28
60
2327
23431
10
18
2345
23473
—
13
17
2338
23457
53
70
2265
23144
92
148
2059
21391
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
8.9e-01
1.4e+00
2.0e+00
1.0e+50
2.9e+00
1.7e+00
1.8e+00
cases:2.64%
controls:1.10%
cases:2.34%
controls:0.60%
cases:0.93%
controls:0.13%
cases:0.47%
controls:0.00%
cases:1.70%
controls:0.10%
cases:3.28%
controls:0.60%
cases:8.46%
controls:1.44%
62
258
2288
23197
55
140
2300
23351
22
30
2333
23461
11
0
2344
23491
40
23
2311
23451
76
139
2242
23075
182
311
1969
21228
macrogol; oral
A06AD15 [21600575]
1.1e+00
1.7e+00
2.0e+00
—
2.1e+00
1.9e+00
1.8e+00
cases:1.57%
controls:0.52%
cases:1.44%
controls:0.26%
cases:0.38%
controls:0.05%
—
—
cases:0.43%
controls:0.05%
cases:1.55%
controls:0.24%
cases:3.53%
controls:0.63%
37
122
2313
23333
34
61
2321
23430
9
12
2346
23479
—
10
12
2341
23462
36
55
2282
23159
76
136
2075
21403
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
5.7e-01
1.1e+00
1.8e+00
3.5e+00
1.9e+00
1.0e+00
8.2e-01
cases:17.87%
controls:10.98%
cases:16.43%
controls:6.36%
cases:5.35%
controls:0.96%
cases:0.68%
controls:0.02%
cases:5.40%
controls:0.85%
cases:16.44%
controls:6.50%
cases:37.33%
controls:20.78%
420
2575
1930
20880
387
1493
1968
21998
126
225
2229
23266
16
5
2339
23486
127
199
2224
23275
381
1509
1937
21705
803
4476
1348
17063
moclobemide; oral
N06AG02 [21604727]
2.5e+00
2.8e+00
—
—
—
3.0e+00
2.3e+00
cases:0.98%
controls:0.08%
cases:0.34%
controls:0.02%
—
—
—
—
—
—
cases:0.60%
controls:0.03%
cases:1.07%
controls:0.11%
23
19
2327
23436
8
5
2347
23486
—
—
—
14
7
2304
23207
23
23
2128
21516
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
1.5e+00
1.7e+00
1.9e+00
—
1.7e+00
1.8e+00
1.9e+00
cases:3.36%
controls:0.78%
cases:2.68%
controls:0.49%
cases:0.85%
controls:0.13%
—
—
cases:0.60%
controls:0.11%
cases:2.67%
controls:0.47%
cases:4.70%
controls:0.71%
79
183
2271
23272
63
116
2292
23375
20
31
2335
23460
—
14
26
2337
23448
62
109
2256
23105
101
154
2050
21385
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
1.0e+00
1.1e+00
2.7e+00
—
2.8e+00
1.5e+00
1.3e+00
cases:2.43%
controls:0.90%
cases:1.91%
controls:0.64%
cases:0.85%
controls:0.06%
—
—
cases:0.81%
controls:0.05%
cases:2.63%
controls:0.60%
cases:8.41%
controls:2.51%
57
211
2293
23244
45
150
2310
23341
20
13
2335
23478
—
19
12
2332
23462
61
139
2257
23075
181
540
1970
20999
Psychological disorders other
P99 [2002000880]
1.5e+00
2.5e+00
2.3e+00
—
—
2.1e+00
2.0e+00
cases:0.98%
controls:0.23%
cases:0.93%
controls:0.08%
cases:0.25%
controls:0.03%
—
—
—
—
cases:1.04%
controls:0.12%
cases:2.84%
controls:0.38%
23
54
2327
23401
22
19
2333
23472
6
6
2349
23485
—
—
24
29
2294
23185
61
82
2090
21457
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
1.9e+00
1.8e+00
1.5e+00
—
1.9e+00
2.1e+00
2.6e+00
cases:2.68%
controls:0.40%
cases:1.36%
controls:0.23%
cases:0.34%
controls:0.08%
—
—
cases:0.47%
controls:0.07%
cases:2.07%
controls:0.25%
cases:5.35%
controls:0.40%
63
94
2287
23361
32
54
2323
23437
8
18
2347
23473
—
11
17
2340
23457
48
59
2270
23155
115
87
2036
21452
clonazepam; oral, parenteral
N03AE01 [21604415]
1.5e+00
1.5e+00
2.2e+00
—
1.9e+00
1.6e+00
1.5e+00
cases:1.70%
controls:0.37%
cases:1.23%
controls:0.26%
cases:0.59%
controls:0.07%
—
—
cases:0.47%
controls:0.07%
cases:1.34%
controls:0.28%
cases:2.09%
controls:0.46%
40
87
2310
23368
29
62
2326
23429
14
16
2341
23475
—
11
16
2340
23458
31
65
2287
23149
45
99
2106
21440
Moderate panic disorder
F41.00 [2000501994]
1.9e+00
2.4e+00
2.1e+00
—
—
2.3e+00
1.5e+00
cases:1.15%
controls:0.17%
cases:0.72%
controls:0.07%
cases:0.25%
controls:0.03%
—
—
—
—
cases:0.82%
controls:0.08%
cases:1.44%
controls:0.32%
27
39
2323
23416
17
16
2338
23475
6
7
2349
23484
—
—
19
19
2299
23195
31
69
2120
21470
pregabalin; oral
N02BF02 [955152]
1.3e+00
1.8e+00
2.0e+00
—
1.9e+00
1.8e+00
1.5e+00
cases:4.81%
controls:1.32%
cases:3.86%
controls:0.67%
cases:1.61%
controls:0.23%
—
—
cases:1.36%
controls:0.20%
cases:3.84%
controls:0.68%
cases:8.04%
controls:1.88%
113
310
2237
23145
91
158
2264
23333
38
54
2317
23437
—
32
48
2319
23426
89
158
2229
23056
173
405
1978
21134
trimipramine; oral, parenteral
N06AA06 [21604693]
2.9e+00
2.6e+00
—
—
—
1.9e+00
2.6e+00
cases:0.81%
controls:0.04%
cases:0.30%
controls:0.02%
—
—
—
—
—
—
cases:0.30%
controls:0.04%
cases:1.02%
controls:0.07%
19
10
2331
23445
7
5
2348
23486
—
—
—
7
10
2311
23204
22
16
2129
21523
zopiclone; oral
N05CF01 [21604654]
1.4e+00
1.7e+00
1.4e+00
—
2.0e+00
1.8e+00
1.7e+00
cases:7.70%
controls:1.93%
cases:5.05%
controls:0.94%
cases:0.98%
controls:0.25%
—
—
cases:1.66%
controls:0.22%
cases:5.52%
controls:0.99%
cases:11.95%
controls:2.38%
181
453
2169
23002
119
221
2236
23270
23
59
2332
23432
—
39
51
2312
23423
128
230
2190
22984
257
512
1894
21027
Physical Medicine And Rehabilitation
25 [38004468]
6.7e-01
1.1e+00
1.2e+00
3.5e+00
1.6e+00
1.2e+00
9.2e-01
cases:7.19%
controls:3.82%
cases:4.42%
controls:1.59%
cases:1.02%
controls:0.32%
cases:0.68%
controls:0.02%
cases:1.40%
controls:0.29%
cases:4.70%
controls:1.52%
cases:11.06%
controls:4.74%
169
897
2181
22558
104
373
2251
23118
24
74
2331
23417
16
5
2339
23486
33
67
2318
23407
109
352
2209
22862
238
1022
1913
20517
Other mixed anxiety disorders
F41.3 [45605492]
1.1e+00
2.0e+00
2.0e+00
1.0e+50
2.3e+00
2.0e+00
1.8e+00
cases:0.38%
controls:0.12%
cases:0.51%
controls:0.07%
cases:0.25%
controls:0.03%
cases:0.47%
controls:0.00%
cases:0.38%
controls:0.04%
cases:0.86%
controls:0.12%
cases:1.77%
controls:0.31%
9
29
2341
23426
12
17
2343
23474
6
8
2349
23483
11
0
2344
23491
9
9
2342
23465
20
27
2298
23187
38
66
2113
21473
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
9.3e-01
1.6e+00
1.9e+00
—
2.7e+00
1.4e+00
1.5e+00
cases:2.00%
controls:0.80%
cases:2.12%
controls:0.42%
cases:0.30%
controls:0.05%
—
—
cases:0.72%
controls:0.05%
cases:1.77%
controls:0.43%
cases:6.14%
controls:1.51%
47
187
2303
23268
50
98
2305
23393
7
11
2348
23480
—
17
11
2334
23463
41
100
2277
23114
132
325
2019
21214
flupentixol; oral, parenteral
N05AF01 [21604531]
2.1e+00
2.9e+00
—
—
—
2.6e+00
2.4e+00
cases:0.60%
controls:0.08%
cases:0.47%
controls:0.03%
—
—
—
—
—
—
cases:0.30%
controls:0.02%
cases:0.79%
controls:0.07%
14
18
2336
23437
11
6
2344
23485
—
—
—
7
5
2311
23209
17
15
2134
21524
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
4.2e-01
9.1e-01
1.6e+00
3.8e+00
1.6e+00
9.1e-01
7.2e-01
cases:20.26%
controls:14.33%
cases:21.87%
controls:10.11%
cases:8.62%
controls:1.81%
cases:2.34%
controls:0.05%
cases:7.70%
controls:1.66%
cases:22.99%
controls:10.71%
cases:44.26%
controls:27.89%
476
3361
1874
20094
515
2374
1840
21117
203
426
2152
23065
55
12
2300
23479
181
390
2170
23084
533
2487
1785
20727
952
6007
1199
15532
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
5.4e-01
9.2e-01
1.6e+00
3.9e+00
1.5e+00
8.5e-01
7.0e-01
cases:13.02%
controls:7.99%
cases:14.01%
controls:6.11%
cases:5.05%
controls:1.05%
cases:1.49%
controls:0.03%
cases:4.21%
controls:1.01%
cases:14.58%
controls:6.78%
cases:31.66%
controls:18.67%
306
1875
2044
21580
330
1436
2025
22055
119
246
2236
23245
35
7
2320
23484
99
236
2252
23238
338
1573
1980
21641
681
4022
1470
17517
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
F25.10 [2000501966]
2.1e+00
2.4e+00
—
1.0e+50
—
2.8e+00
2.6e+00
cases:0.43%
controls:0.05%
cases:0.38%
controls:0.03%
—
—
cases:0.25%
controls:0.00%
—
—
cases:0.56%
controls:0.03%
cases:0.98%
controls:0.07%
10
12
2340
23443
9
8
2346
23483
—
6
0
2349
23491
—
13
8
2305
23206
21
15
2130
21524
melatonin; oral
N05CH01 [21604659]
1.4e+00
1.7e+00
1.9e+00
—
1.7e+00
1.7e+00
1.6e+00
cases:4.04%
controls:1.01%
cases:3.23%
controls:0.62%
cases:1.15%
controls:0.17%
—
—
cases:0.81%
controls:0.14%
cases:4.01%
controls:0.79%
cases:9.48%
controls:2.17%
95
236
2255
23219
76
146
2279
23345
27
41
2328
23450
—
19
34
2332
23440
93
183
2225
23031
204
468
1947
21071
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
1.0e+00
1.6e+00
2.1e+00
—
2.4e+00
1.5e+00
1.3e+00
cases:5.79%
controls:2.21%
cases:5.10%
controls:1.12%
cases:1.10%
controls:0.13%
—
—
cases:1.28%
controls:0.12%
cases:5.22%
controls:1.21%
cases:15.57%
controls:4.70%
136
518
2214
22937
120
263
2235
23228
26
31
2329
23460
—
30
28
2321
23446
121
282
2197
22932
335
1013
1816
20526
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
1.1e+00
1.7e+00
2.2e+00
—
1.8e+00
1.7e+00
1.3e+00
cases:2.43%
controls:0.81%
cases:1.91%
controls:0.35%
cases:0.59%
controls:0.06%
—
—
cases:0.55%
controls:0.09%
cases:2.24%
controls:0.42%
cases:4.79%
controls:1.33%
57
190
2293
23265
45
83
2310
23408
14
15
2341
23476
—
13
21
2338
23453
52
98
2266
23116
103
287
2048
21252
EKG study
11524-6 [3013512]
9.3e-01
1.3e+00
2.1e+00
—
2.7e+00
1.7e+00
1.1e+00
cases:3.70%
controls:1.49%
cases:2.51%
controls:0.66%
cases:0.81%
controls:0.10%
—
—
cases:1.06%
controls:0.07%
cases:3.75%
controls:0.71%
cases:7.76%
controls:2.83%
87
349
2263
23106
59
156
2296
23335
19
23
2336
23468
—
25
17
2326
23457
87
165
2231
23049
167
610
1984
20929
Other depressive episodes
F32.8 [45571759]
1.8e+00
2.4e+00
—
—
—
3.0e+00
2.6e+00
cases:0.77%
controls:0.13%
cases:0.38%
controls:0.03%
—
—
—
—
—
—
cases:0.86%
controls:0.04%
cases:1.63%
controls:0.12%
18
30
2332
23425
9
8
2346
23483
—
—
—
20
10
2298
23204
35
26
2116
21513
Lithium [Moles/volume] in Serum or Plasma
14334-7 [3024666]
1.8e+00
1.5e+00
—
—
1.9e+00
2.1e+00
2.6e+00
cases:0.77%
controls:0.12%
cases:0.55%
controls:0.13%
—
—
—
—
cases:0.38%
controls:0.06%
cases:0.78%
controls:0.10%
cases:2.42%
controls:0.19%
18
29
2332
23426
13
30
2342
23461
—
—
9
14
2342
23460
18
23
2300
23191
52
40
2099
21499
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
5.1e-01
1.1e+00
1.7e+00
3.1e+00
1.8e+00
9.6e-01
7.5e-01
cases:20.26%
controls:13.21%
cases:19.79%
controls:7.93%
cases:5.86%
controls:1.17%
cases:0.81%
controls:0.04%
cases:6.08%
controls:1.05%
cases:19.41%
controls:8.42%
cases:41.98%
controls:25.51%
476
3099
1874
20356
466
1862
1889
21629
138
274
2217
23217
19
9
2336
23482
143
247
2208
23227
450
1955
1868
21259
903
5494
1248
16045
biperiden; oral, parenteral
N04AA02 [21604447]
2.1e+00
2.9e+00
—
—
—
2.0e+00
2.8e+00
cases:0.60%
controls:0.08%
cases:0.38%
controls:0.02%
—
—
—
—
—
—
cases:0.26%
controls:0.03%
cases:0.74%
controls:0.05%
14
18
2336
23437
9
5
2346
23486
—
—
—
6
8
2312
23206
16
10
2135
21529
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
1.1e+00
1.3e+00
2.2e+00
—
2.6e+00
1.5e+00
1.1e+00
cases:3.49%
controls:1.18%
cases:1.66%
controls:0.47%
cases:0.64%
controls:0.07%
—
—
cases:0.68%
controls:0.05%
cases:2.20%
controls:0.52%
cases:6.65%
controls:2.40%
82
276
2268
23179
39
110
2316
23381
15
16
2340
23475
—
16
12
2335
23462
51
121
2267
23093
143
518
2008
21021
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
4.5e-01
9.6e-01
1.5e+00
3.5e+00
1.6e+00
9.3e-01
7.2e-01
cases:20.13%
controls:13.87%
cases:21.61%
controls:9.53%
cases:7.60%
controls:1.74%
cases:1.40%
controls:0.04%
cases:7.53%
controls:1.58%
cases:21.70%
controls:9.86%
cases:43.10%
controls:27.01%
473
3253
1877
20202
509
2239
1846
21252
179
409
2176
23082
33
10
2322
23481
177
371
2174
23103
503
2290
1815
20924
927
5817
1224
15722
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
8.3e-01
1.5e+00
1.8e+00
1.0e+50
2.8e+00
1.4e+00
1.4e+00
cases:4.34%
controls:1.94%
cases:2.38%
controls:0.57%
cases:0.30%
controls:0.05%
cases:0.21%
controls:0.00%
cases:0.64%
controls:0.04%
cases:1.94%
controls:0.51%
cases:7.58%
controls:1.92%
102
456
2248
22999
56
133
2299
23358
7
12
2348
23479
5
0
2350
23491
15
9
2336
23465
45
118
2273
23096
163
414
1988
21125
paroxetine; oral
N06AB05 [21604713]
1.8e+00
1.7e+00
1.5e+00
—
2.1e+00
2.2e+00
1.9e+00
cases:3.02%
controls:0.49%
cases:1.53%
controls:0.28%
cases:0.34%
controls:0.08%
—
—
cases:0.47%
controls:0.06%
cases:1.68%
controls:0.20%
cases:2.60%
controls:0.42%
71
115
2279
23340
36
66
2319
23425
8
18
2347
23473
—
11
14
2340
23460
39
46
2279
23168
56
90
2095
21449
Procedure duration 0 to 9 minutes
ZXE01 [2001311395]
1.5e+00
1.9e+00
—
—
—
3.6e+00
2.6e+00
cases:0.51%
controls:0.12%
cases:0.38%
controls:0.06%
—
—
—
—
—
—
cases:0.95%
controls:0.03%
cases:1.58%
controls:0.12%
12
28
2338
23427
9
13
2346
23478
—
—
—
22
6
2296
23208
34
26
2117
21513
Psychoeducation, group
IER01 [2001304205]
2.7e+00
1.8e+00
—
—
1.0e+50
4.3e+00
2.6e+00
cases:0.64%
controls:0.04%
cases:0.21%
controls:0.03%
—
—
—
—
cases:0.30%
controls:0.00%
cases:2.80%
controls:0.04%
cases:1.44%
controls:0.11%
15
10
2335
23445
5
8
2350
23483
—
—
7
0
2344
23474
65
9
2253
23205
31
24
2120
21515
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
F98.9 [45547725]
1.5e+00
2.7e+00
—
—
—
2.8e+00
2.5e+00
cases:0.43%
controls:0.10%
cases:0.51%
controls:0.03%
—
—
—
—
—
—
cases:0.52%
controls:0.03%
cases:0.88%
controls:0.07%
10
23
2340
23432
12
8
2343
23483
—
—
—
12
7
2306
23207
19
15
2132
21524
Electroconvulsive therapy
AA400 [2001300694]
2.8e+00
—
—
—
—
3.3e+00
3.5e+00
cases:0.68%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.03%
cases:1.81%
controls:0.06%
16
10
2334
23445
—
—
—
—
16
6
2302
23208
39
12
2112
21527
Other nonorganic psychotic disorders
F28 [45605491]
2.0e+00
2.1e+00
—
—
—
2.3e+00
3.1e+00
cases:0.34%
controls:0.05%
cases:0.25%
controls:0.03%
—
—
—
—
—
—
cases:0.26%
controls:0.03%
cases:0.60%
controls:0.03%
8
11
2342
23444
6
7
2349
23484
—
—
—
6
6
2312
23208
13
6
2138
21533
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
7.3e-01
1.5e+00
2.1e+00
—
2.5e+00
1.7e+00
1.0e+00
cases:1.87%
controls:0.91%
cases:1.61%
controls:0.38%
cases:0.47%
controls:0.06%
—
—
cases:0.55%
controls:0.05%
cases:1.73%
controls:0.31%
cases:3.58%
controls:1.32%
44
214
2306
23241
38
90
2317
23401
11
14
2344
23477
—
13
11
2338
23463
40
73
2278
23141
77
284
2074
21255
Paranoid schizophrenia continuous
F20.00 [2000501920]
1.2e+00
1.6e+00
1.9e+00
—
2.2e+00
1.9e+00
1.9e+00
cases:0.43%
controls:0.12%
cases:0.59%
controls:0.12%
cases:0.30%
controls:0.05%
—
—
cases:0.34%
controls:0.04%
cases:0.69%
controls:0.11%
cases:1.21%
controls:0.18%
10
29
2340
23426
14
28
2341
23463
7
11
2348
23480
—
8
9
2343
23465
16
25
2302
23189
26
38
2125
21501
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
1.6e+00
1.8e+00
1.6e+00
—
1.9e+00
1.9e+00
2.2e+00
cases:1.32%
controls:0.27%
cases:1.02%
controls:0.17%
cases:0.25%
controls:0.05%
—
—
cases:0.38%
controls:0.06%
cases:1.21%
controls:0.18%
cases:2.23%
controls:0.25%
31
64
2319
23391
24
39
2331
23452
6
12
2349
23479
—
9
14
2342
23460
28
42
2290
23172
48
54
2103
21485
disulfiram; oral
N07BB01 [21604821]
2.1e+00
2.0e+00
—
—
—
2.9e+00
2.3e+00
cases:1.11%
controls:0.14%
cases:0.42%
controls:0.06%
—
—
—
—
—
—
cases:1.08%
controls:0.06%
cases:1.63%
controls:0.16%
26
32
2324
23423
10
13
2345
23478
—
—
—
25
14
2293
23200
35
34
2116
21505
alprazolam; oral
N05BA12 [21604577]
1.4e+00
1.7e+00
1.6e+00
—
1.9e+00
1.5e+00
1.4e+00
cases:2.47%
controls:0.61%
cases:1.44%
controls:0.28%
cases:0.38%
controls:0.08%
—
—
cases:0.43%
controls:0.06%
cases:1.42%
controls:0.33%
cases:3.02%
controls:0.79%
58
144
2292
23311
34
65
2321
23426
9
19
2346
23472
—
10
15
2341
23459
33
76
2285
23138
65
170
2086
21369
mianserin; oral
N06AX03 [21604732]
2.4e+00
2.4e+00
—
—
—
2.2e+00
2.3e+00
cases:1.49%
controls:0.13%
cases:0.59%
controls:0.06%
—
—
—
—
—
—
cases:0.56%
controls:0.06%
cases:1.67%
controls:0.17%
35
31
2315
23424
14
13
2341
23478
—
—
—
13
14
2305
23200
36
36
2115
21503
Occupational therapy
R4120 [2001310234]
5.5e-01
1.3e+00
2.3e+00
—
2.5e+00
1.7e+00
1.6e+00
cases:0.77%
controls:0.44%
cases:0.51%
controls:0.14%
cases:0.30%
controls:0.03%
—
—
cases:0.26%
controls:0.02%
cases:0.86%
controls:0.16%
cases:2.05%
controls:0.43%
18
104
2332
23351
12
33
2343
23458
7
7
2348
23484
—
6
5
2345
23469
20
38
2298
23176
44
93
2107
21446
Clinic/Center
261Q00000X [38004207]
1.0e+00
2.4e+00
—
—
—
3.3e+00
2.5e+00
cases:0.98%
controls:0.35%
cases:1.06%
controls:0.09%
—
—
—
—
—
—
cases:2.59%
controls:0.10%
cases:3.91%
controls:0.34%
23
81
2327
23374
25
22
2330
23469
—
—
—
60
23
2258
23191
84
74
2067
21465
Nutrition survey
SPAT1139 [2001700240]
1.9e+00
2.7e+00
—
—
1.0e+50
2.5e+00
2.1e+00
cases:1.02%
controls:0.16%
cases:0.98%
controls:0.06%
—
—
—
—
cases:0.34%
controls:0.00%
cases:0.82%
controls:0.06%
cases:1.91%
controls:0.25%
24
37
2326
23418
23
15
2332
23476
—
—
8
0
2343
23474
19
15
2299
23199
41
53
2110
21486
Metabolic syndrome
E66.00 [2000501500]
1.9e+00
2.6e+00
—
1.0e+50
—
2.9e+00
1.8e+00
cases:1.32%
controls:0.20%
cases:1.02%
controls:0.08%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.34%
controls:0.08%
cases:1.86%
controls:0.30%
31
47
2319
23408
24
18
2331
23473
—
8
0
2347
23491
—
31
18
2287
23196
40
64
2111
21475
Neurology
13 [38004458]
8.4e-01
6.8e-01
1.3e+00
3.2e+00
1.1e+00
9.7e-01
1.0e+00
cases:11.15%
controls:5.13%
cases:5.44%
controls:2.83%
cases:2.08%
controls:0.57%
cases:0.64%
controls:0.03%
cases:1.79%
controls:0.58%
cases:7.33%
controls:2.91%
cases:16.92%
controls:6.92%
262
1203
2088
22252
128
665
2227
22826
49
133
2306
23358
15
6
2340
23485
42
136
2309
23338
170
675
2148
22539
364
1490
1787
20049
Remote monitoring CPAP
WX780 [2001310837]
1.9e+00
2.7e+00
—
—
—
2.7e+00
1.8e+00
cases:0.30%
controls:0.05%
cases:0.38%
controls:0.03%
—
—
—
—
—
—
cases:0.39%
controls:0.03%
cases:0.60%
controls:0.10%
7
11
2343
23444
9
6
2346
23485
—
—
—
9
6
2309
23208
13
21
2138
21518
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
7.3e-01
1.1e+00
2.0e+00
—
2.5e+00
1.5e+00
1.3e+00
cases:7.87%
controls:3.95%
cases:6.37%
controls:2.14%
cases:2.29%
controls:0.31%
—
—
cases:3.32%
controls:0.29%
cases:7.94%
controls:1.92%
cases:17.76%
controls:5.71%
185
927
2165
22528
150
503
2205
22988
54
73
2301
23418
—
78
69
2273
23405
184
445
2134
22769
382
1229
1769
20310
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
1.7e+00
1.7e+00
2.3e+00
—
2.5e+00
1.9e+00
1.3e+00
cases:0.77%
controls:0.14%
cases:0.51%
controls:0.09%
cases:0.21%
controls:0.02%
—
—
cases:0.26%
controls:0.02%
cases:0.52%
controls:0.08%
cases:1.16%
controls:0.33%
18
34
2332
23421
12
21
2343
23470
5
5
2350
23486
—
6
5
2345
23469
12
18
2306
23196
25
71
2126
21468
12 lead EKG panel
34534-8 [3044889]
7.1e-01
1.4e+00
2.5e+00
1.0e+50
2.2e+00
1.3e+00
9.5e-01
cases:9.49%
controls:4.91%
cases:8.75%
controls:2.28%
cases:2.93%
controls:0.26%
cases:0.68%
controls:0.00%
cases:2.89%
controls:0.32%
cases:8.46%
controls:2.50%
cases:21.25%
controls:9.41%
223
1152
2127
22303
206
536
2149
22955
69
61
2286
23430
16
0
2339
23491
68
75
2283
23399
196
581
2122
22633
457
2026
1694
19513
pH of Serum or Plasma
2753-2 [3018418]
7.8e-01
1.1e+00
2.0e+00
—
2.4e+00
1.4e+00
1.3e+00
cases:4.34%
controls:2.04%
cases:3.40%
controls:1.14%
cases:1.10%
controls:0.14%
—
—
cases:1.62%
controls:0.15%
cases:4.31%
controls:1.09%
cases:10.74%
controls:3.24%
102
479
2248
22976
80
268
2275
23223
26
34
2329
23457
—
38
35
2313
23439
100
253
2218
22961
231
698
1920
20841
Pediatric Medicine
37 [38004477]
-1.9e-01
2.2e-01
9.2e-01
5.0e+00
1.6e+00
9.1e-01
6.2e-01
cases:14.04%
controls:16.44%
cases:9.64%
controls:7.91%
cases:4.97%
controls:2.03%
cases:8.54%
controls:0.06%
cases:8.72%
controls:1.98%
cases:14.41%
controls:6.37%
cases:10.32%
controls:5.80%
330
3857
2020
19598
227
1858
2128
21633
117
478
2238
23013
201
15
2154
23476
205
465
2146
23009
334
1479
1984
21735
222
1250
1929
20289
Bipolar affective disorder
F31 [45595902]
2.0e+00
2.4e+00
—
—
—
2.1e+00
2.4e+00
cases:1.02%
controls:0.14%
cases:0.47%
controls:0.04%
—
—
—
—
—
—
cases:0.39%
controls:0.05%
cases:1.81%
controls:0.16%
24
32
2326
23423
11
10
2344
23481
—
—
—
9
11
2309
23203
39
35
2112
21504
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
7.5e-01
1.1e+00
2.0e+00
—
2.4e+00
1.4e+00
1.3e+00
cases:7.49%
controls:3.68%
cases:5.69%
controls:1.93%
cases:2.12%
controls:0.31%
—
—
cases:2.89%
controls:0.27%
cases:6.90%
controls:1.73%
cases:15.39%
controls:4.91%
176
863
2174
22592
134
453
2221
23038
50
72
2305
23419
—
68
64
2283
23410
160
401
2158
22813
331
1057
1820
20482
Psychiatric family contact
IGP01 [2001304317]
1.2e+00
1.5e+00
2.3e+00
—
—
2.2e+00
1.7e+00
cases:0.77%
controls:0.22%
cases:0.51%
controls:0.12%
cases:0.25%
controls:0.03%
—
—
—
—
cases:1.04%
controls:0.12%
cases:1.26%
controls:0.23%
18
52
2332
23403
12
28
2343
23463
6
6
2349
23485
—
—
24
27
2294
23187
27
50
2124
21489
Acetaminophen [Moles/volume] in Serum or Plasma
14581-3 [3020485]
2.9e+00
—
—
—
—
3.1e+00
2.9e+00
cases:0.81%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.02%
cases:1.02%
controls:0.06%
19
11
2331
23444
—
—
—
—
11
5
2307
23209
22
12
2129
21527
Fever, unspecified
R50.9 [45582716]
6.8e-01
8.3e-01
2.1e+00
1.0e+50
3.2e+00
1.2e+00
8.6e-01
cases:2.55%
controls:1.31%
cases:0.93%
controls:0.41%
cases:0.38%
controls:0.05%
cases:0.38%
controls:0.00%
cases:0.60%
controls:0.03%
cases:1.25%
controls:0.38%
cases:3.44%
controls:1.48%
60
307
2290
23148
22
96
2333
23395
9
11
2346
23480
9
0
2346
23491
14
6
2337
23468
29
88
2289
23126
74
319
2077
21220
fluvoxamine; oral
N06AB08 [21604716]
2.0e+00
2.3e+00
—
—
—
2.5e+00
2.0e+00
cases:0.81%
controls:0.11%
cases:0.47%
controls:0.05%
—
—
—
—
—
—
cases:0.52%
controls:0.04%
cases:0.46%
controls:0.06%
19
26
2331
23429
11
11
2344
23480
—
—
—
12
10
2306
23204
10
14
2141
21525
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
7.6e-01
9.3e-01
1.7e+00
—
2.6e+00
1.3e+00
1.4e+00
cases:2.04%
controls:0.96%
cases:1.06%
controls:0.42%
cases:0.38%
controls:0.07%
—
—
cases:0.77%
controls:0.06%
cases:1.08%
controls:0.30%
cases:2.60%
controls:0.63%
48
226
2302
23229
25
99
2330
23392
9
17
2346
23474
—
18
13
2333
23461
25
69
2293
23145
56
136
2095
21403
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
1.1e+00
8.3e-01
2.3e+00
—
2.8e+00
1.4e+00
1.2e+00
cases:1.23%
controls:0.42%
cases:0.59%
controls:0.26%
cases:0.34%
controls:0.03%
—
—
cases:0.47%
controls:0.03%
cases:0.99%
controls:0.26%
cases:2.19%
controls:0.68%
29
98
2321
23357
14
61
2341
23430
8
8
2347
23483
—
11
7
2340
23467
23
60
2295
23154
47
146
2104
21393
Reaction to severe stress, unspecified
F43.9 [45552484]
2.8e-01
1.3e+00
2.2e+00
1.0e+50
2.5e+00
1.8e+00
8.7e-01
cases:0.51%
controls:0.39%
cases:0.59%
controls:0.16%
cases:0.30%
controls:0.03%
cases:0.47%
controls:0.00%
cases:0.51%
controls:0.04%
cases:0.78%
controls:0.13%
cases:1.16%
controls:0.49%
12
91
2338
23364
14
37
2341
23454
7
8
2348
23483
11
0
2344
23491
12
10
2339
23464
18
30
2300
23184
25
106
2126
21433
Feeding problem of adult
T05 [2002001069]
3.1e+00
—
1.0e+50
—
—
3.2e+00
2.4e+00
cases:0.89%
controls:0.04%
—
—
cases:0.34%
controls:0.00%
—
—
—
—
cases:0.73%
controls:0.03%
cases:1.77%
controls:0.16%
21
10
2329
23445
—
8
0
2347
23491
—
—
17
7
2301
23207
38
35
2113
21504
2-person team, doctor-nurse
ZXY51 [2001311525]
1.2e+00
2.0e+00
—
1.0e+50
—
2.9e+00
2.5e+00
cases:0.72%
controls:0.22%
cases:0.38%
controls:0.05%
—
—
cases:0.42%
controls:0.00%
—
—
cases:1.12%
controls:0.06%
cases:1.49%
controls:0.13%
17
51
2333
23404
9
12
2346
23479
—
10
0
2345
23491
—
26
14
2292
23200
32
27
2119
21512
Extensive assessment of psychosocial situation
SPAT1241 [2001700342]
1.3e+00
2.8e+00
—
—
—
2.5e+00
2.1e+00
cases:0.60%
controls:0.16%
cases:0.47%
controls:0.03%
—
—
—
—
—
—
cases:0.52%
controls:0.04%
cases:1.21%
controls:0.15%
14
38
2336
23417
11
7
2344
23484
—
—
—
12
10
2306
23204
26
33
2125
21506
Obesity
T82 [2002001125]
2.0e+00
2.8e+00
—
—
—
1.9e+00
1.9e+00
cases:2.00%
controls:0.27%
cases:1.40%
controls:0.09%
—
—
—
—
—
—
cases:0.60%
controls:0.09%
cases:2.60%
controls:0.39%
47
63
2303
23392
33
20
2322
23471
—
—
—
14
22
2304
23192
56
83
2095
21456
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
6.5e-01
1.2e+00
2.0e+00
1.0e+50
2.2e+00
1.4e+00
1.2e+00
cases:5.62%
controls:3.01%
cases:4.67%
controls:1.48%
cases:1.27%
controls:0.17%
cases:0.34%
controls:0.00%
cases:1.70%
controls:0.19%
cases:5.74%
controls:1.46%
cases:15.53%
controls:5.47%
132
707
2218
22748
110
347
2245
23144
30
41
2325
23450
8
0
2347
23491
40
45
2311
23429
133
339
2185
22875
334
1179
1817
20360
Recurrent depressive disorder, current episode moderate
F33.1 [45576543]
1.8e+00
2.6e+00
—
1.0e+50
—
2.0e+00
2.2e+00
cases:1.06%
controls:0.17%
cases:1.06%
controls:0.08%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.86%
controls:0.12%
cases:3.11%
controls:0.36%
25
41
2325
23414
25
19
2330
23472
—
8
0
2347
23491
—
20
27
2298
23187
67
78
2084
21461
Obsessive-compulsive disorder, unspecified
F42.9 [45600745]
2.2e+00
1.8e+00
—
1.0e+50
—
2.3e+00
2.2e+00
cases:0.55%
controls:0.06%
cases:0.34%
controls:0.06%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.60%
controls:0.06%
cases:1.39%
controls:0.16%
13
14
2337
23441
8
13
2347
23478
—
8
0
2347
23491
—
14
14
2304
23200
30
34
2121
21505
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.1e-01
5.9e-01
1.3e+00
3.7e+00
1.4e+00
7.4e-01
4.8e-01
cases:18.04%
controls:13.87%
cases:17.58%
controls:10.58%
cases:6.96%
controls:2.06%
cases:2.25%
controls:0.06%
cases:7.19%
controls:1.84%
cases:20.06%
controls:10.68%
cases:35.52%
controls:25.44%
424
3254
1926
20201
414
2486
1941
21005
164
485
2191
23006
53
13
2302
23478
169
433
2182
23041
465
2480
1853
20734
764
5480
1387
16059
agomelatine; oral
N06AX22 [21604750]
1.7e+00
2.3e+00
—
—
—
2.4e+00
2.1e+00
cases:0.94%
controls:0.17%
cases:0.76%
controls:0.08%
—
—
—
—
—
—
cases:1.16%
controls:0.11%
cases:2.79%
controls:0.34%
22
40
2328
23415
18
18
2337
23473
—
—
—
27
25
2291
23189
60
74
2091
21465
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
7.1e-01
1.2e+00
1.6e+00
—
2.3e+00
1.3e+00
1.4e+00
cases:2.34%
controls:1.16%
cases:1.70%
controls:0.49%
cases:0.42%
controls:0.09%
—
—
cases:0.51%
controls:0.05%
cases:1.51%
controls:0.43%
cases:5.21%
controls:1.36%
55
272
2295
23183
40
116
2315
23375
10
20
2345
23471
—
12
12
2339
23462
35
100
2283
23114
112
293
2039
21246
Other rehabilitation service
R5599 [2001310270]
1.6e+00
2.2e+00
—
—
—
3.0e+00
1.7e+00
cases:0.85%
controls:0.17%
cases:0.59%
controls:0.07%
—
—
—
—
—
—
cases:1.51%
controls:0.07%
cases:1.58%
controls:0.29%
20
41
2330
23414
14
16
2341
23475
—
—
—
35
17
2283
23197
34
62
2117
21477
Medical doctor
Z2221 [2001311556]
7.4e-01
1.0e+00
1.4e+00
—
2.1e+00
1.8e+00
1.4e+00
cases:8.60%
controls:4.31%
cases:3.78%
controls:1.41%
cases:0.93%
controls:0.22%
—
—
cases:2.17%
controls:0.27%
cases:7.81%
controls:1.33%
cases:13.95%
controls:3.90%
202
1010
2148
22445
89
331
2266
23160
22
52
2333
23439
—
51
64
2300
23410
181
308
2137
22906
300
841
1851
20698
Psychiatric pharmacotherapy plan, not specified
IFA01 [2001304251]
1.9e+00
1.9e+00
—
—
—
2.4e+00
2.3e+00
cases:1.06%
controls:0.16%
cases:0.72%
controls:0.11%
—
—
—
—
—
—
cases:1.64%
controls:0.15%
cases:2.65%
controls:0.28%
25
37
2325
23418
17
25
2338
23466
—
—
—
38
35
2280
23179
57
61
2094
21478
Base excess in Venous blood by calculation
1927-3 [3002032]
6.2e-01
7.3e-01
2.2e+00
—
2.5e+00
1.4e+00
1.1e+00
cases:2.04%
controls:1.11%
cases:1.10%
controls:0.54%
cases:0.76%
controls:0.09%
—
—
cases:0.98%
controls:0.08%
cases:1.94%
controls:0.51%
cases:3.58%
controls:1.17%
48
260
2302
23195
26
126
2329
23365
18
21
2337
23470
—
23
19
2328
23455
45
118
2273
23096
77
252
2074
21287
Anxiety disorder/anxiety state
P74 [2002000868]
1.4e+00
2.0e+00
2.2e+00
—
1.9e+00
1.8e+00
1.1e+00
cases:2.09%
controls:0.55%
cases:1.74%
controls:0.24%
cases:0.42%
controls:0.05%
—
—
cases:0.26%
controls:0.04%
cases:1.42%
controls:0.24%
cases:3.35%
controls:1.09%
49
128
2301
23327
41
56
2314
23435
10
11
2345
23480
—
6
9
2345
23465
33
56
2285
23158
72
235
2079
21304
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
5.6e-01
1.0e+00
2.6e+00
—
2.4e+00
1.1e+00
7.9e-01
cases:5.57%
controls:3.25%
cases:3.57%
controls:1.32%
cases:1.32%
controls:0.10%
—
—
cases:1.02%
controls:0.09%
cases:3.67%
controls:1.31%
cases:10.23%
controls:4.90%
131
763
2219
22692
84
310
2271
23181
31
23
2324
23468
—
24
21
2327
23453
85
303
2233
22911
220
1055
1931
20484
CBC panel - Blood by Automated count
58410-2 [40761511]
3.0e-01
6.1e-01
1.3e+00
4.0e+00
1.2e+00
6.4e-01
4.7e-01
cases:21.53%
controls:16.90%
cases:17.92%
controls:10.59%
cases:6.50%
controls:1.81%
cases:1.53%
controls:0.03%
cases:5.06%
controls:1.61%
cases:18.51%
controls:10.74%
cases:40.49%
controls:29.83%
506
3964
1844
19491
422
2487
1933
21004
153
425
2202
23066
36
7
2319
23484
119
379
2232
23095
429
2493
1889
20721
871
6426
1280
15113
CPAP therapy
WX723 [2001310826]
2.0e+00
2.5e+00
—
—
—
2.3e+00
1.7e+00
cases:0.26%
controls:0.03%
cases:0.25%
controls:0.02%
—
—
—
—
—
—
cases:0.39%
controls:0.04%
cases:0.51%
controls:0.10%
6
8
2344
23447
6
5
2349
23486
—
—
—
9
9
2309
23205
11
21
2140
21518
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
8.1e-01
1.2e+00
2.0e+00
—
2.1e+00
1.3e+00
1.1e+00
cases:7.79%
controls:3.62%
cases:7.09%
controls:2.29%
cases:2.34%
controls:0.34%
—
—
cases:2.25%
controls:0.28%
cases:8.63%
controls:2.54%
cases:19.34%
controls:7.30%
183
850
2167
22605
167
538
2188
22953
55
79
2300
23412
—
53
66
2298
23408
200
589
2118
22625
416
1572
1735
19967
pH of Venous blood
2746-6 [3012544]
6.4e-01
7.7e-01
2.1e+00
—
2.5e+00
1.3e+00
1.2e+00
cases:2.09%
controls:1.11%
cases:1.15%
controls:0.54%
cases:0.72%
controls:0.09%
—
—
cases:0.94%
controls:0.08%
cases:1.94%
controls:0.52%
cases:3.63%
controls:1.17%
49
261
2301
23194
27
126
2328
23365
17
21
2338
23470
—
22
19
2329
23455
45
120
2273
23094
78
253
2073
21286
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
7.6e-01
1.2e+00
1.6e+00
—
2.1e+00
1.4e+00
1.3e+00
cases:6.64%
controls:3.21%
cases:6.24%
controls:1.96%
cases:1.78%
controls:0.37%
—
—
cases:2.72%
controls:0.35%
cases:7.42%
controls:1.89%
cases:16.46%
controls:4.87%
156
753
2194
22702
147
460
2208
23031
42
86
2313
23405
—
64
81
2287
23393
172
439
2146
22775
354
1049
1797
20490
Obesity, unspecified
E66.9 [45576460]
1.6e+00
2.7e+00
—
1.0e+50
—
2.6e+00
1.5e+00
cases:1.45%
controls:0.31%
cases:1.44%
controls:0.09%
—
—
cases:0.47%
controls:0.00%
—
—
cases:1.21%
controls:0.09%
cases:1.35%
controls:0.30%
34
72
2316
23383
34
22
2321
23469
—
11
0
2344
23491
—
28
21
2290
23193
29
65
2122
21474
Diabetes non-insulin dependent
T90 [2002001131]
1.1e+00
1.1e+00
1.7e+00
—
1.8e+00
1.5e+00
1.2e+00
cases:2.09%
controls:0.73%
cases:1.23%
controls:0.40%
cases:0.42%
controls:0.08%
—
—
cases:0.51%
controls:0.08%
cases:2.11%
controls:0.48%
cases:4.42%
controls:1.42%
49
172
2301
23283
29
95
2326
23396
10
18
2345
23473
—
12
19
2339
23455
49
111
2269
23103
95
306
2056
21233
General evaluation of the need for rehabilitation
R1100 [2001310172]
1.6e+00
2.6e+00
—
1.0e+50
—
2.7e+00
1.4e+00
cases:0.89%
controls:0.17%
cases:0.68%
controls:0.05%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.34%
controls:0.09%
cases:0.70%
controls:0.17%
21
41
2329
23414
16
12
2339
23479
—
8
0
2347
23491
—
31
22
2287
23192
15
37
2136
21502
Endocrinology
46 [38004485]
4.4e-01
7.0e-01
9.0e-01
3.6e+00
1.2e+00
8.8e-01
5.8e-01
cases:5.96%
controls:3.91%
cases:6.54%
controls:3.35%
cases:2.08%
controls:0.86%
cases:1.66%
controls:0.05%
cases:2.81%
controls:0.86%
cases:8.58%
controls:3.76%
cases:13.58%
controls:8.09%
140
917
2210
22538
154
787
2201
22704
49
202
2306
23289
39
11
2316
23480
66
203
2285
23271
199
874
2119
22340
292
1742
1859
19797
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
5.8e-01
1.1e+00
2.4e+00
—
2.3e+00
1.1e+00
8.2e-01
cases:6.81%
controls:3.92%
cases:4.67%
controls:1.58%
cases:1.49%
controls:0.13%
—
—
cases:1.45%
controls:0.15%
cases:4.75%
controls:1.69%
cases:13.39%
controls:6.38%
160
920
2190
22535
110
372
2245
23119
35
31
2320
23460
—
34
36
2317
23438
110
393
2208
22821
288
1374
1863
20165
Hospital inpatient
ZY000 [2001311598]
1.7e+00
1.5e+00
—
1.0e+50
—
3.8e+00
2.7e+00
cases:0.81%
controls:0.14%
cases:0.25%
controls:0.06%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.16%
controls:0.03%
cases:1.53%
controls:0.10%
19
34
2331
23421
6
13
2349
23478
—
8
0
2347
23491
—
27
6
2291
23208
33
22
2118
21517
Psychiatric treatment plan, extended/prolonged
ICB02 [2001304099]
1.7e+00
1.9e+00
—
—
—
2.3e+00
2.3e+00
cases:0.68%
controls:0.12%
cases:0.47%
controls:0.07%
—
—
—
—
—
—
cases:0.86%
controls:0.09%
cases:1.77%
controls:0.18%
16
28
2334
23427
11
16
2344
23475
—
—
—
20
21
2298
23193
38
38
2113
21501
ferrous glycine sulfate; oral
B03AA01 [21601080]
9.7e-01
1.1e+00
—
—
2.6e+00
1.8e+00
1.8e+00
cases:1.11%
controls:0.42%
cases:0.55%
controls:0.19%
—
—
—
—
cases:0.30%
controls:0.02%
cases:0.86%
controls:0.15%
cases:2.93%
controls:0.50%
26
99
2324
23356
13
44
2342
23447
—
—
7
5
2344
23469
20
35
2298
23179
63
107
2088
21432
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
6.9e-01
1.3e+00
1.7e+00
1.0e+50
2.3e+00
1.1e+00
1.2e+00
cases:3.15%
controls:1.61%
cases:2.29%
controls:0.65%
cases:0.42%
controls:0.08%
cases:0.21%
controls:0.00%
cases:0.64%
controls:0.06%
cases:1.90%
controls:0.62%
cases:7.39%
controls:2.44%
74
378
2276
23077
54
152
2301
23339
10
19
2345
23472
5
0
2350
23491
15
15
2336
23459
44
144
2274
23070
159
526
1992
21013
Systematic individual therapy, cognitive-behavioural
IDY03 [2001304164]
1.0e+00
1.4e+00
—
—
2.2e+00
2.0e+00
1.6e+00
cases:0.81%
controls:0.29%
cases:0.68%
controls:0.16%
—
—
—
—
cases:0.30%
controls:0.03%
cases:2.11%
controls:0.28%
cases:4.09%
controls:0.89%
19
68
2331
23387
16
38
2339
23453
—
—
7
8
2344
23466
49
66
2269
23148
88
192
2063
21347
Urine methamphetamine measurement
313579004 [4198724]
1.3e+00
1.9e+00
—
—
—
2.6e+00
2.4e+00
cases:0.47%
controls:0.12%
cases:0.34%
controls:0.05%
—
—
—
—
—
—
cases:0.35%
controls:0.03%
cases:1.39%
controls:0.13%
11
29
2339
23426
8
12
2347
23479
—
—
—
8
6
2310
23208
30
28
2121
21511
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
4.2e-01
6.3e-01
9.1e-01
2.9e+00
1.4e+00
1.0e+00
8.7e-01
cases:10.47%
controls:7.13%
cases:8.07%
controls:4.46%
cases:2.46%
controls:1.01%
cases:0.64%
controls:0.03%
cases:3.62%
controls:0.90%
cases:10.66%
controls:4.11%
cases:22.36%
controls:10.76%
246
1672
2104
21783
190
1048
2165
22443
58
237
2297
23254
15
8
2340
23483
85
211
2266
23263
247
954
2071
22260
481
2317
1670
19222
Rheumatism, unspecified
M79.0 [45567658]
1.7e+00
3.0e+00
—
—
—
1.8e+00
1.7e+00
cases:0.55%
controls:0.11%
cases:0.42%
controls:0.02%
—
—
—
—
—
—
cases:0.39%
controls:0.06%
cases:0.84%
controls:0.15%
13
25
2337
23430
10
5
2345
23486
—
—
—
9
15
2309
23199
18
32
2133
21507
olanzapine and samidorphan
N05AH53 [955100]
1.5e+00
1.8e+00
—
—
—
2.3e+00
2.5e+00
cases:0.98%
controls:0.22%
cases:0.42%
controls:0.07%
—
—
—
—
—
—
cases:0.65%
controls:0.06%
cases:2.32%
controls:0.19%
23
52
2327
23403
10
16
2345
23475
—
—
—
15
15
2303
23199
50
42
2101
21497
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
8.2e-01
1.1e+00
1.9e+00
—
1.9e+00
1.2e+00
1.3e+00
cases:1.79%
controls:0.80%
cases:1.10%
controls:0.37%
cases:0.38%
controls:0.06%
—
—
cases:0.30%
controls:0.05%
cases:1.25%
controls:0.39%
cases:5.72%
controls:1.61%
42
187
2308
23268
26
86
2329
23405
9
14
2346
23477
—
7
11
2344
23463
29
90
2289
23124
123
346
2028
21193
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
6.0e-01
1.0e+00
1.8e+00
—
2.8e+00
1.2e+00
1.3e+00
cases:1.45%
controls:0.80%
cases:0.85%
controls:0.31%
cases:0.30%
controls:0.05%
—
—
cases:0.51%
controls:0.03%
cases:0.73%
controls:0.22%
cases:1.35%
controls:0.37%
34
188
2316
23267
20
73
2335
23418
7
12
2348
23479
—
12
7
2339
23467
17
51
2301
23163
29
80
2122
21459
Psychiatric treatment plan, monitoring
ICB03 [2001304100]
1.7e+00
1.5e+00
—
—
—
2.7e+00
2.3e+00
cases:0.72%
controls:0.14%
cases:0.51%
controls:0.12%
—
—
—
—
—
—
cases:1.21%
controls:0.08%
cases:2.70%
controls:0.28%
17
32
2333
23423
12
28
2343
23463
—
—
—
28
19
2290
23195
58
60
2093
21479
Fibromyalgia
M79.7 [45553272]
2.0e+00
2.1e+00
2.0e+00
1.0e+50
1.7e+00
2.0e+00
1.9e+00
cases:0.89%
controls:0.12%
cases:0.72%
controls:0.09%
cases:0.21%
controls:0.03%
cases:0.34%
controls:0.00%
cases:0.21%
controls:0.04%
cases:0.91%
controls:0.12%
cases:1.77%
controls:0.26%
21
29
2329
23426
17
20
2338
23471
5
7
2350
23484
8
0
2347
23491
5
9
2346
23465
21
28
2297
23186
38
56
2113
21483
Bipolar affective disorder, current episode manic without psychotic symptoms
F31.1 [45576537]
2.5e+00
2.8e+00
—
—
—
—
2.8e+00
cases:0.60%
controls:0.05%
cases:0.34%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.04%
14
11
2336
23444
8
5
2347
23486
—
—
—
—
14
9
2137
21530
Celiac disease serology panel - Serum
94494-2 [36660697]
5.3e-01
1.2e+00
2.2e+00
—
2.2e+00
1.2e+00
7.0e-01
cases:2.04%
controls:1.22%
cases:1.53%
controls:0.45%
cases:0.30%
controls:0.03%
—
—
cases:0.55%
controls:0.06%
cases:1.68%
controls:0.51%
cases:3.49%
controls:1.76%
48
285
2302
23170
36
106
2319
23385
7
8
2348
23483
—
13
14
2338
23460
39
118
2279
23096
75
380
2076
21159
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
2.6e-01
6.3e-01
1.2e+00
3.6e+00
1.3e+00
6.7e-01
4.3e-01
cases:25.11%
controls:20.55%
cases:25.90%
controls:15.63%
cases:10.36%
controls:3.21%
cases:2.89%
controls:0.09%
cases:9.57%
controls:2.90%
cases:27.83%
controls:16.50%
cases:48.81%
controls:38.20%
590
4821
1760
18634
610
3672
1745
19819
244
754
2111
22737
68
20
2287
23471
225
680
2126
22794
645
3831
1673
19383
1050
8228
1101
13311
Platelets [#/volume] in Blood
26515-7 [3007461]
2.6e-01
6.4e-01
1.2e+00
3.6e+00
1.3e+00
6.7e-01
4.3e-01
cases:25.11%
controls:20.48%
cases:25.90%
controls:15.60%
cases:10.28%
controls:3.21%
cases:2.89%
controls:0.09%
cases:9.49%
controls:2.88%
cases:27.78%
controls:16.47%
cases:48.68%
controls:38.06%
590
4804
1760
18651
610
3664
1745
19827
242
753
2113
22738
68
20
2287
23471
223
677
2128
22797
644
3824
1674
19390
1047
8198
1104
13341
MCH [Entitic mass]
28539-5 [3035941]
2.6e-01
6.4e-01
1.2e+00
3.6e+00
1.3e+00
6.7e-01
4.3e-01
cases:25.11%
controls:20.52%
cases:25.90%
controls:15.61%
cases:10.32%
controls:3.21%
cases:2.89%
controls:0.09%
cases:9.49%
controls:2.89%
cases:27.83%
controls:16.48%
cases:48.72%
controls:38.20%
590
4814
1760
18641
610
3667
1745
19824
243
754
2112
22737
68
20
2287
23471
223
679
2128
22795
645
3825
1673
19389
1048
8227
1103
13312
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
2.6e-01
6.3e-01
1.2e+00
3.6e+00
1.3e+00
6.7e-01
4.3e-01
cases:25.11%
controls:20.54%
cases:25.86%
controls:15.62%
cases:10.28%
controls:3.21%
cases:2.89%
controls:0.09%
cases:9.49%
controls:2.89%
cases:27.83%
controls:16.50%
cases:48.77%
controls:38.19%
590
4817
1760
18638
609
3670
1746
19821
242
755
2113
22736
68
20
2287
23471
223
678
2128
22796
645
3830
1673
19384
1049
8226
1102
13313
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
2.6e-01
6.3e-01
1.2e+00
3.6e+00
1.3e+00
6.7e-01
4.3e-01
cases:25.11%
controls:20.54%
cases:25.90%
controls:15.64%
cases:10.32%
controls:3.21%
cases:2.89%
controls:0.09%
cases:9.49%
controls:2.89%
cases:27.83%
controls:16.51%
cases:48.68%
controls:38.21%
590
4818
1760
18637
610
3674
1745
19817
243
755
2112
22736
68
20
2287
23471
223
679
2128
22795
645
3832
1673
19382
1047
8231
1104
13308
liraglutide; parenteral
A10BJ02 [1123630]
1.8e+00
1.6e+00
—
—
—
2.4e+00
2.2e+00
cases:0.64%
controls:0.11%
cases:0.47%
controls:0.09%
—
—
—
—
—
—
cases:0.69%
controls:0.06%
cases:2.28%
controls:0.25%
15
26
2335
23429
11
22
2344
23469
—
—
—
16
14
2302
23200
49
54
2102
21485
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.6e-01
6.3e-01
1.2e+00
3.6e+00
1.3e+00
6.7e-01
4.3e-01
cases:25.11%
controls:20.60%
cases:25.90%
controls:15.64%
cases:10.32%
controls:3.23%
cases:2.89%
controls:0.09%
cases:9.49%
controls:2.91%
cases:28.00%
controls:16.57%
cases:48.86%
controls:38.29%
590
4832
1760
18623
610
3675
1745
19816
243
758
2112
22733
68
20
2287
23471
223
683
2128
22791
649
3847
1669
19367
1051
8248
1100
13291
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.3e-01
6.1e-01
1.1e+00
3.6e+00
1.1e+00
6.9e-01
5.3e-01
cases:20.47%
controls:15.61%
cases:16.48%
controls:9.65%
cases:5.22%
controls:1.75%
cases:1.66%
controls:0.05%
cases:4.76%
controls:1.56%
cases:17.99%
controls:9.93%
cases:39.98%
controls:28.09%
481
3661
1869
19794
388
2267
1967
21224
123
412
2232
23079
39
11
2316
23480
112
367
2239
23107
417
2304
1901
20910
860
6050
1291
15489
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
2.6e-01
6.3e-01
1.2e+00
3.6e+00
1.3e+00
6.6e-01
4.3e-01
cases:25.19%
controls:20.64%
cases:25.90%
controls:15.69%
cases:10.32%
controls:3.23%
cases:2.89%
controls:0.09%
cases:9.49%
controls:2.91%
cases:27.83%
controls:16.56%
cases:48.77%
controls:38.31%
592
4840
1758
18615
610
3685
1745
19806
243
758
2112
22733
68
20
2287
23471
223
684
2128
22790
645
3845
1673
19369
1049
8252
1102
13287
Pulmonary Disease
29 [38004472]
9.1e-01
1.1e+00
1.5e+00
—
1.8e+00
1.4e+00
1.3e+00
cases:6.60%
controls:2.77%
cases:4.33%
controls:1.46%
cases:1.10%
controls:0.24%
—
—
cases:1.28%
controls:0.22%
cases:5.13%
controls:1.35%
cases:10.79%
controls:3.30%
155
649
2195
22806
102
342
2253
23149
26
56
2329
23435
—
30
52
2321
23422
119
313
2199
22901
232
711
1919
20828
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
4.2e-01
8.8e-01
1.4e+00
2.9e+00
1.2e+00
6.3e-01
5.1e-01
cases:13.32%
controls:9.16%
cases:11.59%
controls:5.14%
cases:2.72%
controls:0.68%
cases:0.38%
controls:0.02%
cases:2.04%
controls:0.61%
cases:10.70%
controls:6.02%
cases:29.75%
controls:20.35%
313
2148
2037
21307
273
1208
2082
22283
64
160
2291
23331
9
5
2346
23486
48
144
2303
23330
248
1397
2070
21817
640
4384
1511
17155
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
9.6e-01
1.2e+00
1.9e+00
—
1.5e+00
1.4e+00
1.1e+00
cases:7.19%
controls:2.89%
cases:3.61%
controls:1.17%
cases:1.02%
controls:0.15%
—
—
cases:0.55%
controls:0.13%
cases:3.97%
controls:1.04%
cases:10.65%
controls:3.83%
169
677
2181
22778
85
275
2270
23216
24
36
2331
23455
—
13
30
2338
23444
92
241
2226
22973
229
826
1922
20713
calcium (different salts in combination); oral
A12AA20 [21600872]
8.6e-01
9.9e-01
1.4e+00
—
1.6e+00
1.5e+00
1.6e+00
cases:5.40%
controls:2.36%
cases:4.29%
controls:1.63%
cases:1.44%
controls:0.34%
—
—
cases:1.57%
controls:0.34%
cases:7.59%
controls:1.78%
cases:13.30%
controls:3.11%
127
554
2223
22901
101
384
2254
23107
34
81
2321
23410
—
37
79
2314
23395
176
413
2142
22801
286
670
1865
20869
Type 2 diabetes mellitus
E11 [45571656]
1.1e+00
1.7e+00
—
—
2.0e+00
1.7e+00
1.3e+00
cases:2.17%
controls:0.70%
cases:1.61%
controls:0.30%
—
—
—
—
cases:0.43%
controls:0.06%
cases:1.60%
controls:0.29%
cases:4.32%
controls:1.21%
51
164
2299
23291
38
70
2317
23421
—
—
10
13
2341
23461
37
68
2281
23146
93
260
2058
21279
ziprasidone; oral, parenteral
N05AE04 [21604529]
2.2e+00
1.9e+00
—
—
—
2.3e+00
3.4e+00
cases:0.64%
controls:0.07%
cases:0.25%
controls:0.04%
—
—
—
—
—
—
cases:0.39%
controls:0.04%
cases:1.26%
controls:0.04%
15
17
2335
23438
6
9
2349
23482
—
—
—
9
9
2309
23205
27
9
2124
21530
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
3.9e-01
8.6e-01
1.4e+00
2.9e+00
1.3e+00
6.1e-01
5.0e-01
cases:12.94%
controls:9.15%
cases:11.08%
controls:5.01%
cases:2.59%
controls:0.66%
cases:0.38%
controls:0.02%
cases:2.13%
controls:0.60%
cases:10.18%
controls:5.81%
cases:29.20%
controls:20.04%
304
2146
2046
21309
261
1178
2094
22313
61
156
2294
23335
9
5
2346
23486
50
142
2301
23332
236
1349
2082
21865
628
4316
1523
17223
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
4.2e-01
8.8e-01
1.4e+00
2.9e+00
1.2e+00
5.9e-01
4.8e-01
cases:12.98%
controls:8.94%
cases:11.00%
controls:4.89%
cases:2.68%
controls:0.66%
cases:0.38%
controls:0.02%
cases:2.00%
controls:0.60%
cases:9.84%
controls:5.70%
cases:28.68%
controls:19.88%
305
2098
2045
21357
259
1148
2096
22343
63
156
2292
23335
9
5
2346
23486
47
141
2304
23333
228
1324
2090
21890
617
4283
1534
17256
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
6.0e-01
1.2e+00
2.0e+00
—
2.1e+00
1.1e+00
8.7e-01
cases:16.34%
controls:9.67%
cases:14.86%
controls:4.78%
cases:4.25%
controls:0.60%
—
—
cases:4.04%
controls:0.53%
cases:13.98%
controls:5.05%
cases:34.59%
controls:18.15%
384
2268
1966
21187
350
1123
2005
22368
100
141
2255
23350
—
95
125
2256
23349
324
1173
1994
22041
744
3909
1407
17630
Fear of mental disorder
P27 [2002000821]
1.8e+00
2.6e+00
—
—
—
2.2e+00
1.3e+00
cases:0.51%
controls:0.09%
cases:0.34%
controls:0.03%
—
—
—
—
—
—
cases:0.26%
controls:0.03%
cases:0.56%
controls:0.15%
12
20
2338
23435
8
6
2347
23485
—
—
—
6
7
2312
23207
12
32
2139
21507
Sleep disturbance
P06 [2002000803]
1.2e+00
2.0e+00
2.3e+00
—
—
1.2e+00
1.2e+00
cases:2.09%
controls:0.66%
cases:1.40%
controls:0.19%
cases:0.30%
controls:0.03%
—
—
—
—
cases:0.95%
controls:0.28%
cases:4.00%
controls:1.28%
49
155
2301
23300
33
45
2322
23446
7
7
2348
23484
—
—
22
65
2296
23149
86
276
2065
21263
Undifferentiated schizophrenia continuous
F20.30 [2000501944]
2.1e+00
1.6e+00
—
—
2.1e+00
1.9e+00
2.2e+00
cases:0.72%
controls:0.09%
cases:0.38%
controls:0.08%
—
—
—
—
cases:0.21%
controls:0.03%
cases:0.43%
controls:0.06%
cases:0.88%
controls:0.10%
17
21
2333
23434
9
18
2346
23473
—
—
5
6
2346
23468
10
15
2308
23199
19
21
2132
21518
Monitoring the use of the aid
R5140 [2001310249]
1.1e+00
2.0e+00
—
—
—
2.7e+00
2.0e+00
cases:0.89%
controls:0.29%
cases:0.85%
controls:0.11%
—
—
—
—
—
—
cases:1.21%
controls:0.09%
cases:2.51%
controls:0.36%
21
67
2329
23388
20
26
2335
23465
—
—
—
28
20
2290
23194
54
78
2097
21461
chlordiazepoxide; oral, parenteral
N05BA02 [21604567]
2.3e+00
2.9e+00
—
—
—
—
2.6e+00
cases:0.47%
controls:0.05%
cases:0.38%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.74%
controls:0.06%
11
11
2339
23444
9
5
2346
23486
—
—
—
—
16
12
2135
21527
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
6.2e-01
7.1e-01
2.1e+00
—
2.6e+00
1.4e+00
1.1e+00
cases:2.04%
controls:1.11%
cases:1.10%
controls:0.54%
cases:0.72%
controls:0.09%
—
—
cases:0.98%
controls:0.08%
cases:1.94%
controls:0.51%
cases:3.63%
controls:1.19%
48
260
2302
23195
26
128
2329
23363
17
21
2338
23470
—
23
18
2328
23456
45
118
2273
23096
78
256
2073
21283
Obesity
E66 [45547648]
1.8e+00
2.5e+00
—
—
—
1.8e+00
1.6e+00
cases:1.49%
controls:0.25%
cases:1.44%
controls:0.11%
—
—
—
—
—
—
cases:0.82%
controls:0.13%
cases:2.70%
controls:0.56%
35
58
2315
23397
34
27
2321
23464
—
—
—
19
31
2299
23183
58
121
2093
21418
amitriptyline; oral, parenteral
N06AA09 [21604696]
1.0e+00
1.3e+00
1.6e+00
—
1.6e+00
1.1e+00
1.1e+00
cases:4.89%
controls:1.80%
cases:3.18%
controls:0.87%
cases:0.89%
controls:0.19%
—
—
cases:0.94%
controls:0.20%
cases:2.93%
controls:0.97%
cases:8.32%
controls:2.82%
115
422
2235
23033
75
205
2280
23286
21
44
2334
23447
—
22
46
2329
23428
68
225
2250
22989
179
607
1972
20932
Addiction caused by alcohol UNS
F10.29 [2000501684]
2.5e+00
—
—
—
—
2.8e+00
2.4e+00
cases:0.51%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.02%
cases:0.74%
controls:0.06%
12
10
2338
23445
—
—
—
—
8
5
2310
23209
16
14
2135
21525
Cocaine [Presence] in Urine
3397-7 [3016879]
7.4e-01
1.1e+00
1.7e+00
—
1.9e+00
1.1e+00
1.2e+00
cases:1.87%
controls:0.90%
cases:1.23%
controls:0.43%
cases:0.38%
controls:0.07%
—
—
cases:0.30%
controls:0.05%
cases:1.34%
controls:0.46%
cases:5.95%
controls:1.83%
44
211
2306
23244
29
100
2326
23391
9
16
2346
23475
—
7
11
2344
23463
31
106
2287
23108
128
394
2023
21145
Extensive initial psychiatric evaluation
IBA04 [2001304046]
1.6e+00
2.0e+00
2.1e+00
1.0e+50
—
2.3e+00
1.7e+00
cases:1.15%
controls:0.23%
cases:0.85%
controls:0.11%
cases:0.21%
controls:0.03%
cases:0.76%
controls:0.00%
—
—
cases:0.95%
controls:0.09%
cases:2.05%
controls:0.39%
27
54
2323
23401
20
26
2335
23465
5
6
2350
23485
18
0
2337
23491
—
22
22
2296
23192
44
84
2107
21455
Disturbance of activity and attention
F90.0 [45542870]
1.1e+00
1.0e+00
1.3e+00
—
1.5e+00
1.4e+00
1.2e+00
cases:2.00%
controls:0.64%
cases:1.61%
controls:0.59%
cases:0.85%
controls:0.23%
—
—
cases:1.19%
controls:0.26%
cases:2.76%
controls:0.72%
cases:5.02%
controls:1.51%
47
151
2303
23304
38
139
2317
23352
20
53
2335
23438
—
28
61
2323
23413
64
166
2254
23048
108
326
2043
21213
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
1.2e+00
1.3e+00
2.6e+00
—
—
1.6e+00
9.7e-01
cases:0.77%
controls:0.24%
cases:0.51%
controls:0.14%
cases:0.30%
controls:0.02%
—
—
—
—
cases:0.69%
controls:0.15%
cases:1.58%
controls:0.60%
18
57
2332
23398
12
33
2343
23458
7
5
2348
23486
—
—
16
34
2302
23180
34
130
2117
21409
Emergency Room and Inpatient Visit
ERIP [262]
6.8e-01
1.1e+00
2.0e+00
1.0e+50
1.7e+00
1.4e+00
7.7e-01
cases:4.04%
controls:2.09%
cases:3.10%
controls:1.08%
cases:0.68%
controls:0.09%
cases:1.91%
controls:0.00%
cases:0.60%
controls:0.11%
cases:4.10%
controls:1.06%
cases:8.88%
controls:4.33%
95
490
2255
22965
73
254
2282
23237
16
22
2339
23469
45
0
2310
23491
14
26
2337
23448
95
245
2223
22969
191
932
1960
20607
Assessment of need for psychiatric treatment
IAA01 [2001304011]
1.7e+00
1.9e+00
—
—
—
2.3e+00
1.7e+00
cases:1.36%
controls:0.25%
cases:1.15%
controls:0.17%
—
—
—
—
—
—
cases:1.34%
controls:0.14%
cases:2.74%
controls:0.53%
32
58
2318
23397
27
39
2328
23452
—
—
—
31
33
2287
23181
59
114
2092
21425
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
6.8e-01
9.6e-01
2.0e+00
—
1.4e+00
1.3e+00
1.2e+00
cases:4.85%
controls:2.52%
cases:3.57%
controls:1.40%
cases:1.15%
controls:0.16%
—
—
cases:0.94%
controls:0.22%
cases:4.66%
controls:1.28%
cases:12.65%
controls:4.19%
114
590
2236
22865
84
329
2271
23162
27
38
2328
23453
—
22
52
2329
23422
108
298
2210
22916
272
903
1879
20636
Benzodiazepines [Presence] in Urine
3390-2 [3000764]
7.3e-01
9.7e-01
1.8e+00
—
1.9e+00
1.1e+00
1.1e+00
cases:1.96%
controls:0.96%
cases:1.23%
controls:0.47%
cases:0.38%
controls:0.06%
—
—
cases:0.30%
controls:0.05%
cases:1.42%
controls:0.48%
cases:6.23%
controls:2.11%
46
224
2304
23231
29
111
2326
23380
9
15
2346
23476
—
7
11
2344
23463
33
111
2285
23103
134
454
2017
21085
Cannabinoids [Presence] in Urine
3427-2 [3028300]
7.2e-01
9.6e-01
1.7e+00
—
1.9e+00
1.2e+00
1.1e+00
cases:1.96%
controls:0.96%
cases:1.23%
controls:0.48%
cases:0.38%
controls:0.07%
—
—
cases:0.30%
controls:0.05%
cases:1.51%
controls:0.48%
cases:6.18%
controls:2.13%
46
226
2304
23229
29
112
2326
23379
9
16
2346
23475
—
7
11
2344
23463
35
111
2283
23103
133
459
2018
21080
Chronic alcohol abuse
P15 [2002000811]
2.1e+00
2.0e+00
—
—
—
1.8e+00
1.7e+00
cases:0.47%
controls:0.06%
cases:0.25%
controls:0.03%
—
—
—
—
—
—
cases:0.30%
controls:0.05%
cases:0.88%
controls:0.17%
11
14
2339
23441
6
8
2349
23483
—
—
—
7
12
2311
23202
19
36
2132
21503
Rehabilitative psychiatric group intervention, functional
IER04 [2001304208]
2.0e+00
1.1e+00
—
—
—
3.0e+00
2.5e+00
cases:0.51%
controls:0.07%
cases:0.21%
controls:0.07%
—
—
—
—
—
—
cases:0.78%
controls:0.04%
cases:1.12%
controls:0.09%
12
17
2338
23438
5
17
2350
23474
—
—
—
18
9
2300
23205
24
19
2127
21520
Procedure duration 120 to 149 minutes
ZXE15 [2001311406]
1.3e+00
1.4e+00
—
1.0e+50
—
3.4e+00
2.8e+00
cases:1.23%
controls:0.33%
cases:0.38%
controls:0.09%
—
—
cases:0.30%
controls:0.00%
—
—
cases:1.38%
controls:0.05%
cases:2.32%
controls:0.15%
29
77
2321
23378
9
22
2346
23469
—
7
0
2348
23491
—
32
11
2286
23203
50
32
2101
21507
Mental disorder, not otherwise specified
F99 [45605525]
1.0e+00
2.5e+00
—
—
—
2.0e+00
1.9e+00
cases:0.60%
controls:0.21%
cases:0.85%
controls:0.07%
—
—
—
—
—
—
cases:0.56%
controls:0.07%
cases:1.72%
controls:0.27%
14
50
2336
23405
20
16
2335
23475
—
—
—
13
17
2305
23197
37
58
2114
21481
Psychiatric network contact
IGV01 [2001304319]
1.5e+00
1.8e+00
—
—
—
2.1e+00
2.1e+00
cases:0.64%
controls:0.14%
cases:0.55%
controls:0.09%
—
—
—
—
—
—
cases:0.78%
controls:0.10%
cases:1.58%
controls:0.19%
15
33
2335
23422
13
22
2342
23469
—
—
—
18
23
2300
23191
34
42
2117
21497
Other specified anxiety disorders
F41.8 [45595908]
1.8e+00
2.1e+00
—
1.0e+50
—
2.2e+00
1.4e+00
cases:1.19%
controls:0.20%
cases:1.06%
controls:0.13%
—
—
cases:0.68%
controls:0.00%
—
—
cases:1.47%
controls:0.16%
cases:2.42%
controls:0.61%
28
48
2322
23407
25
31
2330
23460
—
16
0
2339
23491
—
34
38
2284
23176
52
132
2099
21407
Recurrent depressive disorder
F33 [45576542]
1.4e+00
2.2e+00
—
—
—
2.2e+00
1.7e+00
cases:0.51%
controls:0.13%
cases:0.51%
controls:0.06%
—
—
—
—
—
—
cases:0.69%
controls:0.08%
cases:1.81%
controls:0.32%
12
31
2338
23424
12
14
2343
23477
—
—
—
16
18
2302
23196
39
70
2112
21469
Opiates [Presence] in Urine
3879-4 [3027008]
7.2e-01
9.1e-01
1.7e+00
—
1.9e+00
1.1e+00
1.1e+00
cases:1.96%
controls:0.96%
cases:1.19%
controls:0.48%
cases:0.38%
controls:0.07%
—
—
cases:0.30%
controls:0.05%
cases:1.42%
controls:0.47%
cases:6.14%
controls:2.13%
46
225
2304
23230
28
113
2327
23378
9
16
2346
23475
—
7
11
2344
23463
33
110
2285
23104
132
458
2019
21081
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.9e-01
5.3e-01
1.1e+00
3.5e+00
1.2e+00
5.6e-01
3.1e-01
cases:18.68%
controls:15.93%
cases:18.13%
controls:11.49%
cases:6.75%
controls:2.27%
cases:2.29%
controls:0.07%
cases:6.55%
controls:2.08%
cases:19.15%
controls:11.92%
cases:36.68%
controls:29.75%
439
3736
1911
19719
427
2699
1928
20792
159
534
2196
22957
54
17
2301
23474
154
488
2197
22986
444
2767
1874
20447
789
6407
1362
15132
Therapeutic discussion
SPAT1240 [2001700341]
1.1e+00
1.6e+00
1.8e+00
—
9.5e-01
9.6e-01
9.3e-01
cases:6.26%
controls:2.09%
cases:4.33%
controls:0.92%
cases:1.27%
controls:0.21%
—
—
cases:0.68%
controls:0.26%
cases:2.42%
controls:0.94%
cases:7.21%
controls:2.98%
147
490
2203
22965
102
217
2253
23274
30
50
2325
23441
—
16
62
2335
23412
56
218
2262
22996
155
641
1996
20898
Emergency Room Visit
ER [9203]
6.3e-01
1.0e+00
1.9e+00
—
1.6e+00
1.2e+00
9.3e-01
cases:44.43%
controls:29.83%
cases:25.18%
controls:10.77%
cases:8.20%
controls:1.27%
—
—
cases:5.49%
controls:1.20%
cases:27.78%
controls:10.24%
cases:53.18%
controls:30.93%
1044
6997
1306
16458
593
2529
1762
20962
193
299
2162
23192
—
129
281
2222
23193
644
2377
1674
20837
1144
6662
1007
14877
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
6.2e-01
8.8e-01
2.0e+00
—
1.8e+00
1.2e+00
8.1e-01
cases:9.11%
controls:5.09%
cases:6.11%
controls:2.62%
cases:2.25%
controls:0.32%
—
—
cases:1.87%
controls:0.31%
cases:7.64%
controls:2.42%
cases:18.22%
controls:9.03%
214
1194
2136
22261
144
616
2211
22875
53
75
2302
23416
—
44
73
2307
23401
177
561
2141
22653
392
1945
1759
19594
propranolol; oral, parenteral
C07AA05 [21601670]
8.8e-01
1.4e+00
1.3e+00
—
1.4e+00
1.2e+00
1.1e+00
cases:6.98%
controls:3.02%
cases:5.22%
controls:1.40%
cases:0.98%
controls:0.27%
—
—
cases:0.98%
controls:0.25%
cases:5.13%
controls:1.57%
cases:13.58%
controls:4.92%
164
708
2186
22747
123
329
2232
23162
23
63
2332
23428
—
23
59
2328
23415
119
365
2199
22849
292
1059
1859
20480
Feeling anxious/nervous/tense
P01 [2002000798]
1.0e+00
1.6e+00
2.0e+00
—
1.2e+00
5.9e-01
6.8e-01
cases:7.11%
controls:2.63%
cases:6.41%
controls:1.30%
cases:1.70%
controls:0.23%
—
—
cases:0.72%
controls:0.21%
cases:2.67%
controls:1.51%
cases:10.23%
controls:5.44%
167
617
2183
22838
151
306
2204
23185
40
55
2315
23436
—
17
49
2334
23425
62
350
2256
22864
220
1171
1931
20368
pH of Specimen
17433-4 [3019225]
9.6e-01
1.2e+00
1.3e+00
—
2.2e+00
1.2e+00
1.6e+00
cases:1.28%
controls:0.49%
cases:0.98%
controls:0.29%
cases:0.21%
controls:0.06%
—
—
cases:0.38%
controls:0.04%
cases:0.86%
controls:0.26%
cases:3.16%
controls:0.68%
30
116
2320
23339
23
67
2332
23424
5
13
2350
23478
—
9
10
2342
23464
20
60
2298
23154
68
147
2083
21392
Bipolar affective disorder, current episode mild or moderate depression
F31.3 [45571755]
1.6e+00
2.7e+00
—
—
—
—
2.8e+00
cases:0.38%
controls:0.08%
cases:0.38%
controls:0.03%
—
—
—
—
—
—
—
—
cases:1.07%
controls:0.06%
9
18
2341
23437
9
6
2346
23485
—
—
—
—
23
14
2128
21525
hydrochlorothiazide and potassium-sparing agents
C03EA01 [21601543]
1.2e+00
1.4e+00
1.8e+00
—
—
1.5e+00
1.3e+00
cases:1.57%
controls:0.49%
cases:0.85%
controls:0.22%
cases:0.30%
controls:0.05%
—
—
—
—
cases:1.04%
controls:0.24%
cases:1.72%
controls:0.46%
37
115
2313
23340
20
52
2335
23439
7
12
2348
23479
—
—
24
55
2294
23159
37
99
2114
21440
Inpatient Visit
IP [9201]
5.0e-01
7.5e-01
1.4e+00
—
2.1e+00
1.4e+00
9.3e-01
cases:4.26%
controls:2.63%
cases:2.21%
controls:1.06%
cases:0.47%
controls:0.11%
—
—
cases:0.85%
controls:0.11%
cases:3.19%
controls:0.83%
cases:7.72%
controls:3.18%
100
616
2250
22839
52
249
2303
23242
11
26
2344
23465
—
20
25
2331
23449
74
193
2244
23021
166
685
1985
20854
Assessment of vocational rehabilitation needs in a mental health context
IBB03 [2001304050]
2.3e+00
—
—
—
—
2.3e+00
2.5e+00
cases:0.26%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.26%
controls:0.03%
cases:0.65%
controls:0.06%
6
6
2344
23449
—
—
—
—
6
6
2312
23208
14
12
2137
21527
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
9.9e-01
1.6e+00
—
—
2.3e+00
9.8e-01
1.2e+00
cases:1.45%
controls:0.54%
cases:1.06%
controls:0.21%
—
—
—
—
cases:0.34%
controls:0.03%
cases:0.78%
controls:0.29%
cases:2.37%
controls:0.76%
34
127
2316
23328
25
49
2330
23442
—
—
8
8
2343
23466
18
68
2300
23146
51
163
2100
21376
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
1.0e+00
1.3e+00
2.2e+00
—
1.5e+00
1.3e+00
1.3e+00
cases:1.79%
controls:0.64%
cases:1.15%
controls:0.32%
cases:0.42%
controls:0.05%
—
—
cases:0.26%
controls:0.06%
cases:1.47%
controls:0.41%
cases:5.25%
controls:1.53%
42
151
2308
23304
27
76
2328
23415
10
11
2345
23480
—
6
13
2345
23461
34
96
2284
23118
113
330
2038
21209
furosemide; oral, parenteral
C03CA01 [21601518]
1.2e+00
1.1e+00
1.3e+00
—
1.1e+00
1.1e+00
1.3e+00
cases:2.89%
controls:0.91%
cases:2.25%
controls:0.76%
cases:0.89%
controls:0.25%
—
—
cases:0.55%
controls:0.18%
cases:2.07%
controls:0.73%
cases:4.09%
controls:1.17%
68
213
2282
23242
53
178
2302
23313
21
58
2334
23433
—
13
42
2338
23432
48
169
2270
23045
88
252
2063
21287
Gas panel - Venous blood
24339-4 [3000991]
5.1e-01
5.5e-01
2.0e+00
—
2.6e+00
1.4e+00
1.0e+00
cases:1.62%
controls:0.98%
cases:0.81%
controls:0.47%
cases:0.55%
controls:0.08%
—
—
cases:0.77%
controls:0.06%
cases:1.60%
controls:0.42%
cases:2.65%
controls:0.96%
38
230
2312
23225
19
110
2336
23381
13
18
2342
23473
—
18
13
2333
23461
37
97
2281
23117
57
207
2094
21332
pH of Capillary blood
2745-8 [3009343]
7.6e-01
9.0e-01
1.5e+00
—
2.6e+00
1.3e+00
1.4e+00
cases:2.04%
controls:0.96%
cases:1.02%
controls:0.42%
cases:0.34%
controls:0.07%
—
—
cases:0.77%
controls:0.06%
cases:1.04%
controls:0.29%
cases:2.46%
controls:0.63%
48
226
2302
23229
24
98
2331
23393
8
17
2347
23474
—
18
13
2333
23461
24
67
2294
23147
53
136
2098
21403
Open wound of wrist and hand, part unspecified
S61.9 [45554740]
1.1e+00
2.6e+00
—
—
—
2.5e+00
1.8e+00
cases:0.51%
controls:0.18%
cases:0.30%
controls:0.02%
—
—
—
—
—
—
cases:0.26%
controls:0.02%
cases:0.93%
controls:0.15%
12
42
2338
23413
7
5
2348
23486
—
—
—
6
5
2312
23209
20
33
2131
21506
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
285 [2001600217]
2.1e+00
—
—
—
—
2.8e+00
2.0e+00
cases:0.47%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.02%
cases:0.93%
controls:0.13%
11
13
2339
23442
—
—
—
—
8
5
2310
23209
20
27
2131
21512
Gonarthrosis, unspecified
M17.9 [45606128]
1.9e+00
1.9e+00
—
—
—
1.6e+00
1.5e+00
cases:0.81%
controls:0.12%
cases:0.38%
controls:0.06%
—
—
—
—
—
—
cases:0.35%
controls:0.07%
cases:1.26%
controls:0.28%
19
28
2331
23427
9
14
2346
23477
—
—
—
8
16
2310
23198
27
60
2124
21479
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
1.7e+00
2.0e+00
—
—
—
1.7e+00
1.6e+00
cases:0.55%
controls:0.10%
cases:0.81%
controls:0.11%
—
—
—
—
—
—
cases:0.60%
controls:0.12%
cases:2.88%
controls:0.62%
13
24
2337
23431
19
26
2336
23465
—
—
—
14
27
2304
23187
62
133
2089
21406
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
3.9e-01
6.3e-01
2.0e+00
—
2.4e+00
1.1e+00
1.4e+00
cases:1.40%
controls:0.96%
cases:0.85%
controls:0.46%
cases:0.47%
controls:0.06%
—
—
cases:0.72%
controls:0.07%
cases:1.29%
controls:0.42%
cases:2.84%
controls:0.73%
33
224
2317
23231
20
107
2335
23384
11
15
2344
23476
—
17
16
2334
23458
30
98
2288
23116
61
157
2090
21382
Feeling depressed
P03 [2002000800]
1.2e+00
1.9e+00
2.2e+00
—
7.2e-01
7.2e-01
8.5e-01
cases:5.74%
controls:1.73%
cases:4.97%
controls:0.80%
cases:1.10%
controls:0.13%
—
—
cases:0.30%
controls:0.14%
cases:1.73%
controls:0.84%
cases:7.02%
controls:3.12%
135
405
2215
23050
117
189
2238
23302
26
30
2329
23461
—
7
34
2344
23440
40
196
2278
23018
151
672
2000
20867
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
7.2e-01
8.6e-01
1.5e+00
—
2.6e+00
1.2e+00
1.5e+00
cases:1.96%
controls:0.96%
cases:0.98%
controls:0.42%
cases:0.30%
controls:0.07%
—
—
cases:0.68%
controls:0.05%
cases:0.91%
controls:0.28%
cases:2.46%
controls:0.58%
46
226
2304
23229
23
98
2332
23393
7
16
2348
23475
—
16
12
2335
23462
21
64
2297
23150
53
126
2098
21413

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
729
1669
5.84
315.52
6.9
6.7
1.12
1.10
mmol/l
0.89
672
1569
610
1197
6.50
310.83
3.3
2.9
0.23
0.22
g/l
0.30
559
1126
1207
4856
4.00
243.15
3.2
2.9
2.35
2.35
mmol/l
0.15
1114
4525
1352
6282
3.65
210.92
2.5
1.7
96.56
97.36
pmol/l
0.25
816
3587
701
2105
4.29
209.27
4.3
4.4
0.83
0.82
mmol/l
0.83
666
2006
1336
6202
3.62
207.86
5.3
4.7
37.95
37.37
g/l
3.67
1260
5839
1425
6906
3.63
206.73
8.7
6.2
1.22
1.21
mmol/l
0.49
1287
6027
1298
6047
3.51
198.13
8.0
5.9
1.22
1.22
mmol/l
1.55
1228
5626
607
1707
4.42
196.69
1.9
1.6
1124.89
1111.63
nmol/l
0.13
496
1338
1581
8556
3.50
184.41
3.6
2.4
69.09
70.88
nmol/l
1.95
1496
8097
958
3870
3.46
180.55
2.0
1.5
21.21
20.10
nmol/l
1.61
885
3491
944
3883
3.36
171.09
4.4
3.5
7.39
7.39
ph
2.52
664
2642
401
928
4.99
164.21
3.0
2.2
—
—
—
0
0
1047
5131
2.85
131.93
2.8
2.2
2.61
2.50
mg/l
0.99
931
4481
1185
6281
2.76
126.95
4.1
3.0
29.21
28.18
u/l
0.26
1129
6010
510
1685
3.57
126.77
2.9
2.3
—
—
—
0
0
1868
12597
3.21
124.46
8.4
6.5
75.31
74.14
u/l
0.55
1785
11944
612
2342
3.17
119.13
2.4
2.3
2.40
2.41
mmol/l
0.97
531
2068
353
963
4.12
115.27
1.6
1.6
0.20
0.23
mg/l
0.55
136
384
992
5021
2.67
113.34
3.7
2.4
62.37
56.81
u/l
0.62
899
4695
148
181
8.64
113.17
15.0
13.4
0.62
0.59
mmol/l
0.59
141
164
529
1920
3.25
111.95
2.1
2.2
387.96
387.70
nmol/l
0.01
486
1786
1229
6973
2.57
109.76
1.7
1.4
1.32
1.68
u/ml
0.65
343
1933
1330
7936
2.52
105.10
5.6
5.3
9.53
10.05
umol/l
1.01
1228
7445
491
1865
3.05
94.79
2.7
1.7
—
—
—
0
0
902
4678
2.49
94.11
3.9
3.5
7.81
8.41
mmol/l
2.18
779
4239
1054
5919
2.39
91.48
1.7
1.5
1.95
1.97
g/l
0.26
625
3845
1525
10068
2.42
90.93
8.6
6.4
0.04
0.04
e9/l
1.48
1331
8855
1524
10067
2.42
90.63
8.5
6.4
0.50
0.53
e9/l
4.27
1332
8860
1524
10079
2.41
90.19
6.6
4.3
6.08
6.11
mmol/l
0.18
1434
8823
1643
11245
2.47
89.81
14.0
8.6
3.81
3.97
e9/l
2.32
1432
9818
600
2619
2.72
88.82
2.6
2.4
13.44
14.77
umol/l
4.40
564
2441
1087
6250
2.35
88.60
7.6
6.6
—
—
—
0
0
1555
10437
2.40
88.00
9.5
6.7
0.16
0.18
e9/l
3.10
1382
9313
102
109
9.72
86.37
5.9
5.0
199.15
185.07
umol/l
0.12
53
60
620
2788
2.65
86.18
2.0
1.5
429.10
27877239.83
pmol/l
2.66
552
2468
1551
10456
2.38
85.99
8.5
6.3
1.98
2.03
e9/l
1.44
1386
9446
2155
17061
3.69
85.57
7.1
4.4
13.92
14.27
pmol/l
11.31
2051
15820
526
2188
2.80
85.14
2.8
1.8
—
—
—
0
0
1423
9315
2.30
83.54
8.5
6.4
8.02
8.09
%
0.50
1340
8820
1417
9274
2.30
83.02
8.5
6.5
0.67
0.65
%
0.49
1328
8748
125
180
7.27
82.92
25.1
25.0
1386.95
1411.47
nmol/l
0.11
125
174
1417
9289
2.29
82.48
8.4
6.4
2.53
2.70
%
2.34
1329
8775
548
2368
2.70
82.06
2.8
1.8
—
—
—
0
0
551
2389
2.70
81.95
2.6
2.3
2.57
2.52
g/l
1.19
498
2205
547
2393
2.67
79.68
2.8
1.8
—
—
—
0
0
1820
13395
2.50
79.16
4.6
3.3
53.84
57.31
ug/l
0.72
1742
12773
544
2384
2.66
78.89
2.8
1.8
—
—
—
0
0
363
1293
3.13
77.32
6.0
5.4
7.37
7.37
ph
1.51
219
796
1440
9652
2.24
77.30
8.2
6.1
54.93
55.82
%
2.35
1370
9301
362
1296
3.11
76.38
6.0
5.4
6.01
5.74
kpa
7.05
354
1261
355
1259
3.13
76.12
6.0
5.4
1.41
1.37
mmol/l
0.06
314
1057
134
227
6.19
76.09
6.8
6.2
362.64
373.63
umol/l
0.32
111
200
1450
9799
2.22
75.52
8.4
6.3
31.22
30.50
%
1.84
1379
9383
724
3698
2.37
75.03
2.8
2.0
222.73
172.26
u/l
0.33
692
3534
492
2116
2.67
73.61
2.7
2.4
20.86
23.73
%
5.00
459
1964
2235
18540
4.19
73.26
20.8
9.4
3.87
3.87
mmol/l
0.53
2200
17954
2234
18533
4.17
73.07
20.7
9.3
139.42
139.43
mmol/l
0.11
2204
18014
526
2358
2.58
72.17
2.7
1.7
—
—
—
0
0
714
3712
2.32
70.29
2.5
2.7
71.10
104.07
ug/g
4.18
546
2921
315
1122
3.08
66.62
5.1
5.3
4.55
4.83
kpa
1.66
308
1092
2258
19217
4.20
63.36
8.8
5.1
1.71
1.75
mu/l
0.98
2200
18405
2087
16995
2.80
63.23
5.6
3.2
5.64
5.47
mmol/l
4.94
1993
16060
1340
9240
2.02
60.39
13.4
9.0
0.00
0.00
e9/l
0.95
1084
7592
291
1052
3.01
59.69
8.8
7.9
1.19
1.28
mmol/l
0.98
286
1026
1822
14168
2.20
57.82
4.7
2.8
31.69
29.23
u/l
1.43
1754
13655
306
1158
2.88
57.70
10.7
8.9
—
—
—
0
0
684
3757
2.15
56.88
3.4
2.4
—
1.00
—
0
6
721
4058
2.11
56.14
5.3
3.9
95.03
95.66
%
0.31
704
3953
266
956
3.00
54.97
5.6
5.3
5.23
5.08
kpa
2.55
257
918
422
1928
2.44
54.23
1.2
1.2
—
—
—
0
0
364
1554
2.58
54.05
2.9
2.3
33.18
34.14
u/l
0.13
307
1284
261
939
3.00
53.80
5.5
5.3
7.40
7.41
ph
3.02
216
777
884
5456
1.98
52.65
3.9
2.9
155.61
107.11
e6/l
0.19
655
3949
786
4706
2.00
50.68
3.7
2.8
0.32
0.26
e6/l
0.32
554
3264
197
633
3.30
49.09
4.5
4.5
129.59
131.12
g/l
0.48
191
622
360
1610
2.45
48.10
3.2
3.6
4.38
4.73
pmol/l
10.69
328
1470
98
192
5.28
47.57
2.7
1.8
—
—
—
0
0
442
2176
2.26
47.32
1.8
1.7
364.72
318.37
mu/l
1.09
382
1969
877
5556
1.91
47.12
7.5
5.5
—
—
—
0
0
88
158
5.74
46.95
3.4
1.9
285.74
288.28
mosm/kgh2o
0.56
70
125
470
2391
2.20
46.34
1.3
1.2
—
—
—
0
0
743
4480
1.95
46.11
3.4
2.4
25.54
49.63
ng/l
0.48
314
1698
856
5439
1.89
45.13
9.4
5.9
1.10
1.07
inr
1.16
723
4510
574
3198
2.04
44.38
3.2
2.5
508.60
548.51
mosm/kgh2o
3.05
501
2779
137
372
3.84
44.04
1.4
1.4
293.78
315.79
ug/g
0.49
67
182
1059
7269
1.82
43.04
4.9
3.4
84.36
73.45
e6/l
0.19
689
4404
426
2164
2.18
41.78
3.5
3.2
1142.02
646.16
ng/l
0.42
326
1682
165
530
3.27
41.03
4.8
4.4
0.60
0.64
%
0.92
165
530
493
2667
2.07
40.93
3.3
2.6
4.55
4.80
e6/l
0.17
217
1222
134
379
3.68
40.59
3.1
4.2
24.57
24.16
mmol/l
0.64
127
370
1886
15591
1.99
40.48
6.2
3.9
37.29
36.14
mmol/mol
4.48
1799
14944
258
1069
2.58
40.21
9.1
8.7
7.41
7.42
ph
0.91
130
571
256
1063
2.58
39.71
9.1
8.6
0.59
0.23
mmol/l
0.59
214
815
587
3431
1.94
38.89
4.9
3.7
—
—
—
0
0
229
912
2.67
38.63
9.5
9.4
95.88
96.32
%
0.37
221
875
301
1374
2.36
37.95
3.4
3.3
1.61
1.62
%
0.09
261
1249
252
1070
2.51
37.23
9.3
8.6
12.57
14.39
kpa
6.53
243
1026
252
1070
2.51
37.23
9.3
8.6
5.20
4.96
kpa
3.32
243
1022
307
1425
2.32
37.21
1.2
1.2
54.08
4.52
u/ml
—
6
15
248
1049
2.52
36.92
8.4
8.7
5.79
6.14
mmol/l
0.58
238
1011
231
945
2.60
36.87
4.4
4.1
74.62
63.92
ng/l
0.74
199
873
367
1855
2.15
36.07
2.9
3.1
5.53
6.23
umol/l
0.46
293
1551
681
4276
1.83
35.60
2.5
1.9
0.75
0.98
mg/l
1.98
468
3120
2275
20586
3.20
34.92
20.9
10.5
66.66
65.60
umol/l
0.98
2261
20304
599
3647
1.86
34.41
3.1
2.5
9.97
9.76
e6/l
0.09
540
3239
2282
20708
3.28
34.38
14.1
8.4
24.86
23.69
u/l
1.59
2240
20172
492
2815
1.94
34.21
3.2
2.5
1.00
1.23
e6/l
0.47
219
1382
181
680
2.80
34.10
5.8
6.0
—
—
—
0
0
397
2136
2.03
32.82
2.2
1.6
—
—
—
0
0
393
2111
2.03
32.62
2.2
1.8
—
—
—
0
0
1214
9129
1.67
32.29
3.9
3.0
6.36
6.28
ph
1.38
643
5092
292
1416
2.21
31.64
1.7
1.5
7.22
9.11
u/l
2.02
238
1136
216
935
2.44
30.45
3.9
3.1
1.22
1.23
mmol/l
0.81
184
797
2247
20424
2.68
29.91
18.1
10.1
18.00
20.01
mg/l
2.73
1810
16024
390
2150
1.97
29.88
1.6
1.4
13.70
17.62
iu/l
2.56
319
1784
76
178
4.37
29.81
1.9
1.6
0.91
1.35
promille
1.87
59
142
155
576
2.81
29.77
10.9
10.1
24.20
23.84
mmol/l
0.57
149
565
121
391
3.20
29.74
2.9
2.6
1.67
2.76
index
0.45
58
217
46
69
6.77
29.31
1.3
1.7
134.19
135.67
nmol/l
0.06
46
69
2042
17913
1.96
29.19
5.0
3.5
2.64
2.75
mmol/l
7.42
1944
17164
917
6548
1.65
28.84
2.0
1.7
1.32
1.25
mmol/l
1.64
788
5898
307
1577
2.08
28.55
1.3
1.2
21.43
184.50
titre
—
7
52
334
1773
2.03
28.40
1.6
1.3
—
—
—
0
0
863
6105
1.65
27.95
3.2
2.2
—
—
—
0
0
240
1136
2.24
27.46
5.1
3.0
7.37
7.34
ph
1.07
189
811
111
358
3.20
27.37
1.7
2.3
197.41
221.27
ug/l
0.11
94
318
200
877
2.40
27.34
1.8
1.6
0.25
0.51
nmol/l
7.88
160
735
368
2064
1.92
26.58
1.6
1.5
—
—
—
0
0
501
3102
1.78
26.33
4.2
3.9
49.16
68.81
mg/l
1.22
340
2176
88
251
3.60
26.32
3.1
2.9
29.70
32.44
umol/l
0.42
81
232
505
3148
1.76
25.88
5.1
4.5
8.87
12.10
mg/mmol
0.76
332
2176
1895
16419
1.74
25.86
3.9
2.9
1.22
1.13
mmol/l
3.56
1784
15723
426
2533
1.83
25.56
1.4
1.3
100.35
147.20
u/ml
1.42
130
952
2018
17835
1.84
25.36
4.6
3.4
4.50
4.63
mmol/l
9.68
1936
17167
747
5197
1.63
25.29
3.7
3.1
1.02
1.92
kg/l
1.08
470
3370
1699
14338
1.64
25.26
5.8
4.0
270.36
1335.93
e6/l
1.53
28
168
2006
17756
1.81
24.29
4.6
3.3
1.47
1.50
mmol/l
2.77
1908
17040
496
3128
1.74
24.22
1.5
1.4
465.14
561.64
titre
0.50
70
658
260
1353
2.03
23.16
1.2
1.2
—
—
—
0
0
373
2209
1.81
22.45
4.0
2.7
592.50
409.70
ng/l
0.18
156
1007
628
4304
1.62
22.05
2.0
1.7
—
—
—
0
0
581
3914
1.64
21.84
1.4
1.3
97.49
22.11
iu/ml
0.45
122
1045
540
3571
1.66
21.83
1.4
1.3
2.73
9.02
u/ml
6.96
189
1465
740
5288
1.58
21.74
5.6
4.1
—
—
—
0
0
295
1645
1.90
21.44
1.4
1.4
—
—
—
0
0
537
3563
1.65
21.37
2.8
2.3
7151.64
7595.90
u/l
0.10
186
1496
404
2490
1.75
21.13
2.3
2.0
—
—
—
0
0
2067
18656
1.80
20.84
25.5
12.6
13.32
13.20
%
5.17
2054
18400
192
941
2.13
20.01
2.9
3.0
69.79
70.19
e9/l
0.04
120
635
28
37
7.64
19.94
1.9
1.6
—
—
—
0
0
86
292
3.02
19.48
3.8
3.0
—
—
—
0
0
115
458
2.59
19.29
4.8
6.1
—
—
—
0
0
262
1466
1.88
18.75
5.1
5.0
0.61
0.79
%
0.38
66
365
254
1416
1.89
18.38
5.2
5.1
0.08
0.12
%
0.32
59
315
133
583
2.35
18.16
2.4
1.9
6.31
5.97
ug/l
0.06
110
511
341
2086
1.74
18.13
4.4
2.8
29.53
29.17
s
0.54
327
2019
164
786
2.16
18.08
1.1
1.1
—
—
—
0
0
249
1399
1.87
17.56
4.6
4.7
0.38
0.47
%
0.29
63
343
74
248
3.04
17.17
4.3
2.8
2.24
1.85
mmol/l
0.30
41
124
1382
11626
1.45
16.73
4.5
3.3
0.00
0.01
estimate
1.80
302
2430
123
541
2.34
16.67
2.2
2.1
—
—
—
0
0
1377
11582
1.44
16.64
4.5
3.3
4.77
4.16
estimate
0.04
305
2479
56
162
3.51
16.48
2.1
1.6
62.54
75.78
mmol/l
0.84
41
144
80
287
2.85
16.46
3.0
3.7
31.95
26.14
mu/l
0.44
72
269
266
1561
1.79
16.25
2.4
2.9
9.95
10.42
g/l
1.78
248
1465
1361
11467
1.43
16.00
4.5
3.3
0.00
0.00
estimate
0.27
305
2496
250
1456
1.80
15.65
5.6
5.3
0.00
0.06
%
1.91
53
304
215
1196
1.87
15.61
1.7
1.9
1.23
1.37
g/l
1.32
200
1127
499
3479
1.55
15.53
2.3
2.4
305.11
300.10
umol/l
0.59
440
3185
84
332
2.58
14.37
1.6
1.1
—
—
—
0
0
116
531
2.24
14.35
1.2
1.5
51.67
85.88
titre
3.01
12
68
186
1032
1.87
13.60
2.0
1.7
7.69
6.91
nmol/l
0.42
158
945
119
577
2.12
12.77
1.2
1.1
—
—
—
0
0
2262
21509
1.96
12.40
16.9
9.1
—
—
—
0
0
231
1414
1.70
12.09
2.3
2.3
18.03
16.09
au/ml
0.18
17
183
217
1309
1.72
11.98
1.2
1.2
—
—
—
0
0
129
676
1.96
11.22
1.8
1.6
378.02
374.25
mu/l
0.03
112
565
152
854
1.83
10.70
1.6
1.6
5.45
7.29
u/ml
0.47
24
257
392
2794
1.48
10.62
1.6
1.6
—
—
—
0
0
152
861
1.82
10.42
1.1
1.1
6.05
5.99
eliau/ml
0.01
24
132
154
877
1.81
10.38
3.3
2.9
20.14
20.70
s
1.02
124
748
46
158
2.95
10.34
1.1
1.1
120.09
118.03
pmol/l
0.10
46
158
212
1329
1.65
10.12
1.3
1.2
11.52
28.95
au/ml
—
5
63
414
5534
0.69
10.07
1.6
1.6
997.50
979.77
mu/l
0.17
349
4829
116
610
1.95
10.01
1.5
1.4
13.03
15.60
u/l
0.58
104
524
80
368
2.21
9.87
1.2
1.1
—
—
—
0
0
826
6760
1.34
9.83
3.2
2.6
0.15
0.05
0.28
13
78
96
479
2.04
9.62
1.4
1.8
388.04
8609.26
e6/l
0.53
82
378
95
473
2.05
9.57
1.3
1.8
13.47
21.03
e6/l
0.33
76
349
59
241
2.48
9.53
1.5
2.3
—
—
—
0
0
21
44
4.80
9.52
3.5
1.2
—
—
—
0
0
337
2380
1.48
9.51
3.6
2.8
5.23
4.64
e9/l
0.19
283
2154
128
713
1.84
9.29
1.3
2.4
65.59
67.85
g/l
2.83
117
680
98
504
1.98
9.05
2.0
2.3
1.17
1.21
g/l
0.17
85
447
185
1153
1.65
9.04
2.8
2.2
0.15
0.21
e6/l
0.51
178
1085
746
6084
1.33
8.90
4.6
3.3
0.00
0.00
estimate
2.12
299
2397
106
564
1.92
8.87
2.5
3.6
62.05
99.93
ng/l
1.61
87
491
28
80
3.53
8.51
2.9
3.2
—
—
—
0
0
93
482
1.97
8.42
1.3
2.0
—
—
—
0
0
43
164
2.65
8.03
1.6
1.3
0.24
0.29
nmol/l
0.13
29
115
814
6805
1.30
7.90
2.5
2.0
—
—
—
0
0
87
451
1.96
7.89
1.3
1.9
—
—
—
0
0
72
349
2.09
7.85
1.2
1.1
—
—
—
0
0
156
967
1.65
7.81
2.2
2.3
5.21
7.53
iu/ml
0.59
30
242
116
663
1.79
7.78
1.2
1.2
—
—
—
0
0
128
753
1.74
7.78
2.2
2.2
1.12
1.17
g/l
0.81
123
721
125
732
1.75
7.72
2.3
2.2
0.21
0.22
g/l
0.35
120
700
186
2773
0.64
7.70
1.2
1.2
—
—
—
0
0
161
1010
1.64
7.69
3.4
3.1
—
—
—
0
0
111
635
1.78
7.44
1.3
1.3
1.43
5.02
u/ml
—
6
62
99
548
1.84
7.39
1.3
1.3
—
—
—
0
0
122
719
1.73
7.38
1.4
1.4
183.52
230.94
u/ml
1.65
71
428
110
630
1.78
7.34
1.3
1.3
13.82
12.55
u/ml
0.06
11
88
238
1651
1.49
7.30
1.4
1.3
—
—
—
0
0
104
590
1.80
7.17
7.7
8.6
1.19
1.14
mg/l
0.24
94
558
128
772
1.69
7.13
1.8
2.4
2.11
3.62
iu/l
4.62
56
373
25
75
3.36
7.09
1.2
1.3
135.40
158.08
mmol/24h
0.77
25
75
147
923
1.63
7.02
1.2
1.3
0.22
0.74
u/ml
—
6
49
54
245
2.23
6.98
3.5
3.2
6.68
6.20
pmol/l
0.17
54
245
232
1619
1.48
6.91
4.0
3.0
34.13
33.08
%
0.63
176
1271
19
48
3.98
6.88
1.6
3.5
7.86
7.58
mmol/l
0.08
19
48
68
340
2.03
6.87
5.0
6.9
1.24
1.20
mmol/l
0.15
63
288
48
209
2.32
6.84
1.3
1.2
—
—
—
0
0
68
343
2.01
6.71
4.1
2.7
1.02
0.79
nmol/l
0.66
57
298
149
953
1.60
6.61
1.4
1.3
—
—
—
0
0
17
42
4.07
6.34
2.8
3.3
1.01
0.82
nmol/l
—
10
34
49
225
2.20
6.19
1.3
1.2
—
—
—
0
0
847
7279
1.25
6.19
2.0
1.9
—
—
—
0
0
31
115
2.72
6.17
1.3
1.9
1.64
3.64
nmol/l
0.53
21
91
45
201
2.26
6.08
1.9
2.1
—
—
—
0
0
87
493
1.79
6.07
1.1
1.1
3.97
2.97
eliau/ml
0.31
41
232
51
244
2.11
5.84
1.9
2.0
5.05
4.82
mmol/24h
0.18
46
225
1180
10560
1.23
5.82
2.8
2.3
—
—
—
0
0
256
1886
1.40
5.70
1.4
1.3
553.95
236.23
u/ml
0.47
236
1749
10
11
9.12
5.28
1.8
1.5
524.12
576.93
nmol/l
—
10
11
788
6815
1.23
5.23
3.8
2.7
0.23
0.02
estimate
0.55
256
2073
30
121
2.50
5.11
3.9
3.1
14.88
14.27
index
0.11
16
84
70
393
1.80
5.09
1.2
1.2
—
—
—
0
0
21
70
3.02
5.09
7.5
4.9
64.20
82.81
mg/l
0.61
15
58
40
184
2.19
5.09
4.2
3.4
1.20
1.02
%
0.20
35
166
981
8695
1.22
5.08
4.3
3.1
0.01
0.02
estimate
1.03
241
2069
37
165
2.26
5.07
3.3
1.9
24.30
30.02
mg/l
0.42
23
109
72
411
1.77
4.97
1.4
1.4
—
8.20
—
0
7
101
633
1.62
4.95
1.6
1.5
—
—
—
0
0
9
10
9.02
4.78
2.2
1.6
397.20
367.40
ug/l
—
9
10
11
17
6.49
4.77
5.9
3.4
—
—
—
0
0
97
608
1.62
4.76
1.6
1.5
131.92
137.12
au/ml
0.15
25
156
18
57
3.17
4.75
1.3
1.2
—
—
—
0
0
60
329
1.84
4.73
2.6
1.9
3.75
2.50
ug/l
0.30
54
297
44
217
2.05
4.72
2.7
1.6
80.17
109.21
mu/l
0.22
37
199
45
225
2.02
4.65
1.2
1.4
77.27
73.53
%
1.67
40
215
21
74
2.85
4.65
2.2
2.6
1.33
1.61
nmol/l
0.44
16
60
254
1934
1.35
4.63
1.5
1.4
—
—
—
0
0
2332
22875
1.79
4.58
32.5
15.8
270.43
266.48
e9/l
2.52
2310
22457
2332
22881
1.78
4.48
32.3
15.7
89.59
89.25
fl
3.24
2322
22715
37
175
2.13
4.44
1.1
1.1
—
—
—
0
0
2332
22885
1.77
4.42
32.3
15.7
29.79
29.80
pg
0.09
2322
22719
2332
22886
1.77
4.41
33.1
16.0
39.70
40.22
%
1.17
2322
22710
36
169
2.15
4.40
1.1
1.3
—
353.75
—
0
8
2332
22887
1.77
4.39
32.4
15.7
4.47
4.50
e12/l
2.84
2301
22439
26
106
2.47
4.37
1.2
1.7
0.68
0.83
%
—
9
53
17
55
3.10
4.35
2.0
2.3
108.88
87.60
ug/l
0.42
17
55
45
232
1.96
4.30
3.3
2.9
1.28
1.34
mmol/l
0.32
45
225
2332
22897
1.75
4.24
32.5
15.8
6.67
6.87
e9/l
5.39
2303
22428
2332
22899
1.75
4.21
32.8
15.9
131.92
133.22
g/l
6.93
2321
22734
155
2129
0.71
4.17
1.6
1.6
70.63
59.62
ug/l
1.57
155
2129
254
1971
1.32
4.08
4.4
3.1
—
—
—
0
0
62
361
1.74
4.06
3.0
2.4
134.05
130.91
g/l
0.78
56
311
62
362
1.73
4.02
1.5
1.7
0.74
0.66
g/l
0.34
47
280
252
3188
0.77
3.92
1.6
1.6
3.08
3.22
ratio
1.00
163
2198
42
219
1.93
3.91
1.2
1.4
516.85
548.39
mu/l
0.08
37
209
73
452
1.63
3.83
1.3
1.3
5.13
3.93
u/ml
0.31
38
207
39
201
1.95
3.77
1.5
1.4
463.86
474.27
pmol/l
0.04
28
180
236
1839
1.31
3.69
2.4
1.8
0.00
0.06
estimate
2.90
63
472
241
3029
0.77
3.56
1.6
1.6
66.14
61.51
ug/l
0.68
198
2598
10
21
4.77
3.55
3.3
2.1
—
—
—
0
0
14
46
3.05
3.52
2.0
2.2
198.05
107.99
ng/l
0.29
14
46
41
224
1.84
3.36
1.3
1.3
—
—
—
0
0
23
102
2.27
3.28
1.2
1.7
—
—
—
0
0
227
2834
0.78
3.19
1.5
1.5
1.20
1.14
ratio
0.35
130
1707
23
104
2.22
3.15
1.6
1.3
61.00
70.23
umol/l
1.10
23
104
1119
10325
1.16
3.09
3.0
2.8
—
—
estimate
—
0
0
18
75
2.41
2.96
1.0
1.1
4.43
5.02
u/ml
0.04
13
60
100
714
1.42
2.79
1.2
1.1
—
—
—
0
0
158
1216
1.32
2.76
1.1
1.1
—
—
—
0
0
14
54
2.60
2.70
1.0
1.1
—
—
—
0
0
206
2546
0.79
2.67
1.4
1.4
3.10
3.27
mmol/l
1.45
125
1587
24
119
2.03
2.65
1.3
1.0
421.87
391.21
nmol/l
0.35
24
112
27
140
1.94
2.64
1.0
1.1
—
—
—
0
0
41
243
1.70
2.63
4.1
4.4
30.98
109.08
u/ml
0.90
13
86
19
87
2.19
2.56
1.8
2.8
10.21
53.65
mg/l
1.70
11
66
126
952
1.34
2.52
2.5
1.8
0.02
0.04
estimate
0.61
58
392
25
129
1.95
2.49
1.0
1.2
2.65
17.42
u/ml
0.95
15
89
96
699
1.39
2.43
1.9
1.9
—
—
—
0
0
20
96
2.09
2.42
2.4
2.3
104.60
105.98
mmol/l
0.48
20
96
20
96
2.09
2.42
2.4
2.3
3.75
3.95
mmol/l
0.89
20
96
38
228
1.68
2.36
2.1
2.6
83.18
80.71
ug/min
0.02
21
153
39
236
1.66
2.35
1.1
1.0
—
—
—
0
0
11
39
2.83
2.34
1.3
3.0
0.64
0.61
mmol/l
0.68
11
39
28
154
1.83
2.33
1.1
1.1
2.97
19.14
u/ml
0.65
23
105
22
112
1.97
2.30
1.1
1.3
0.03
3.02
u/ml
1.93
22
112
12
47
2.56
2.26
1.8
1.4
—
—
—
0
0
45
287
1.58
2.22
3.2
3.1
—
—
—
0
0
11
41
2.69
2.20
2.2
3.7
16.17
16.56
%
0.11
11
41
64
444
1.45
2.15
1.8
2.1
11.00
9.97
mg/l
0.68
59
427
31
182
1.71
2.11
1.2
1.3
—
—
—
0
0
5
10
5.00
2.07
1.8
1.4
—
—
—
0
0
10
37
2.71
2.06
1.0
1.2
—
—
—
0
0
6
15
4.00
2.03
2.7
2.3
223.33
221.22
mmol/l
—
6
15
41
262
1.57
2.03
2.0
1.8
23325.56
9041.99
e6/l
0.63
27
196
12
50
2.41
2.02
2.3
2.7
20.71
31.01
umol/l
—
7
40
36
224
1.62
1.99
1.4
1.5
—
—
—
0
0
51
345
1.49
1.97
2.5
3.9
4.22
4.00
e9/l
0.25
51
345
26
149
1.75
1.94
1.5
1.2
—
—
—
0
0
6
16
3.75
1.93
1.7
1.1
—
—
—
0
0
11
46
2.40
1.85
1.2
1.6
—
—
—
0
0
10
223
0.45
1.84
1.1
1.3
61.00
68.68
ug/l
—
10
223
17
86
1.98
1.84
1.5
1.5
80.82
85.33
nmol/24h
0.11
17
86
44
294
1.50
1.82
1.2
1.3
—
50.21
—
0
18
36
230
1.57
1.81
1.3
1.4
6.40
6.18
g/l
0.23
22
163
211
1775
1.21
1.81
2.5
2.2
6.27
6.26
ph
0.05
129
1142
143
1155
1.25
1.80
2.3
2.6
7.51
5.42
umol/l
0.35
102
872
82
616
1.34
1.79
3.2
4.5
200.14
378.69
mg/l
1.15
43
305
12
54
2.23
1.73
6.8
3.7
—
—
—
0
0
29
178
1.64
1.72
2.1
2.6
635.55
492.58
e6/l
1.18
22
134
8
30
2.67
1.72
6.3
8.4
1.80
2.59
mg/l
—
8
24
5
13
3.85
1.71
1.4
1.1
—
—
—
0
0
196
2314
0.83
1.70
1.5
1.5
—
—
—
0
0
26
157
1.66
1.65
1.8
3.1
1.32
1.84
ratio
0.65
14
89
7
25
2.80
1.65
1.1
1.4
55.43
63.72
ug/l
—
7
25
929
8720
1.11
1.62
2.1
1.9
—
—
—
0
0
35
229
1.53
1.62
1.3
1.4
2.97
2.85
g/l
0.17
23
161
35
229
1.53
1.62
1.3
1.4
0.33
0.37
g/l
0.36
23
160
5
14
3.57
1.61
2.4
3.0
28.60
29.35
umol/l
—
5
14
191
2247
0.84
1.60
1.5
1.5
1.27
1.25
mm
0.19
133
1670
16
84
1.91
1.59
3.8
3.6
0.69
0.71
index
0.03
16
84
5
15
3.34
1.52
2.4
2.7
37.60
37.45
umol/l
—
5
15
202
2350
0.85
1.50
1.6
1.6
—
—
—
0
0
64
478
1.35
1.49
2.3
3.5
56.97
57.35
%
0.08
64
478
31
202
1.54
1.48
1.6
1.5
—
—
—
0
0
17
94
1.81
1.47
2.6
2.3
1.21
1.20
mmol/l
0.30
17
94
17
292
0.58
1.46
2.8
3.2
—
—
—
0
0
7
28
2.50
1.45
1.0
1.6
—
—
—
0
0
5
16
3.13
1.43
2.2
1.8
—
—
—
0
0
10
46
2.18
1.39
1.3
1.4
—
—
—
0
0
32
214
1.50
1.37
1.3
1.2
0.64
0.68
ratio
0.18
22
124
47
339
1.39
1.37
2.3
2.2
—
—
—
0
0
6
23
2.61
1.36
1.2
2.0
39.10
45.15
g/l
—
6
23
34
231
1.48
1.36
1.3
1.2
—
—
—
0
0
11
54
2.04
1.32
1.1
1.1
—
—
—
0
0
37
259
1.43
1.29
1.2
1.1
25.22
36.59
mg/l
2.71
31
213
11
55
2.00
1.27
1.2
1.5
—
—
—
0
0
14
77
1.82
1.25
1.3
1.1
—
—
—
0
0
36
501
0.71
1.21
1.3
1.3
—
—
—
0
0
5
19
2.63
1.21
6.4
6.7
4.46
5.58
kpa
—
5
19
28
188
1.49
1.21
2.1
2.7
202.82
202.26
e6/l
0.00
22
149
50
375
1.34
1.18
1.6
1.5
0.49
0.50
e9/l
0.09
50
375
20
125
1.60
1.17
2.4
2.1
0.33
0.24
e9/l
0.47
14
65
10
50
2.00
1.16
1.0
1.0
—
—
—
0
0
15
87
1.73
1.14
63.7
42.8
7.97
6.88
ug/l
1.60
15
75
105
872
1.21
1.12
3.1
2.6
1.02
1.02
ratio
0.10
88
758
31
217
1.43
1.11
2.1
2.7
1721.92
1333.99
e6/l
1.46
25
176
10
51
1.96
1.11
1.1
1.1
—
—
—
0
0
94
780
1.21
1.03
1.1
1.1
3.34
5.62
u/ml
0.98
50
432
7
34
2.06
1.02
1.1
3.6
—
10.32
—
0
13
25
171
1.47
1.02
1.0
1.0
12.77
15.33
u/ml
0.17
14
114
5
23
2.17
0.98
1.0
1.1
—
—
—
0
0
86
712
1.21
0.97
1.1
1.1
7.02
9.17
u/ml
0.29
41
363
7
36
1.95
0.97
1.1
1.2
—
—
—
0
0
18
116
1.55
0.96
2.8
2.7
2.88
1.73
g/24h
—
9
73
55
435
1.27
0.94
11.9
6.7
—
—
—
0
0
53
419
1.27
0.91
1.3
1.1
231.45
3482.64
iu/ml
0.70
11
114
29
394
0.73
0.90
1.2
1.3
367.11
592.77
pmol/l
—
7
44
29
210
1.38
0.90
1.1
1.2
1.06
1.05
ratio
0.15
23
177
12
72
1.67
0.85
1.5
2.1
1980.00
1906.07
ml
—
7
67
6
31
1.94
0.84
1.3
1.1
0.03
0.02
u/ml
—
6
31
18
121
1.49
0.82
2.3
4.6
—
—
—
0
0
6
32
1.88
0.81
1.2
1.0
—
—
—
0
0
8
48
1.67
0.78
1.1
1.0
—
—
—
0
0
8
48
1.67
0.78
1.1
1.0
—
—
—
0
0
211
1912
1.11
0.76
1.3
1.3
223.95
233.17
miu/ml
0.13
94
993
6
34
1.77
0.76
1.2
1.1
1.13
0.39
u/ml
—
6
20
10
59
1.70
0.75
1.1
1.1
—
—
—
0
0
18
124
1.45
0.74
2.2
2.2
—
—
—
0
0
5
24
2.08
0.74
1.2
1.0
96.00
102.67
titre
—
5
24
52
425
1.23
0.71
1.1
1.1
—
—
—
0
0
25
185
1.35
0.71
2.2
2.3
68.00
72.99
%
0.48
25
179
15
217
0.69
0.70
2.5
3.9
20.67
24.82
u/ml
0.28
15
212
241
2212
1.10
0.70
1.3
1.2
—
—
—
0
0
5
27
1.85
0.68
1.0
1.2
—
22.00
—
0
5
18
245
0.73
0.62
2.0
1.9
—
—
—
0
0
10
63
1.59
0.61
1.5
1.5
—
—
—
0
0
13
88
1.48
0.60
2.5
3.2
—
—
—
0
0
136
1224
1.12
0.59
1.8
2.4
22.32
42.95
u/ml
1.35
129
1186
16
114
1.41
0.58
2.2
2.2
—
—
—
0
0
8
53
1.51
0.58
1.3
1.8
—
—
—
0
0
32
256
1.25
0.56
1.4
1.3
533.33
1071.79
titre
—
6
39
11
73
1.51
0.56
1.7
1.6
—
—
—
0
0
805
8312
0.95
0.55
2.6
2.2
—
—
—
0
0
21
159
1.32
0.55
1.1
1.1
—
—
—
0
0
67
579
1.16
0.55
1.2
1.1
2.73
15.69
au/ml
—
9
149
102
910
1.13
0.53
1.1
1.1
1.80
2.62
u/ml
0.43
58
518
73
639
1.15
0.51
1.1
1.1
0.23
0.25
u/ml
0.06
35
209
35
287
1.22
0.51
1.3
1.3
—
—
—
0
0
10
67
1.49
0.49
1.3
1.3
165.32
126.44
pmol/l
—
10
67
14
101
1.39
0.49
1.4
1.5
0.00
0.00
estimate
-0.00
14
101
7
46
1.52
0.48
1.0
1.5
8.57
9.19
mmol/l
—
7
46
106
956
1.11
0.48
1.7
1.7
—
—
—
0
0
47
545
0.86
0.45
1.4
1.5
34.02
37.44
nmol/l
0.25
41
511
866
8424
1.04
0.44
2.1
1.9
—
—
—
0
0
97
877
1.11
0.43
1.2
1.1
0.92
1.56
u/ml
0.79
53
442
11
79
1.39
0.40
1.3
1.2
27.82
28.42
s
0.33
11
79
15
114
1.32
0.40
1.6
1.7
—
—
—
0
0
25
204
1.23
0.40
1.1
1.3
3.49
2.75
u/ml
0.14
18
103
12
159
0.75
0.38
1.2
1.2
8.00
8.74
mm/h
0.13
12
159
11
80
1.38
0.38
1.0
1.3
—
—
—
0
0
5
36
1.39
0.38
1.2
1.6
—
—
—
0
0
17
213
0.80
0.37
1.1
1.1
1996.64
1477.12
miu/ml
0.85
17
213
113
1041
1.09
0.36
1.2
1.1
1.89
2.85
u/ml
0.61
64
594
11
146
0.75
0.36
1.1
1.1
—
—
—
0
0
22
266
0.82
0.35
1.0
1.1
10.52
12.64
u/ml
—
9
110
49
432
1.14
0.35
1.4
1.2
—
—
—
0
0
10
133
0.75
0.33
1.3
1.2
—
—
—
0
0
333
3464
0.95
0.33
2.3
2.2
—
—
—
0
0
28
237
1.18
0.33
1.2
1.2
—
—
—
0
0
6
88
0.68
0.33
1.5
1.8
—
2737.14
—
0
14
35
305
1.15
0.30
1.1
1.1
1.48
4.18
u/ml
1.06
18
130
8
63
1.27
0.27
1.0
1.2
—
4.50
iu/ml
—
0
6
14
113
1.24
0.26
1.3
2.8
20.16
264.85
ug/l
0.72
14
104
13
105
1.24
0.24
1.2
1.5
—
—
—
0
0
28
245
1.14
0.24
1.2
1.1
7.61
5.56
iu/ml
—
7
65
20
232
0.86
0.23
1.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
5.59
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
68
633
1.08
0.21
1.3
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.3
—
6.18
—
0
13
98
926
1.06
0.20
1.2
1.1
3.60
6.72
u/ml
1.05
53
561
6
49
1.22
0.20
1.0
1.0
17.83
6.30
u/ml
—
6
49
96
908
1.06
0.19
3.8
3.9
1.26
2.03
ug/l
1.20
80
809
42
385
1.09
0.19
3.2
2.8
21.15
24.54
mg/l
0.24
22
259
5
66
0.76
0.17
1.8
2.5
35.40
27.97
%
—
5
66
6
76
0.79
0.15
1.0
1.1
—
58.41
—
0
17
14
121
1.16
0.15
1.6
1.3
—
—
—
0
0
9
83
1.08
0.14
1.3
1.1
35.66
29.98
iu/ml
—
9
83
923
9313
0.98
0.13
1.8
1.9
—
—
—
0
0
106
1101
0.96
0.13
1.5
1.4
—
—
—
0
0
56
529
1.06
0.13
2.3
2.6
0.49
0.69
ug/l
2.12
30
283
152
1566
0.97
0.13
1.5
1.6
—
—
—
0
0
5
47
1.06
0.09
3.2
1.8
—
4.69
%
—
0
13
5
48
1.04
0.09
1.8
2.0
—
—
—
0
0
6
54
1.11
0.09
1.2
2.4
—
—
—
0
0
81
787
1.03
0.07
2.5
4.1
70.98
68.14
ug/l
0.01
58
549
9
87
1.03
0.07
25.8
35.0
204.33
141.42
ug/l
—
9
76
12
109
1.10
0.06
1.1
1.1
—
—
—
0
0
66
643
1.03
0.05
1.2
1.1
—
—
—
0
0
66
644
1.02
0.04
1.2
1.1
—
—
—
0
0
29
302
0.96
0.04
1.1
1.1
0.38
3.62
u/ml
1.38
15
97
12
111
1.08
0.04
1.2
1.1
—
—
—
0
0
22
210
1.05
0.03
2.9
2.0
3.58
1.47
u/ml
—
7
73
29
280
1.04
0.03
1.0
1.1
0.57
1.59
u/ml
0.54
13
90
25
255
0.98
0.00
1.5
1.6
—
—
—
0
0
25
255
0.98
0.00
1.5
1.6
—
—
—
0
0
25
255
0.98
0.00
1.5
1.6
—
—
—
0
0
25
255
0.98
0.00
1.5
1.6
—
—
—
0
0
45
452
0.99
0.00
1.4
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
2.4
—
39.56
—
0
9
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
0.36
—
0
5
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
28.06
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.4
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint F5_EATOTH and mortality.

Females

Parameter HR [95% CI] p-value
F5_EATOTH 2.97 [2.39, 3.69] < 0.001
Birth year 0.998 [0.99, 1.01] 0.568

During the follow-up period (1.1.1998 — 31.12.2019), 554 out of 14118 females with F5_EATOTH died.

Males

Parameter HR [95% CI] p-value
F5_EATOTH 3.202 [2.4, 4.27] < 0.001
Birth year 0.989 [0.98, 1.0] 0.024

During the follow-up period (1.1.1998 — 31.12.2019), 336 out of 2302 males with F5_EATOTH died.

Mortality risk

Mortality risk for people of age

years, who have F5_EATOTH.

N-year risk Females Males
1 0.372% 0.71%
5 2.025% 4.507%
10 4.697% 10.503%
15 9.267% 18.197%
20 15.444% 29.237%

Relationships between endpoints

↥

Index endpoint: F5_EATOTH – Other eating disorders

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data